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ABSTRACT 
 
Ageing and age-related diseases are multidimensional processes characterised by the 
accumulation of damaged mitochondria and a reduced capacity to respond to stress. While 
mitochondria play a central role in cellular signalling and stress adaptation, how damaged 
mitochondria accumulate and whether this affects healthy lifespan and onset of age-related 
diseases is unclear. In the following chapters, I demonstrate how mitochondrial turnover is 
involved in the process of stress adaptation, mediated by mitochondrial reactive oxygen species 
(mtROS), using the power of Drosophila genetics. 
 
I focus on the role of mitochondria, specifically on how Reactive oxygen species (ROS) are 
involved in the process of temperature adaptation. Additionally, I establish that ROS acts as a 
signalling molecule in communicating with different downstream processes. Combining 
different approaches to measure ROS, I have dissected the nature of this signal.  
 
I show that an increase in mtROS associated with thermal stress is produced as a consequence of 
over-reduction of the electron transport chain and identify the molecular intermediate as H2O2. 
Moreover, I study in detail the downstream targets and demonstrate that the levels of mtROS 
regulate levels of Pink1. Furthermore, I provide evidence that mitochondrial H2O2 (mtH2O2) act 
as a mitochondrial signal to activate mitophagy, and to repress Target of rapamycin (TOR). 
When this signal is supressed, mitochondrial respiration is markedly diminished, canonical 
Pink1-Parkin mediated mitophagy is obstructed and TOR signalling is hyper-activated. This in 
turn causes the accumulation of damaged proteins and organelles and a drastic reduction in fly 
lifespan. I show that restoring mitophagy in a low mtH2O2 background restores mitochondrial 
respiration, TOR signalling and rescues lifespan. 
 
In the following chapters, I describe in detail a novel mitochondrial H2O2-Pink1/Parkin-TOR 
signalling axis that regulates cellular quality control and how it can be modulated by 
pharmacological and genetic interventions. My results also reveal the existence of a novel ROS 
signalling pathway that regulates mitochondrial density, which in turn determines the activation 
of TOR signalling and lifespan.  
 
 
  
ii 
In summary, I show that (1) mtH2O2 is instrumental for the process of canonical Pink1-Parkin 
mediated mitophagy; (2) mtH2O2 production can be precisely regulated in vivo; (3) 
Mitochondrial turnover determines the activation of TOR signalling; and (4) Mitochondrial 
turnover is important in maintaining homeostasis of an organism. 
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Chapter 1. Introduction 
 
 
1.1 An overview of mitochondria 
 
Mitochondria are distinctive organelles found in the cytoplasm of nearly all eukaryotic cells. 
They are thought to have originated from an ancient symbiosis event that occurred when a 
nucleated cell engulfed a Rickettsia- like ancestor prokaryote (Emelyanov, 2001). As a result 
of this event, the host and the endosymbiont gradually co-evolved becoming dependent on 
one another. Conversely, the host cell relied on the engulfed prokaryote to live in a nutrient-
rich environment free from predators. Over time, the engulfed prokaryote developed into the 
mitochondria and energy produced due to endosymbiosis became critical to eukaryotic 
evolution (Roger, 1999). Mitochondria have their own circular DNA (mtDNA), consisting of 
37 genes, which encode 13 polypeptides and are exclusively used in the electron transport 
chain (ETC) for generating adenosine triphosphate (ATP) (Lightowlers et al., 2015). The 
remaining genes encode for tRNAs and rRNAs (Wallace, 1999). The number of mitochondria 
per cell varies between cell-types and species. For example, in mammals, red blood cells have 
none while more metabolically active cell-types, such as skeletal muscle, can have thousands 
(Zhang et al., 2011). 
 
Mitochondria are double-membrane organelles consisting of an outer membrane surrounding 
an inner membrane. The space between the two membranes is termed as the intermembrane 
space. The inner membrane has a greater surface area and hence folds back on itself, creating 
compartments known as cristae that protrudes into the innermost space termed the 
mitochondrial matrix (Palade, 1952). Figure 1.1 shows the mitochondrial structure. The 
respiratory chain complexes are concentrated in the cristae membranes. The matrix mainly 
consists of the mtDNA and its protein scaffold, collectively known as the nucleoid. mtDNA is 
typically held in concatenated rings with a single mitochondrion containing 2-5 copies of its 
genome (Pohjoismaki et al., 2009). Within the matrix are also present the nuclear-encoded 
ribosomes that translate the 13 mitochondrial transcripts into proteins. The matrix also 
contains enzymes that are responsible for the tricarboxylic acid cycle (TCAC) reactions that 
act as entry of electrons into the inner membrane, where they are transferred from one protein 
complex to another (Balaban, 1990). The inner mitochondrial membrane is the site of ETC, 
which contains protein Complexes I-V. Protons build up in the spaces between the inner and 
outer membrane creating a proton gradient for ATP synthesis. The inner membrane is largely 
impermeable to all molecules except those ferried through a pore such as the TIM (translocase 
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of the inner membrane) complex. Alternatively, there are also other pores like Porins or 
Calcium uniporters that help in the exchange of a large array of molecules through passive 
diffusion or membrane potential respectively. Shuttles for ADP, ATP, Aspartate and Malate 
have also been described (Klingenberg, 2008). The intermembrane space is a key component 
in the process of mitochondrial oxidative phosphorylation (Campbell, 2002). Protons 
translocated from the matrix by Complex I, Complex III and Complex IV into the 
intermembrane space generate an electro-chemical gradient across the inner membrane 
providing energy that is used by Complex V to synthesize ATP from adenosine diphosphate 
(ADP) and inorganic phosphate (Pi) (Cooper, 2000). The mitochondrial inner membrane also 
contains various proteases such as HTRA2/OMI (Kang et al., 2013) and the iAAA proteases 
involved in mitochondrial quality control. The outer membrane acts as a gateway to the 
mitochondrion, containing a series of channel proteins called PORINS that allow the free 
movement of small proteins and ions into the intermembrane space (Alberts, 2002). The outer 
membrane also contains complex protein channels called TOM (translocase of the outer 
membrane), and the TOM/TIM complex allows only nascent mitochondrial proteins to 
permeate through the membrane (Pfanner and Geissler, 2001). This process is carried out by a 
mitochondrial isoform of heat shock protein 70 (HSP70)  in an ATP-dependent fashion 
whereupon they are folded and processed by other mitochondrial HSPs and proteases (Kang 
et al., 1990).  
 
Mitochondria are integral to many cellular functions, including maintaining energy 
homeostasis, synthesis of iron-sulphur clusters (ISC) and heme cofactors, storage and 
regulation of calcium, thermogenesis, initiating apoptosis and numerous other roles in 
signalling processes that vary depending on tissue type (Lackner and Nunnari, 2009). Hence 
dysfunctional mitochondria are implicated in many diseases. Inherited mitochondrial diseases 
typically result in progressive, thus far incurable neuropathies and myopathies (tissues most 
dependent on mitochondrial function). However, many sporadic and age-related diseases are 
also thought to have a mitochondrial component (Lane et al., 2015). 
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Figure 1.1 Mitochondrial structure   
Different parts of the mitochondria are denoted with different colours in the figure. 
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1.2 The Electron Transport Chain (ETC) 
 
ETC is the key component of mitochondria and is absolutely essential to maintain metabolism 
through the synthesis of ATP and the assembly of iron-sulphur clusters (Karp, 2008). 
Oxidative phosphorylation (OXPHOS) is considered to be the most efficient way of 
generating energy in aerobic cells and its malfunction can cause severe damage to the cell. 
Alternatively, glycolysis is used to produce energy albeit in a less efficient way, considering 
the amount of ATP generated per molecule of glucose oxidized to form pyruvate and the 
amount of waste produced. 
 
Oxidative phosphorylation takes place as a step-wise process which requires five multiprotein 
enzyme complexes (Complex I, II, III, IV and V). All these components are embedded in the 
cristae of the mitochondria, where the two electron carriers, cytochrome c and coenzyme Q 
co-exist. The initiation of ETC takes place by transferring the electrons to carrier molecules 
NADH (Nicotinamide adenine dinucleotide) and FADH2 (Flavin adenine dinucleotide). 
Electrons are also contributed to the ETC by glycerol-3-phosphate dehydrogenase, by 
transferring two electrons from FADH2 to the ETC. There are also few other proteins like 
flavoproteins (Flavoprotein Fp1 and Flavoprotein Fp2) that can transfer electrons as well. 
Overall, these electron carriers are produced by the Krebs’ cycle inside the mitochondrion, the 
only exception being glycerol 3 phosphate dehydrogenase (G3PDH). The transfer of electrons 
generates a proton motive force (Dimroth et al., 2000) which consequentially generates the 
energy used for oxidative phosphorylation. The electrons are transferred in a stepwise 
manner, from the FMNH2 (Flavin mononucleotide, reduced) through the iron-sulphur clusters 
of Complex I to the ubiquinone pool, in a two-step transfer process (Mitchell, 1979). In this 
process, 4 protons are translocated from the mitochondrial matrix to the intermembrane space 
(Hirst, 2005). Ubiquinol is oxidized by Complex III (cytochrome bc1 complex), where 
another proton translocation event occurs (Trumpower, 1990). Four protons are pumped in 
this process by Complex III to the intermembrane space (Schultz and Chan, 2001). Complex 
III transfers two electrons to the other mobile electron carrier of the ETC, cytochrome c 
(Hunte et al., 2003). Complex IV, also known as cytochrome c oxidase, re-oxidizes 
cytochrome c and translocates four protons across the inner membrane. It then transfers four 
electrons and two protons to oxygen, which is the terminal electron acceptor (Yoshikawa et 
al., 2006).  
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Complex II (succinate dehydrogenase) is involved in a different pathway to the one followed 
by NADH. The stepwise electron transfer is similar, but unlike the NADH pathway there is no 
proton translocation by the succinate dehydrogenase (SDH). Complex II also transfers 
electrons to ubiquinone thereby reducing the ubiquinone pool (Cecchini, 2003). In this 
process, an electrochemical gradient resulting in a potential of 150-180 mV is produced which 
is known as the proton motive force. It is generated as a result of accumulation of protons in 
the inter-membrane space and is used to produce ATP when protons diffuse back into the 
matrix through Complex V (also known as ATP synthase). The electrochemical gradient 
drives the formation of ATP from ADP and free phosphate (Pi) at Complex V (Boyer, 1997).  
Figure 1.2 illustrates the function of different complexes in the ETC and complete working of 
the OXPHOS (Oxidative Phosphorylation) system. 
 
In this process, electrons can escape from Complexes I, II or III and reduce oxygen to 
superoxide (or other types of ROS) (Porter and Brand, 1995; Finkel and Holbrook, 2000). 
This can result in oxidative stress which is thought to be responsible for the decline in 
mitochondrial function associated with ageing (Rattan, 2006; Valko et al., 2007). However, 
there is no electron leak at Complex IV, where always four electrons (and two protons) are 
used to reduce oxygen to water.  
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Figure 1.2 Production of adenosine triphosphate by the flow of electrons through different 
multiprotein complexes located in the inner mitochondrial membrane 
The multiprotein complexes are connected to each other by the electron carrier’s cytochrome c and 
coenzyme Q. This figure also points out the most important sites of ROS production. 
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1.3 Mitochondrial biogenesis 
 
Over the years, it has been proved that physical activity increases the amount of mitochondria 
in order to compensate for the energy expenditure during exercise (Melanson et al., 2009). 
However, the molecular mechanisms of this process are being elucidated only very recently. 
Mitochondrial biogenesis is also considered as a major tool that is responsible for maintaining 
mitochondrial number within the cell. It is not only a change in number of mitochondria but it 
is also responsible for maintaining mitochondrial size and mass (Dominy and Puigserver, 
2013). Mitochondria have a bacterial origin and hence have its own genome and can auto 
replicate. The mitochondrial genome is very small and encodes only a few very important 
proteins and their function is mainly supported by proteins that are encoded in the nucleus. 
Proteins that are made in the nucleus are recognised by mitochondria through a mitochondrial 
targeting sequence in the protein itself (Alberts, 2002). This targeting sequence is detected by 
the translocases of inner and outer mitochondrial membrane (TIM and/or TOM) (Neupert and 
Herrmann, 2007) and the strict regulation of protein translocation has been shown to play a 
vital role in mitochondrial biogenesis. Moreover, mitochondrial biogenesis is a process where 
mitochondria are formed de novo from pre-existing mitochondria, hence stringent conditions 
are absolutely essential. This important regulation of mitochondria is the reason behind 
changes in activity of the mitochondria in different tissues and increase in their number with 
respect to ATP requirement (Jornayvaz and Shulman, 2010). 
 
In recent years, studies in many model organism has made it evident that Peroxisome 
Proliferator activated receptor co-activator 1  or PGC1α is the factor responsible for control 
of mitochondrial biogenesis (Fernandez-Marcos and Auwerx, 2011) (Lin et al., 2002). Also, 
activation of PGC1α in turn increases the activation of Nuclear respiratory factor (NRF1 
and/or 2) (Wu et al., 1999). NRF2 is responsible for the transcription of many mitochondrial 
genes. It activates mitochondrial transcription factor A or TFAM which is responsible for 
increase in mtDNA content. This signalling cascade was described in several model 
organisms by utilizing genetic and pharmacological interventions. Additionally, novel results 
emerging from this field have also described the interaction of PGC1α with many other 
proteins, one of them being UCP1 (Uncoupling Protein 1). PGC1α induced the activity of 
UCP1 which also led to an increase in mitochondrial biogenesis (Puigserver et al., 1998). 
Thus PGC1α is responsible for linking several stimuli and cues from the environment. This 
denotes the importance of mitochondrial biogenesis, as it can be induced by different stimulus 
so that the cell can respond to different requirements (Jornayvaz and Shulman, 2010).  
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Several studies have demonstrated that induction of PGC1α activity is pivotal in activation of 
mitochondrial biogenesis. After this discovery, there have been numerous studies 
demonstrating the activation of PGC1α by investigating many upstream events that lead to its 
induction. One of the most prominent studies showed that the activation of AMPK 
(Adenosine Mono-Phosphate Kinase) is responsible for the induction of PGC1α (Wan et al., 
2014). AMPK is a major energy sensor for the cell and it is activated when the ATP/AMP 
ratio inside the cell is low (Wang et al., 2003), which in turn activates PGC1α and NRF1 
and/or 2 leading to increased mitochondrial biogenesis. Experiments performed with mice 
expressing the catalytically inactive version of AMPK showed a decrease in activity of 
PGC1α and less mitochondria per volume of the cell (Kobilo et al., 2014). On the contrary, 
overexpression of AMPK or expressing a constitutively active version of AMPK, increased 
PGC1α induction and mitochondrial content (Liang et al., 2014). AMPK overexpression in 
mice also protected the observed decrease in mitochondrial content with age (Canto et al., 
2009). On the other hand, expression of phospho-mimetic active version of AMPK in 
C.elegans and D.melanogaster has been demonstrated to extend lifespan and maintain 
mitochondrial content by increasing expression of PGC1α (Mair et al., 2011; Burkewitz et al., 
2015; Ulgherait et al., 2014). It has also been demonstrated that the loss of function mutation 
in AMPK decreases lifespan of mice (Viollet et al., 2003). In addition to this, overexpression 
of AMPK has been demonstrated to increase lifespan non-cell autonomously as well 
(Ulgherait et al., 2014). 
 
Over the last few years, it has been shown that Nitric Oxide (NO) increases mitochondrial 
content (Nisoli and Carruba, 2006). Increase in Nitric Oxide Synthase (NOS) within the cell 
increases the content of nitric oxide, leading to an increase in guanylate cyclase. This in turn 
increases cyclic guanidine mono-phosphate or cGMP, which leads to PGC1α induction and 
mitochondrial biogenesis (Nisoli et al., 2004).  
 
One of the major regulators of mitochondrial biogenesis is the silent mating type information 
regulation 2 homologue or SIRT1 (Lagouge et al., 2006). It has been demonstrated that 
fasting in many model organisms activates nutrient sensing signalling conducted by SIRT1 
(Li, 2013). This activation of nutrient signalling increases the activity of SIRT1, which 
activates PGC1α by deacetylation. Studies have demonstrated that resveratrol, a drug that 
induces the expression of SIRT1, increases the induction of PGC1α thereby increasing 
mitochondrial biogenesis (Lagouge et al., 2006). Moreover overexpression of SIRT1 has also 
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produced similar results. However, the effect of resveratrol in inducing SIRT1 has not been 
convincingly demonstrated (Higashida et al., 2013).  
 
Mitochondrial biogenesis is controlled differently in different tissues. One of the factors that 
regulates this mechanism is the p38 mitogen activated protein kinase or p38 MAPK (Ihsan et 
al., 2015). It has been demonstrated that muscle activation or contraction increases the 
expression of p38 MAPK, which leads to an increase in PGC1α and mitochondrial biogenesis 
(Knutti et al., 2001). This has also been demonstrated by experiments on p38 MAPK 
overexpressing mice (Nishida et al., 2004). Figure 1.3 is a schematic representation of all the 
upstream elements discovered that converge onto PGC1α. 
 
All the above mentioned mechanism have also been linked to caloric restriction (Canto and 
Auwerx, 2009). Although it is not very clear how this happens and the mechanism is 
unknown, it can be hypothesized that it is an evolutionary adaptation linking the mitochondria 
to environmental cues. As energy efficiency of the whole organism is regulated by 
mitochondria, it is clearly evident that there is an increase in less damaged mitochondria in 
the organism. These mitochondria utilize less oxygen from the environment, thereby 
producing less ROS. However, more work on this hypothesis is necessary in order to better 
understand the basic biology of the system. Understanding this mechanism can lead to the 
development or discovery of novel therapeutics that can potentially be a cure for 
mitochondrial diseases.  
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Figure 1.3 The mitochondrial biogenesis pathway 
Several upstream elements like AMPK, Nitric Oxide, SIRT1 and p38 MAPK 
converge on to PGC1-α which regulates NRF-2 and TFAM, which in turn 
regulates mtDNA content and mitochondrial biogenesis. 
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1.4 Mitochondrial diseases 
 
The entire organism requires functioning of mitochondria for ATP production. This is 
essential because the mitochondria are one of the only sites in the cell where consumed food 
is converted to ATP by the process of cellular respiration (Alberts, 2002). ATP can be made 
through glycolysis (glucose metabolism) as well, but contributing to only less than 10% of all 
the ATP produced in most tissues. Mitochondrial diseases are caused by mutations in 
mitochondrial (Taylor and Turnbull, 2005) and nuclear DNA (Angelini et al., 2009). It can be 
acquired and inherited from both parents containing mutations in their mitochondrial as well 
as the nuclear genome. The nuclear DNA is in two pairs of equivalent chromosomes which 
are inherited in a Mendelian fashion, one from the male and one from the female. Whereas, 
the mitochondrial DNA is only inherited from the female parent (Taylor and Turnbull, 2005). 
Genome variants are another complication, where the same mutation manifests as different 
disease in different individuals (Stankiewicz and Lupski, 2010). For example, the same 
mutation can manifest as a liver syndrome in one patient and a neuronal disease in a different 
patient. They also cause changes in severity of the disease making it extremely difficult to 
predict the cause. Moreover, the manifestation of diseases also depends on the mitochondrial 
mutation specific to the tissue. For example, a mitochondrial mutation in the brain or the 
heart, where the energy demands are high, can cause a severe phenotype (Stankiewicz and 
Lupski, 2010); whereas, the same mutation in the blood or the liver may not cause the same 
severe phenotype. A few different diseases caused due to the mitochondrial dysfunction are 
described below. 
 
Mitochondrial myopathies are the most common diseases caused due to mitochondrial 
dysfunction. This is a maternally inherited disease and is caused due to an inherited mutation 
in the mitochondrial DNA. Mitochondrial myopathies cause ragged red fibres in muscle and 
causes muscular dysfunction. It is manifested with accumulation of glycogen and neutral 
lipids (Fernandez-Sola et al., 1992).  
 
Diabetes mellitus and sensorineural hearing loss is another case of mutation in mitochondrial 
DNA that is inherited maternally. It has been found that this is caused by a point mutation in 
the 3243rd base pair in the circular human mitochondrial DNA. However, not all patients have 
a causal inherited mutation. The patients inheriting this mutation generally show symptoms of 
diabetes and have severe hearing loss (Kitabchi et al., 2009).  
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Mitochondrial encephalomyopathy, lactic acidosis and stroke like episodes (MELAS) is the 
most studied mitochondrial disease. This disease is maternally inherited, but in some cases it 
is caused by certain mutations in the nuclear genome as well. The patients inheriting one or 
more of either mitochondrial mutations or nuclear mutations generally show symptoms of 
muscle weakness, migraine, nervous disorders and seizures. Accumulation of lactic acid is 
generally found in all these cases, which is hypothesized to be the primal cause of all these 
phenotypes (Tzoulis et al., 2012). Patients with MELAS are found with a mutation in the 
mitochondrial DNA region encoding subunits of the OXPHOS Complex I like ND1 or ND5 
or a mutation in tRNA encoding region of the mitochondrial DNA (Pavlakis et al., 1984). 
However mutations in the tRNA encoding region has been shown to cause more severe 
phenotypes. 
 
Leigh syndrome is one the most predominant mitochondrial diseases found around the world 
(Baertling et al., 2013). Patients with these acquired mutations show severe symptoms of 
neurometabolic disorders and severely damaged nervous system. The muscular system is also 
affected with symptoms of ataxia. Respiratory failure manifests in the final stages of this 
disease. Mutation in the SURF1 gene encoded in the nucleus or mt-ATP6 gene encoded in the 
mitochondria has been found responsible for this mitochondrial disease. SURF1 is responsible 
for the assembly of OXPHOS Complex IV and mt-ATP6 is a part of the Complex V in the 
ETC that aids in producing ATP in the mitochondria (Baertling et al., 2014). Figure 1.4 
summarizes few of the many mitochondrial diseases caused by mitochondrial and nuclear 
DNA mutations in different tissues. 
 
Our knowledge on mitochondria has improved significantly over the years; however there are 
only limited opportunities to treat mitochondrial diseases. Many vitamins like vitamin K and 
vitamin E have been prescribed for the improvement of the mitochondrial disease phenotypes. 
(Parikh et al., 2009). However, the efficiency of neither vitamin E nor vitamin K intervention 
has yet been thoroughly established. On the other hand, membrane penetrating antioxidants 
have been developed and used to improve the phenotypes caused by mitochondrial diseases. 
Some examples of the same are pyruvate and N-acetylcysteine. These antioxidants have been 
shown to decrease the oxidative stress caused by mitochondrial dysfunction (Enns, 2014). 
Recently a technique known as spindle transfer has been developed, which involves the 
transfer of nuclear DNA into another healthy egg, leaving the mutated mitochondrial DNA 
behind. This process has been tested in primates and has been very successful using a pro-
nuclear transfer technique (Tachibana et al., 2009). Moreover, research conducted in the 
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Wellcome Trust Centre for Mitochondrial Research at Newcastle University has demonstrated 
that dysfunctional mitochondria of a mother with mitochondrial DNA mutations can be 
replaced with the healthy mitochondria of another woman by using a new IVF-based 
technique. This process enables the nuclear DNA, which encodes 99.9 % of the genetic 
information from the mother and father, to remain unchanged (Cravel et al., 2010).  
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Figure 1.4 Mitochondrial diseases in humans 
A summary of few of the many mitochondrial diseases caused by mitochondrial 
and nuclear DNA mutations in different tissues (Adapted from Fauci et al, 
2011). 
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1.5 Ageing 
 
Ageing is a multi-faceted process which leads to the loss of molecular fidelity and an 
increased vulnerability to cellular stress. There is a very complicated etiology provided by 
recent studies, proving that ageing has a strong genetic component, and that genetic 
modifications can alter lifespan in many model organisms such as Drosophila melanogaster 
(flies), Caenorhabditis elegans (worms) and Mus musculus (mice) (Longo and Fontana, 
2011).  Notable attempts to combat ageing have been made and among these are the 
experimental trials using “anti-ageing drugs” on nematodes, flies and vertebrates like mice 
and rats (Anisimov et al., 2011). One example of such drug is rapamycin, which increases 
both mean and maximum lifespan even when administrated to old mice (Wang et al., 2011). 
Additionally, some genetic strategies like knockout of daf-2 (Insulin Receptor) and 
overexpression of daf-16 (FOXO) have been demonstrated to extend the lifespan of 
nematodes (around 70-80%) (Kenyon et al., 1993; Kenyon, 2011). However, a much smaller 
effect was observed in other model organisms, such as flies or mice (20-40%) (Clancy et al., 
2001; Bluher et al., 2003; Dillin et al., 2002; Giannakou et al., 2004). Genetics has been 
demonstrated to determine only a part of human longevity with the rest being determined by 
other factors such as diet, exercise and other environmental factors (Rattan, 2012). 
Additionally, this is only true for mean lifespan; whereas, maximum lifespan of an organism 
is genetically pre-programmed (Prinzinger et al., 2005). 
 
1.6 Molecular theories of ageing 
 
The molecular theories of ageing focuses on damage or loss of functionality of biological 
molecules. This includes all kinds of molecules like proteins, DNA and/or lipids, which might 
affect the protein synthesis or gene regulation of the organism (Weinert and Timiras, 2003b). 
There are two basic theories found under this category. They are i) genetic and ii) non-
genetic. As the name suggests, the genetic theories of ageing emphasizes the role of specific 
genes in relation to ageing (Kanungo, 1975). One prominent genetic theory is the codon 
restriction theory. Codon restriction theory states that ageing is caused by a decrease in the 
accuracy of protein translation; thereby leading to a decrease in efficiency of protein synthesis 
(Strehler et al., 1971). One of the other genetic theories is the Hayflick’s Limit theory. This 
theory states that, there is a limit to the number of times a cell can divide (Hayflick and 
Moorhead, 1961; Shay and Wright, 2000). This phenomenon has since been demonstrated to 
be related to telomerase which an enzyme that protects it from continuous shortening 
(Olovnikov, 1996). However most of these theories have been challenged over the years. 
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The non-genetic theories of ageing have their foundation on the physiological aspects of 
ageing. The accumulative waste theory of ageing (Hirsch et al., 1989) proposes that, 
accumulation of cellular debris causes ageing. This theory is supported by the fact that, 
accumulation of the pigment lipofuscin is the most reliable ageing biomarker. Lipofuscin are 
fine granular pigmented molecules, which are debris products of lysosomal digestion. 
Essentially, lipofuscin is the by-product of incomplete oxidation of unsaturated fatty acids, 
glycoxidation of proteins and partial digestion of cellular organelles (Gaugler, 1997). When 
these by-products accumulate they can interfere with normal cellular function (Weinert and 
Timiras, 2003).  
 
A more recent theory is the thiol redox hypothesis. All biological systems contain redox 
elements and the organization of these elements occurs through a redox circuit. These redox-
sensitive elements are insulated and can be activated only with the help of specific catalytic 
mechanism. The redox hypothesis states that, disruption of these redox sensitive thiol 
elements by, i.e. accumulation of oxidative stress, is the cause of ageing (Jones, 2008). On the 
other hand, cellular theories are often closely related to the functions at molecular levels as 
well. One example of this theory is the process of apoptosis, a form of programmed cell death. 
Apoptosis has been demonstrated to play a predominant role in ageing (Warner, 1997). This 
view on cellular theories is compatible with the oxidative stress theories of ageing where these 
phenomena also lead to cell death (Weinert and Timiras, 2003a). 
 
1.7 Mitochondrial Free Radical Theory of Ageing 
 
Mitochondrial Free Radical Theory of Ageing (MFRTA) is one of the most prominent 
theories in the era of ageing research and it can be integrated into almost all the theories 
mentioned earlier. MFRTA was first proposed by Denham Harman in 1956, as the “Free 
radical theory of ageing”. Harman stated ageing as a consequence of accumulation of damage 
caused by radicals, generated during normal metabolic processes (Harman, 1956). Harman's 
free radical theory of ageing was further revised and published in the year 1972, as the 
“Mitochondrial Free Radical Theory of Ageing”  (Harman, 1972; Harman, 1983) which states 
that the respiratory complexes of the ETC produces reactive oxygen species (ROS) as a by-
product of normal oxygen metabolism. Furthermore, MFRTA states that these ROS molecules 
go on to damage nucleic acid, proteins and lipids. This in-turn would lead to age-related 
disorders and diminished longevity. Many facts relate mitochondrial ROS with ageing: 
increased ROS production, accumulation of mutations in mitochondrial DNA (mtDNA) and 
progressive respiratory chain dysfunction (Kirkinezos and Moraes, 2001). In proof of this 
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concept, caloric restriction extended lifespan in most animal species (Guarente, 2005; 
Partridge et al., 2005; Sinclair, 2005). Such extension is related with a reduction in the 
generation of damage (including mtROS) and not with an increase in amount of antioxidant 
defences or repair mechanisms (Sanz et al., 2006).  
 
However, some evidence contradicts MFRTA. For example, the administration of 
antioxidants does not extend lifespan  (Sanz et al., 2006); although it could be argued that 
these antioxidants are not targeted to the appropriate place. The manipulation of endogenous 
antioxidant levels does not produce the expected change in lifespan, either. For example, the 
knock-out of superoxide dismutase 1 or 2 dramatically reduces the lifespan of flies and 
mammals (Mackay and Bewley, 1989), but this phenomenon does not occur in C. elegans 
(Van Raamsdonk and Hekimi, 2009). Moreover, heterozygous knock-out mice for SOD2 are 
long-lived in spite of having much higher levels of oxidative damage (Zhang et al., 2009). On 
the other hand, over-expression of SOD2 in flies has no effect on lifespan (Mockett et al., 
1999). Although over expression of SOD1 increases its lifespan by 30% (Orr and Sohal, 
1994), this is paradoxically related with more oxidative stress rather than less (Parkes et al., 
1998; Sohal, 2002; Magwere et al., 2006). These contradictory results can be explained by 
hypothesising that ROS acts more as signalling molecule than as an agent for causing damage. 
 
1.8 Drosophila as a model system 
 
Drosophila is one of the most widely used model systems for studies on genetics and 
developmental biology (Reeve, 2001). It was first used in the early 1900’s by Thomas H. 
Morgan, Jeff Bridges and Alfred Sturtevant for the study of sex linkage and genetic 
recombination. Since then, Drosophila has been widely used in genetics and molecular 
biology. It’s numerous advantages, including; short generation time, low cost, ease of culture, 
well-characterised genetics and high number of offsprings, make it ideal to study ageing 
(Rubin and Lewis, 2000). Furthermore, it has been used as the model organism as there is a 
high (around 70%) sequence similarity (Reiter et al., 2001) between Drosophila and humans. 
Thus, results gained in Drosophila can be used to highlight possible novel genetic pathways 
in humans. Drosophila has a genome of just 13,600 protein-coding genes, when compared to 
the 40,000 genes in human genome (Halligan and Keightley, 2006), and it is less redundant. It 
was completely sequenced in the year 2000 (Adams et al., 2000). The fact that the genetic 
information in flies are distributed on four chromosomes, 3 pairs of autosomal chromosomes, 
and one pair of sex chromosomes, make it easier for genetic interventions. 
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Genetics has been a valuable tool in research, and numerous approaches have been used to 
gain insight into the function of those genes that have orthologues in humans. To generate 
these detectable phenotypes there has been two main approaches: i) by using the gain of 
function, which involves conferring new or additional function of the protein by the process 
of target specific mutation (gain of function mutation) or adding additional DNA segments to 
increase the translation of the protein (transgenic overexpression); and ii) by using a loss of 
function, which involves mutations that confers to the loss of protein function or knocking-
down or knocking-out of genes by targeted RNAi or deletion events respectively.  The double 
stranded RNA mediated RNA interference (RNAi) strategy has been recently introduced as a 
powerful tool. RNAi involves the use of double stranded RNA or small interfering RNA, to 
knockdown expression of a specific gene by causing degradation of the target RNA (Mello 
and Conte, 2004). The transgenic approach has been used in this thesis and involves the over 
expression of a gene in the fly or for expressing a protein from another organism (Ciona 
intestinalis) in the fruit flies, to study its molecular functions in the whole organism.  
 
1.9 The GAL4/UAS and the Geneswitch/UAS system in Drosophila 
 
The GAL4/UAS system is one of the most powerful systems used for increasing or reducing 
gene expression in Drosophila. The GAL4/UAS adapted from yeast is a system made up of 
two elements, namely the yeast GAL4 activator protein and the UAS (Upstream Activating 
Sequence). The gene of interest is cloned into a vector, which is primarily coupled with the 
UAS sequence. The GAL4 binds very specifically to the promoter of the desired gene and 
drives its expression via interaction with the UAS (Brand and Perrimon, 1993; Duffy, 2002). 
However, neither the GAL4 protein (derived from yeast) nor the UAS exist in wild type flies, 
making the system very specific. 
 
In Drosophila, the system is split into two parts; the GAL4 driver is maintained in a separate 
line and the gene of interest  is kept under the control of the UAS in another line (Busson and 
Pret, 2007). When the two lines are crossed, the binding of the driver (GAL4) to the UAS site 
takes place, leading to the expression of the desired gene in resulting offsprings (Jones, 2009). 
Figure 1.5 is a schematic representation of how the GAL4/UAS system works.  
In the GeneSwitch/UAS system, the elements are similar; however this is a conditional 
expression system which is a modified version of the yeast GAL4 protein. It is activated only 
in presence of the inducer drug RU-486. Moreover, expression of the construct in 
GeneSwitch/UAS system depends on dosage of the drug. Thus increasing or decreasing the 
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dosage of Mifepristone or RU-486 (inducer drug) in the culture vial can increase or decrease 
the efficiency of expression. These are the systems that allow spatial and temporal expression 
or knockdown of genes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 20 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GAL4 Driver UAS-Transgene
X F0
UAS-TransgenePromoter
F1 Progeny 
With the 
expression of 
the transgene
Figure 1.5 The GAL4/UAS system  
Virgin females with the GAL4 driver are crossed to males with the 
UAS-Transgene (F0). This results in binding of the GAL4 promoter to 
the UAS-Transgene, resulting in F1 progeny with expression of the 
transgene.  Fly images taken from Roote and Prokop, 2013. 
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1.10 Drosophila melanogaster as a model system to study ageing 
 
The development of the fruit fly undergoes a four stage life cycle; egg, larva, pupa and imago 
or adult over a span of 10 days. Once fertilized, the embryo develops in the egg for around 
one day at 25oC before hatching as a larva. The larva progresses through three stages of 
development over four days, until it pupates. The tiny larva that emerges is called the first 
instar larvae. It feeds on the substrate that the eggs were laid in and after a day it molts into a 
larger worm-like form known as the second instar larvae. This again feeds and molts into the 
third instar larvae in the next 2 days. The larvae would have significantly grown at this stage 
and will start to move and climb the surface of its container where it undergoes pupation. 
During pupation, metamorphosis takes place and the adult fly emerges from an eclosion 
(pupal case) over the course of 4 days. Most of the embryonic and larval tissue is destroyed 
during metamorphosis. The adult tissues are developed from a group of undifferentiated, 
mitotic cells known as imaginal discs and histoblasts formed since early-embryonic 
development. Figure 1.6 shows the life cycle of Drosophila. 
 
Drosophila is poikilothermic and does not thermoregulate as mammals do. The metabolic rate 
and lifespan is determined by their environmental temperature. Thus, ambient temperature 
affects the development time, fecundity and fertility in fruit flies. When in lower 
temperatures, they slow the development process; whereas, higher temperatures have the 
opposite effect. Especially at higher temperature it has been shown that they accumulate 
damage faster and they have a very short lifespan. This short lifespan and their limited 
complexity for the control of lifespan make it a very valuable tool for ageing studies. This has 
been used to our advantage in this work. 
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Figure 1.6 Drosophila life cycle  
Drosophila lay their eggs, the eggs hatch into first instar larva which develops 
through different stages until it pupates. Drosophila then hatch from the pupae, 
where the larvae have been metamorphosing to form adults (Adapted from Elland, 
2006).   
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1.11 Alternative respiratory enzymes 
 
One of the major causes of mitochondrial dysfunction is the failure of the ETC (Koenig, 
2008). Hence therapeutics is mainly aimed to decrease mitochondrial dysfunction in 
mitochondrial diseases. However, it has been debated whether this is because of the loss of 
ATP or the excess ROS generated by ETC (Adam-Vizi et al., 2005; Brookes et al., 2004). 
The ETC contains five respiratory complexes; hence the damage to one of these components 
can cause the failure of the whole system. An idea to prevent or improve the failure of ETC 
complexes is to bypass this damage. Many eukaryotes and some prokaryotes contain 
alternative respiratory enzymes in their mitochondria to bypass this damage in their ETC 
components. This can be explained as an evolutionary mechanism to protect themselves 
against toxins that were present in the environment at early stages of evolution. These toxins 
were able to block the respiration of an organism by blocking its ETC. However, as toxins in 
the environment started reducing, higher organisms arrested the production of these 
alternative respiratory enzymes (McDonald et al., 2004), and was eventually removed from 
the genome of higher organisms. 
  
The alternative respiratory enzymes are non-proton pumping but help in electron transfer. Due 
to this function they can compensate for the loss of ATP only partially, but can be more 
effective to bypass damage to the ETC components. These alternative respiratory enzymes are 
smaller than the ETC components; hence are easy to assemble by the organism and are less 
prone to damage dependent loss of function (Unden and Bongaerts, 1997).  
 
Alternative Oxidase (AOX) is one example for this alternative enzyme. It is present in the 
ETC of the mitochondria in all plants and fungi and also in some higher organisms like Ciona 
intestinallis. It is a comparatively small protein and has no proton pumping properties. The 
protein accepts electrons from ubiquinol and reduces oxygen directly to water, bypassing the 
function of Complex III and IV. AOX is also resistant to cyanide and this can be explained as 
an evolutionary adaptation (Veiga et al., 2003). Figure 1.7 shows how AOX works in ETC. 
 
Few other examples of alternative respiratory enzymes are NADH dehydrogenase internal 1 
(NDi1), NADH Dehydrogenase external 1 (NDe1) and NADH Dehydrogenase external 2 
(NDe2). Budding yeast does not have the ETC Complex I, but has NDi1 inside the 
mitochondrial membrane facing the mitochondrial matrix. They also contain NDe1 and 
NDe2, which are present in the intermembrane space. The alternative respiratory enzyme 
NDi1 has been demonstrated to bypass the dysfunction of Complex I (Sanz et al., 
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2010;Cannino et al., 2012a). Moreover, plants contain all of the above mentioned alternative 
respiratory enzymes, making their ETC extremely branched; therefore less prone to damage 
(Affourtit et al., 2001). Figure 1.7 shows how NDi1 works in ETC. 
 
These alternative respiratory enzymes are potentially a good method to identify diseases in 
lower model organisms, which can thereby lead to inventing and discovering potential cure in 
humans. However, adding to this potential benefit, expression of an exogenous protein can 
cause opposing immune reactions. These enzymes have shown to produce many beneficial 
effects and some have been discussed below. The expression of AOX has been successfully 
achieved in mice and flies. AOX expression in flies rescued several phenotypes caused by the 
knockdown of Complex IV subunit CoxVb, Surf1 which is a Complex IV assembly factor and 
Cyclope (Complex IV subunit COXVIc  (Fernandez-Ayala et al, 2009) (Kemppainen et al., 
2014). AOX expression has also been shown to rescue the phenotypic effects caused by the 
mutation in Dj-1β, which is involved in Parkinson’s disease (Fernandez-Ayala et al., 2009). 
AOX expression was also used to rescue the loss in survival caused by cyanide poisoning in 
mice (El-Khoury et al., 2013). In this study, we have used the expression of AOX to analyse 
the role of ROS signalling in flies (Figure 1.7). AOX also prevents over-reduction of the 
ubiquinone pool, which we hypothesize as the signal responsible for several cellular 
signalling mechanisms.  
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NDi1 and AOX bypass Complex I and Complex III of the ETC respectively, thereby 
reducing the leak of electrons; thereby production of ROS. This aids in rescuing disease 
phenotypes caused by Complex I and Complex III. Additionally AOX and NDi1 oxidise and 
reduce the ubiquinone pool respectively.   
Figure 1.7 Schematic diagram illustrating the effects on electron transport after the 
expression of alternative enzymes; AOX and NDi1  
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1.12 Reactive oxygen species (ROS) 
 
Free radicals are defined as an atom or group of atoms with one or more unpaired electrons. 
They are typically very reactive and therefore they have a very short half-life. They are 
generally unavoidable consequences of aerobic metabolism and are produced by stepwise 
reduction of oxygen due to electron transfer. ROS is a collective term, which includes many 
molecules containing oxygen centred radical. However, ROS is also subcategorized to free 
radicals which are molecules with unpaired electrons. A few examples of these kind of 
molecules are, the hydroxyl radical (OH-) and Superoxide (O2-). Additionally, Hydrogen 
peroxide (H2O2) is not a free radical but is ROS. 
 
Accumulation of ROS inside the cell is the major cause of oxidative damage, which is termed 
as oxidative stress. One of the major implications of the free radical theory of ageing is that, 
ROS causes cellular damage. Energy production by the ETC leads to the formation of ROS, 
which causes accumulation of damage in mitochondria (Sanz et al., 2008;Luo et al., 2013). 
For a good part of 20th century existence of ROS in vivo was not acknowledged or were 
usually considered as deleterious entities, but the dual nature of ROS in both damage and 
signalling have been extensively studied. Many studies have been emerging showing ROS as 
signalling molecules (D'Autreaux and Toledano, 2007).  
 
There are two types of oxygen molecules that are highly reactive (i) Singlet oxygen or 1O2 is 
produced by the absorption of sufficient energy to reverse the spin of an oxygen electron (ii) 
Superoxide or O2- is produced by stepwise monovalent reduction of the oxygen atom 
(Valentine et al., 1984). This is a very harmful by-product and can react with an array of 
molecules. However 1O2 is studied mostly in plants thorough generation of hydroxyl radicals. 
It oxidizes protein, unsaturated fatty acids and DNA in plants (Triantaphylides and Havaux, 
2009).  
 
Superoxide is very well studied in many higher organisms. However, its reactivity is still not 
completely understood. It is the primary free radical in the cascade to generate other 
components of ROS. Since it is the primary step in this reaction, it is one of the most highly 
reactive ROS species and its reactive half-life is approximately 1µs (Fridovich et al., 1997). 
Due to its considerably short half-life, superoxide can be involved in a lot of redox reactions 
and is generally dismutated to H2O2 either non-enzymatically by auto dismutation, or 
enzymatically by Superoxide Dismutase (SOD), which catalyses this reaction (McCord et al., 
1969). 
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SOD 
2O2- + 2H+  H2O2+O2 
 
 
Hydrogen peroxide is generated under both normal and stress conditions. It is produced by 
several sources like mitochondria, endoplasmic reticulum and in cytoplasm (Boveris et al., 
1972). Its reactivity with other molecules is more predominant than superoxide because of it 
half-life of around 1ms (Gough et al., 2011). Hydrogen peroxide is a better studied molecule 
in the process of signalling, as H2O2 does not contain any charge and  can  permeate through 
biological membranes (Veal et al., 2007). Due to this property, combined with considerably 
high half-life, it can activate signalling cascades and cause damage far away from the site of 
production. H2O2 generally activates or deactivates an enzyme by targeting its methionine or 
cysteine residues. This can change the conformational state or folding of the protein and this 
determines its activity (Chung et al., 2013).  
 
Hydroxyl radicals or peroxinitrite are the most reactive oxygen species. Hydroxyl radicals are 
produced in a two-step process involving H2O2 and O2-, which involves a metal catalysis part 
as well (Cohen and Heikkila, 1974). These are called as Fenton reactions. 
 
 
Fe3+ + O2 .-  Fe2+ + O2 
Fe2+ + H2O2  Fe3+ + -OH + .OH 
O2.- + H2O2  .OH + -OH + O2 
 
 
Nitric oxide is formed by the oxidation of nitrogen, which is catalysed by an enzyme called 
nitric oxide synthase. Since nitric oxide contains an unpaired electron it is extremely reactive. 
However peroxynitrite a by-product of the nitric oxide, formed by the reaction between 
superoxide and nitric oxide is the much more harmful than nitric oxide itself (Hou et al., 
1999). Nitric oxide also acts an important messenger acting in vasodilation and 
neurotransmission. It also acts as an anti-tumor and anti-pathogenic agent. A sufficient level 
of nitric oxide is also very important in protection of organs like liver from ischemic damage. 
On the other hand, sustained levels of nitric oxide can cause tissue toxicity and also vascular 
collapse. Moreover an increase in nitric oxide has been discovered to be a causal agent for 
diseases like Juvenile Diabetes and Multiple Sclerosis (Heinrich et al., 2013).  
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N2 + O2  2NO 
 
1.13 The role of ROS in signalling and oxidative damage 
 
Role of ROS in signalling is considered to be an evolutionary adaptation that prevents 
excessive damage caused by different ROS entities (Dowling et al., 2009). Its role in 
activation of an array of transcription factors is already a very well-studied mechanism. 
Redox signalling, another well-studied concept, can be facilitated by ROS molecules; where 
the amino acid residues of proteins are oxidized by ROS (Ray et al., 2012). Due to their 
abundance in the cell, proteins are one of the main targets of oxidation by ROS. Oxidation 
causes changes like polarity or size in the amino acids leading to a change in the polypeptide; 
thereby changing the structure, stability and activity of the protein.  
 
Accumulation of O2- is generally connected more to stress than signalling as it cannot diffuse 
through biological membranes. Moreover, O2- is extremely reactive compared to its 
counterparts and it reacts with many molecules close to its site of production. Superoxide 
reacts mainly with iron-sulphur clusters and releases free iron, toxic to the cellular 
environment. However, the role of superoxide in signalling has been shown to activate 
antioxidant response and cell death in many organisms (Kim and Park, 2003; Kadowaki et al., 
2005). There are also studies on the presence of a superoxide channel present in mitochondria 
that can transport superoxide from the inside to the outside which is used for signalling (Han 
et al., 2003).  
 
Hydrogen peroxide is studied more extensively than superoxide as a signalling molecule due 
to its very high reactive half-life of 1ms; hence proteins in vicinity are more prone to 
reduction or oxidation (Schaar et al., 2015). As mitochondria are dynamic organelles they can 
also be transported to a certain site, for H2O2 to diffuse through the mitochondrial membrane 
and act in signalling (Bienert et al., 2006). Some extensively studied processes in which H2O2 
is involved are (i) activation of Hypoxia inducible factor (HIF), which is responsible for 
maintaining metabolism within the cell (Jung et al., 2008) (ii) activation of Phophoinositol 3 
Kinase or PI3K that induces growth (Sadidi et al., 2009) (iii) activation of nuclear factor 
kappa-light-chain-enhancer of activated B cells or NF-kappaB responsible for controlling 
several processes like survival, production of antioxidants, activation of transcription factors 
and also in prevention of cancer (Oliveira-Marques et al., 2009) (iv) activation of Mitogen 
activated protein kinase or MAPK which is responsible for proliferation of cell (Bhat and 
Zhang, 1999). These signalling cascades consequently control important systems like increase 
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in stem cell renewal, differentiation and proliferation, immune response and longevity. Figure 
1.8 is a flowchart showing the role of ROS in activating and deactivating different signalling 
mechanisms. 
 
Although recent studies have significantly improved our understanding of the role of ROS in 
signalling, more studies and more precise techniques to study ROS in vivo will help us 
discover novel mechanisms which are absolutely essential for the cell. Improvement in these 
techniques will also aid us to delineate the pros and cons of ROS.  
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Figure 1.8 A flow chart showing different ROS entities acting in several signalling pathways  
 
Different ROS entities like H2O2, O2- and NO play a role in activating and deactiving many 
signalling mechanisms. 
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1.14 Role of ROS in diseases 
 
The role of ROS has been studied in many diseases like Alzheimer’s, Parkinson’s and other 
neurodegenerative disorders (Alfadda and Sallam, 2012). However, it is still unclear whether 
ROS is a cause or consequence of these disease phenotypes. The only clear evidence is the 
studies that show the role of ROS in cardiovascular disease. It has been demonstrated that 
ROS causes oxidation of low density lipoprotein (LDL) which leads to atherogenesis, 
consequentially leading to atherosclerosis and then cardiovascular diseases (Vogiatzi et al., 
2009). 
 
It is hypothesized that ROS plays a role in many cases of cancer (Liou and Storz, 2010). For 
example, it has been shown that ROS can cause oxidative DNA damage, thereby increasing 
the risk of cancer. However, whether this is a cause of cancer progression or a consequence of 
cancer cell metabolism is still unclear. In mice, the only study that has surfaced is the 
knockout of antioxidants, which increases DNA polymorphisms, in turn increasing the risk of 
cancer (Van Remmen et al., 2003; Tony et al., 2009). Another concept is the role of ROS in 
ageing (Loeb et al., 2005), where it is demonstrated in many organisms that consuming a low 
calorie diet increases lifespan significantly. It is hypothesized that this increase in lifespan is 
due to the decrease in oxidative stress, which is facilitated by decrease in ROS (Ungvari et al., 
2008).  
 
1.15 Antioxidants 
 
Superoxide dismutase (SOD) is the primary line of defence against ROS. It helps the cell in 
breaking down superoxide to hydrogen peroxide, with the help of metal ion cofactors. Three 
superoxide dismutases have been discovered across different model organism namely; 
copper/zinc, manganese, ferrous and nickel superoxide dismutase. In humans, copper/zinc 
cofactor based superoxide dismutase is present in the cytosol and in the mitochondrial inner 
membrane space and the manganese version is present in mitochondria. The version of 
superoxide dismutase present in mitochondria is proven to be very important as mitochondria 
are the source of abundant ROS production (Li et al., 2011). It has been demonstrated that 
mice lacking the mitochondrial version of superoxide dismutase die as soon as they are born. 
However, the mice lacking other types of superoxide dismutases do not have a very well 
defined pathology (Hashizume et al., 2008). It is hypothesized that the progression of damage 
is much more prominent than the homeostatic state. Although there have been so many 
studies with the same enzyme, it is still not completely clear how the enzyme functions. For 
example, in worms, it has been demonstrated that loss of all superoxide dismutase genes does 
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not have any effect on lifespan (Van Raamsdonk and Hekimi, 2012). Overexpression of these 
genes does not cause any beneficial effects either (Perez et al., 2009). Additionally, in flies it 
has been demonstrated that overexpression of Sod2 increases lifespan (Sun et al., 1999); 
however overexpression of SOD2 in mice does not (Huang et al., 2000). 
 
The catalase enzyme catalyses the conversion of H2O2 to H2O and O2. An iron or manganese 
cofactor is used in this process. In humans, the catalase enzyme is generally found localizing 
to peroxisome (Walton and Pizzitelli, 2012). The cofactor of catalase enzyme is oxidized by 
one molecule of H2O2 and then is regenerated by transferring the bound oxygen to the second 
molecule of the substrate. The role of catalase is very well studied and is an important step in 
making the ROS molecule inert. However knockout of catalase does not cause any deleterious 
effects in mice (Hamilton et al., 2012).  
 
Peroxiredoxins are also used in the conversion of H2O2 to H2O. Moreover, it is also used in 
the conversion of organic hydroperoxides and peroxynitrates. Peroxiredoxins are enzymes 
that require a cysteine oxidization to be active (Rhee et al., 2005) and due to its extremely 
high importance in an organism’s array of processes, knockout of this enzyme in mice led to a 
shortened lifespan (Lee et al., 2003). 
 
Thioredoxins and glutathione peroxidases are one of the most abundant antioxidants present 
in any system across species. Thioredoxins are highly reactive reducing agents that are 
responsible for keeping the enzymes in a reduced state. They facilitate the reduction of 
proteins by cysteine thiol-disulfide exchange. On the other hand glutathione peroxidases are 
present in three forms (i) reductases; that catalyses the conversion of H2O2 to organic 
hydroperoxide; (ii) peroxidases; that catalyses the conversion of H2O2 to H2O and O2  and; 
(iii) Transferases; that are responsible for lipid peroxidation (Harris et al., 2015). Peroxidases 
are the one of the most abundant antioxidant in the cell. Experiments have demonstrated that 
knockout of glutathione peroxidase significantly reduces lifespan in mice (de Haan et al., 
1998). 
 
1.16 Role of autophagy in cellular maintenance 
 
Autophagy is a process that is used by the cell for intracellular degradation. It involves the 
formation of an isolation membrane in one portion of the cytoplasm. A double membrane 
structure is formed called autophagosome, which is a vacuole like structure that engulfs all the 
organelles and intracellular debris. It then fuses with the lysosome; an organelle responsible 
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for digesting the debris by utilizing its acidic environment. As damaged proteins or organelles 
are degraded by the lysosome, amino acids and nutrient components of those structures are 
released back to the cellular environment as building blocks of components that were digested 
(Glick et al., 2010).  
 
Autophagy has been studied for a long time as a bulk or non-specific process that just engulfs 
a part of the cytoplasm, but recent evidence shows that autophagy is a more specific process. 
It has been demonstrated to be targeted specifically to damaged parts of the cell; like 
organelles or even proteins (Li et al., 2012). Further investigation has led to the discovery of 
diseases like Carney complex syndrome, Crohn’s disease, Vici syndrome, Hereditary spastic 
paraparesis; that are caused by disruption of these specific autophagy pathways (Jiang and 
Mizushima, 2014) (Kaushik et al., 2010). 
 
1.17 Autophagy: process and function 
 
TOR or mTOR (mammalian/mechanistic Target of Rapamycin), is a serine/threonine kinase 
that regulates a wide array of functions like cell growth, cell survival, protein synthesis and 
translation (described in detail in Chapter 1.22). Adding to these functions, TOR is also a 
major regulator of autophagy. The activation of TOR is responsible for deactivation or 
destabilization of the Unc-51 like Autophagy Activating Kinase 1 (ULK1) complex that 
consists of Autophagy related 13 (ATG13), Family Kinase-Interacting Protein of 200 kDa 
(FIP200) and ATG101 proteins. In absence of TOR activation (i.e. under conditions of 
starvation, where nutrients are much more necessary to survive than to promote growth), 
phosphorylation of ULK1 is halted stabilizing the complex. It is then translocated to the 
endoplasmic reticulum that provides a membrane source for the autophagosome (Jung et al., 
2010). In parallel, PI3K activation also activates several autophagy genes. The recruiting of 
ATG’s is responsible for the formation and expansion of the isolation membrane and 
eventually an omegasome (Heras-Sandoval et al., 2014). More specifically, LC3 or ATG8 is 
responsible for a very important step in autophagy which is the maturation of autophagosome. 
In the absence of lipidation of LC3, the autophagosome formation is disrupted and autophagy 
is terminated. This step has been proven to be absolutely essential, as rescuing the phenotype 
caused by a mutation in LC3 has not been demonstrated (Tanida et al., 2008). Following this 
step, SNARE (soluble NSF attachment protein receptor protein) and HOPS (homotypic fusion 
and protein sorting protein) tether and form a complex. This is the final step in the process 
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where the fusion of autophagosome and lysosome occur (Jiang et al., 2014). Figure 1.9 
illustrates the process of autophagy. 
 
Although the signalling cascade was discovered in budding yeast, in the past two decades it 
has been studied in many other organisms like worms, flies, mice and primates. Discovery of 
these processes has led to the development of many knockout animals. Most of the knockouts 
in the autophagy signalling cascade produced similar phenotype which is evident that 
autophagy is a linear signalling cascade (Mizushima and Levine, 2010). It is still unclear how 
damage to organelles or proteins is detected by the autophagic machinery. Pharmacological 
targets are being discovered and developed alongside the discovery of new genes in the 
autophagy pathway (Rubinsztein et al., 2012).  
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Figure 1.9 The process of autophagy 
Autophagy is a complex process involving many proteins for activation and sustenance 
(Adapated from Kimmelman, 2011). 
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1.18 Various kinds of autophagy that occur within the cell 
 
Autophagy is mainly subdivided into macro-autophagy, micro-autophagy and chaperone 
mediated autophagy. Macro-autophagy is bulk degradation or non-specific of debris within 
the cell, but in recent years more specific macro autophagic processes have been discovered 
(Feng et al., 2014). Some examples of specific macro-autophagy are; (i) Mitophagy or the 
degradation of mitochondria (described in detail in Chapter 1.19); (ii) Pexophagy or the 
degradation of peroxisomes; that are detected by PEX proteins which translocate to the 
surface of peroxisomes. This recruits the ATG protein, ATG30, which flows into the 
canonical autophagy pathway for degradation of the whole organelle; (iii) Reticulophagy or 
the degradation of the Endoplasmic Reticulum; LC3 has been demonstrated to localize to ER 
in order to detect and activate downstream elements to sequester ER to the lysosome and; (iv) 
Aggrephagy or recycling of damaged and aggregated proteins is a more specific process. 
Disruption of aggrephagy has also been shown to cause many diseases (Reggiori et al., 2012). 
Aggrephagy is usually an aggregation of damaged proteins that cannot be recycled. These 
aggregated proteins are usually targeted by p62, which recruits and activates LC3 for further 
autophagic degradation (Reggiori et al., 2012).  
 
Microautophagy is a more unspecific process which does not involve any recruitment or 
specific activation. It is generally a direct lysosomal degradation process which is just bulk 
turnover of many or most of the cytosolic components. However, recently there are reports 
showing more specific microautophagy. Three types of microautophagy have been discussed 
extensively; (1) Micropexophagy, the process of degradation of damaged or superfluous 
peroxisomes. In this process of autophagy, instead of the peroxisomes being targeted or 
sequestered to the lysosome, the lysosome fuses with the peroxisome directly (Mijaljica et al., 
2011); (2) Micromitophagy, the process of unspecific recycling of damaged mitochondria. It 
is split in two; (i) Involves engulfment of mitochondria by the lysosome and; (ii) 
Mitochondria fuse with lysosome for its degradation. Among other kinds of microautophagy, 
micromitophagy is least characterised (Mijaljica et al., 2011) and; (3) Microautophagy of the 
nucleus, is the process of degradation of a damaged part of the nucleus. In this process the 
damaged nucleus is engulfed by endoplasmic reticulum membrane and the lysosome then 
engulfs this structure for degradation (Mijaljica et al., 2011). 
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Another major kind of autophagy is chaperone mediated autophagy (Kaushik and Cuervo, 
2012). Chaperone mediated autophagy is a specific target recognition process. This type of 
autophagy is mainly for damaged proteins that are targeted by specific chaperones like 
HSC70 or HSP90. The proteins targeted by these chaperones are recognized by LAMP2 
(Lysosome associated membrane protein 2), which sequesters them directly to the lysosomes. 
 
1.19 Mitochondrial specific autophagy or mitophagy 
 
Mutation in PTEN-induced putative kinase (PINK1) and/or PARKIN genes in humans have 
been associated with familial and sporadic forms of Parkinson’s disease. In 2008, Richard 
Youle and his colleagues established that PARKIN and PINK1 are responsible for 
degradation of damaged mitochondria (Narendra et al., 2008). They described the mechanism 
as a canonical PINK1-PARKIN pathway that is responsible to detect and recycle damaged 
mitochondria. PINK1 is a protein that is encoded in the nucleus and transported to the 
mitochondria. Under normal circumstances, PINK1 is usually cleaved in the mitochondria by 
different proteases. This cleaved version of PINK1 is completely inactive. When cells are 
subjected to CCCP, depolarization of the mitochondria is answered by stabilization of PINK1 
(Narendra et al., 2008). Under these circumstances, PINK1 is not processed by proteases; 
however, the mechanism of how this happens is still unclear. The stabilized version of PINK1 
is responsible for recruiting and activating PARKIN. PARKIN then ubiquitinates several 
proteins on the outer membrane of mitochondria like Mfn2 or Drp1, which are responsible for 
recruiting several ATG proteins. Consequentially damaged mitochondria as a whole organelle 
is transported to the lysosome for complete degradation (Narendra et al., 2008; Jin et al., 
2010). It is becoming more evident that the activation of PINK1 and PARKIN can occur only 
through the detection of damaged mitochondria. It has also been demonstrated that PINK1 
auto phosphorylates itself when mitochondria depolarize, which is responsible for the 
activation of other downstream processes (Okatsu K et al., 2012). Few other studies have also 
demonstrated that p62 and LC3 can orchestrate the sequestering of the mitochondria to the 
autophagosome; however, these studies are not very clear (Park et al., 2014; Strappazzon et 
al., 2015). More importantly, Pink1 and Parkin knockout mice show a very mild phenotype of 
Parkinson’s when compared to human cohorts (Chesselet and Richter, 2011). Figure 1.10 is a 
schematic representation of canonical mitophagy. 
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Figure 1.10 Schematic representation of canonical mitophagy 
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1.20 Proteasomal degradation of damaged proteins 
 
Protein turnover is generally the balance between protein synthesis and protein degradation. 
When this balance is lost, the cell is under stress which causes many disease phenotypes. In 
general, protein synthesis happens when in an anabolic or a more fed state; and protein 
breakdown happens when in a catabolic or a starved state. Decrease in breakdown of proteins 
have also been found to be directly proportional to increase in age (Razanov et al., 2002).  
 
Proteosomal degradation of ubiquitinated protein is a process that recognizes independent 
proteins and breaks down the peptide bonds in an energy dependent manner. This process is 
also mainly used in the breakdown of misfolded proteins and broken down proteins are 
generally 7-8 base pairs long. They are further degraded into separate amino acid components. 
These amino acids can be used for manufacture of new proteins. Proteasomal assembly and 
components are different in different model organisms, but the number or subunits that are 
necessary to be assembled are always very complex. In most organisms, the proteasome 
consists of a 20S, 16S, 19S and a 11S subunits (Murata et al., 2009). The whole complex is 
responsible for breaking down proteins by breaking peptide bonds between amino acids using 
ATP, produced by the cell. This is the final step of protein degradation. Before this process 
the proteins are tagged with a marker or a flag for degradation. This tagging is undertaken by 
ubiquitin, a very small protein of around 8kDa, that is responsible for tagging damaged 
proteins and is present in all organisms. These ubiquitin tagged proteins are then poly-
ubiquitinated, a process by which the ubiquitin protein binds to itself to form a long poly-
ubiquitin chain. Formation of this chain is the final stage in targeting damaged proteins to the 
proteasome (Li and Ye, 2008). 
 
1.21 Role of dysfunctional autophagy and protein turnover in disease 
 
Dysfunctional autophagy is involved in many disease phenotypes. One of the first ever 
described diseases involving dysfunctional autophagy is Static encephalopathy of childhood 
with Neuro-degeneration in Adulthood (SENDA). In patients, a mutation in WIPI4 gene was 
discovered. With the help of more functional studies in other model organisms like worms 
and flies (Grimmel et al., 2015), this gene was found to be involved in the formation of the 
autophagosome. This was the first ever study showing the link between autophagy and 
neurodegenerative disease (Saitsu et al., 2013). The most important characteristic of this 
disease is accumulation of iron in the brain. Patients suffering from the disease present with 
symptoms like spastic paraplegia, mental retardation, Parkinsonism and dystonia. Even 
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though studies have been very thorough, it has proven to be extremely difficult to find a 
mechanism of why accumulation of iron in the brain occurs. Following this, finding a cure for 
the same has been a daunting task for researchers in the field (Ebrahimi-Fakhari, 2013). 
 
Parkinson’s disease is the second most common form of progressive neurodegeneration. 
There are two kinds of this disease; the autosomal recessive and the sporadic form of 
Parkinson’s. Even though extensively studied, neither a proper mechanism nor a cure to 
Parkinson’s has yet been found. Patients with familial Parkinson’s are found to have 
mutations in PARKIN, PINK1, SNCA (α-Synuclein), LRKK2 (Leucine-rich repeat kinase 2) or 
GBA (Glucocerebrosidase) (Nalls et al., 2001). Moreover as PARKIN and PINK1 have been 
recently discovered to be involved in mitophagy, patients with Parkinson’s are found to have 
an accumulation of dysfunctional mitochondria and symptoms such as tremors, muscle 
rigidity, gait and flexed posture are seen among many other phenotypes. It has been especially 
difficult for researchers to find a cure because of the dual or multiple functions of the same 
protein (Duty and Jenner, 2011). For example, PARKIN is involved in other processes like 
ER protein translocation along with protein degradation (Takahashi et al., 2003), and a defect 
in autophagy is not the only phenotype caused by PINK1 or PARKIN mutation.  
 
Studies showing involvement of autophagy in cancer has been very complicated, since 
autophagy in cancer is like a double-edged sword. In primary stages of cancer, autophagy is 
inhibited to prevent cancer, as the cells lose their recycling ability. After the development of 
cancer, autophagy is necessary for the maintenance involving cyto protection (Mathew et al., 
2007). Mutation in the BECLIN1 gene has been found in many cancers like breast, ovarian 
and prostate cancer. BECLIN is involved in recruiting ATG14, which progresses into 
autophagy. Other than autophagy, BECLIN is also very important for its anti-apoptotic effect, 
which is necessary to prevent cancer in the early stages (Qu et al., 2003). Several other 
proteins, apart from BECLIN, like ATG5 and UVRAG have been found mutated in many 
cancer types (Park et al., 2014). Cancer is the most extensively studied disease; therefore, 
prevention or cure of cancer is not far-fetched.  
 
Defective proteasomal degradation of damaged proteins is also involved in many diseases. 
One of the most extensively studied diseases among this is Alzheimer’s. It is the cause of 60-
70% of dementia cases and is a chronic neurodegenerative disease. Patients present with 
symptoms like short-term memory loss, problems with language, disorientation and 
behavioural issues. Even though extensive research for Alzheimer’s is happening for the past 
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century, no treatment to improve the symptoms have been discovered yet due to the 
complexity of molecular mechanisms involved (Ubhi and Masliah, 2013).  
 
Examples of few other diseases caused by dysfunctional autophagy or protein turnover are; (i) 
Crohn’s disease, which is caused due to a mutation in the ATG16 gene (Baumgart and 
Sandborn, 2012). These patients present with symptoms like weight loss and severe vomiting; 
(ii) Hereditary spastic paraplegia is another disease that is caused due to a dysfunctional 
SPASTIN (SPG4) protein. SPASTINS are generally involved in membrane trafficking and 
proteolysis. Patients are found to have many conditions of neurological disorders (Depienne et 
al., 2007) and; (iii) Another very rare disease is Vici Syndrome, which is caused due to a 
mutation in the EPG5 gene, which is involved in autophagosome maturation. Patients with the 
Vici syndrome present with a multisystem disorder (del Campo et al., 1999). However, with 
the emergence of exome sequencing and whole genome sequencing, there have been many 
new genes discovered involved in these processes. Due to the discovery, pharmacological 
interventions have been more plausible.  
 
 
1.22 The TOR signalling pathway 
 
Most of the organisms have evolved specific mechanisms to efficiently switch between 
catabolic and anabolic states, which allowed them to survive and respond to stress under the 
conditions where nutrient availability is scarce. One such pathway is the mTOR or the 
mammalian Target of Rapamycin pathway. The mTOR (TOR hereafter) pathway responds to 
several environmental changes and it is apparent that TOR controls many of the cellular 
processes. Its most significant role has been related to growth and proliferation, as nutrient 
sensing is a very important signal for the growth of an organism. mTOR is a serine/threonine 
protein kinase and it belongs to the phophoinositide3-kinase (PI3K) family. This protein 
kinase interacts with several proteins in order to form two protein complexes namely, TOR 
Complex 1 and TOR Complex 2. Both the TOR complexes are large and contain six and 
seven very well studied protein components respectively. These proteins bind to their specific 
complexes in order to inhibit or activate them; sensing the conditions which are dictated to 
them by upstream regulating elements (Laplante and Sabatini, 2012).  
 
TOR was first discovered in the model organism Saccharomyces cerevisiae, where genetic 
screens identified TOR Complex 1 and TOR Complex 2 as targets of the molecule rapamycin. 
Rapamycin is a macrolide produced by Streptomyces hygroscopicus bacteria that gained 
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attention because of its anti-proliferative and anti-inflammatory properties (Li et al., 2014). 
Shortly after the discovery of TOR and rapamycin, many different approaches were used to 
identify the physical binding of rapamycin to TOR to inhibit TOR Complex 1. Although the 
inhibitory effects of rapamycin on TOR signalling is clear, the mechanism of action has 
proven to be much more complex than originally anticipated. However the process by which 
rapamycin forms a complex with FK506-binding protein and directly interacts and inhibits 
TOR Complex 1 but not TOR Complex 2 is still in the dark. The hypothesis that rapamycin 
may interfere with the structural integrity of TOR Complex 1 or with the specific activity of 
its kinase domain has still not been proven 20 years after the discovery of TOR signalling.  
 
TOR has been proven to regulate many cellular mechanisms downstream and it is one of the 
major nutrient sensors in all organisms. Because of the complex signalling networks linked 
with TOR, it is a major cause for numerous diseases. TOR deregulation, mostly hyper-
activation, has been linked to human diseases like cancer, obesity, type 2 diabetes and 
neurodegeneration. Furthermore, it has been demonstrated in several model organisms, 
ranging from yeast to mice, that activation or repression of TOR both genetically and 
pharmacologically can improve diseases phenotypes. Repression of TOR pharmacologically 
by rapamycin has also been shown to extend lifespan. This has led to pharmacologically 
activation or repression of the pathways for treatment of diseases. Moreover, as rapamycin is 
already a FDA approved drug, discovering its mode of action will be an important step 
forward in the future (Dazert and Hall, 2011).   
 
1.23 Upstream regulators of TOR 
 
TOR complexes are very well characterised and it has been demonstrated that both these 
complexes converge from two very different and distinct upstream regulators. TOR Complex 
1 integrates several inputs like growth factors, oxygen levels of the cell, amount of amino 
acids and it also senses the energy status of the cell. Since the number of upstream elements 
that are sensed by the TOR Complex 1 is numerous, downstream cellular mechanism like 
protein synthesis, autophagy and lipid synthesis, are also varied (Laplante and Sabatini, 
2012). Most of these process and signalling cascades have been described in detail in the 
Chapter 1.24. 
 
One of the most important signalling responses that are mediated by TOR is oxygen sensing 
(Filomeni et al., 2014). Oxygen sensing pathway also determines the energy status of the cell 
and this converges on to TOR signalling pathway (Filomeni et al., 2014). This response is 
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mainly mediated by Adenosine monophosphate-activated protein kinase or AMPK, which is 
the major fuel gauge of the cell that detects the balance between three forms of nucleotides 
namely; Adenosine monophosphate (AMP), Adenosine diphosphate (ADP) and Adenosine 
triphosphate (ATP). In conditions of low energy state or low oxygen state, AMPK 
phosphorylates the heterodimer Tuberous Sclerosis Complex 1 and 2 (TSC 1 and 2). TSC 1 
and 2 complex is a GTPase activation protein responsible for the activation of Ras homolog 
enriched in brain protein or RHEB. This activation activates RHEB, which in turn binds to the 
TOR complex. Overall in case of oxygen sensing mechanism, AMPK is responsible for 
deactivation or repression of TOR in conditions of low energy or low oxygen. This leads to 
improvement in glycolysis and energy production by better recycling of the available 
nutrients. On the other hand, it also might be responsible for halting development or growth of 
the organism which requires a constant supply of energy.   
 
In recent years, TOR has also been demonstrated to respond to DNA damage, which is also a 
cause of oxygen stress or low energy stress (Xu et al., 2012). It has been shown that DNA 
damage increases the expression of Phosphatase and Tensin homolog deleted on chromosome 
10 or PTEN. Increase in PTEN has been shown to downregulate TOR signalling axis 
severely, which in turn is shown to increase DNA damage response. A feedback loop 
involving the activation of AMPK has also been demonstrated to be involved in response to 
DNA damage (Shen et al., 2007).  
 
Insulin signalling is one of the processes that is extensively controlled by TOR. Most of the 
signalling pathways that control insulin signalling converge on to the TOR signalling 
pathway, which then controls downstream cellular processes. Insulin signalling is initiated by 
insulin receptors which are present on the surface of cellular membranes (Laplante and 
Sabatini, 2012). These insulin receptors (INR’s) are ubiquitous and are also present in almost 
all organisms. The insulin signalling pathway then branches into two distinct pathways, the 
PI3K and RAS pathways (Oldham and Hafen, 2003). Phophotidyl inositol 3-kinase or PI3K 
activation controls AKT or the Protein Kinase B signalling (PKB), and RAS activation 
controls the extracellular regulated signalling regulated kinase or ERK1 pathway (Guardiola-
Diaz et al., 2012). Both these pathways are studied for their involvement in metastasis. AKT 
pathway follows the canonical route of TSC 1 and 2 inhibition, which activates TOR 
signalling. It has also been demonstrated that AKT, upon sensing nutrients or insulin, can 
directly bind and inhibit RAPTOR which is a negative regulator of TOR, again leading to the 
hyper-activation of TOR.  
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Tumor Necrosis Factor α or TNF α, another widely studied molecule for its mechanistic 
action in metastasis, is also involved in activation of TOR by an inhibitory phosphorylation of 
TSC 1 and 2. This leads to a persistent activation of TOR. Nutrient and insulin signalling are 
also major regulators of growth and proliferation. Canonical WNT pathway controls TOR 
signalling which is very important for maintaining homeostasis of the organism. WNT 
pathway controls cell growth, proliferation, polarity differentiation and development. WNT 
activation inhibits glycogen synthase kinase 3 β (GSK3), which in turn activates the TSC 1 
and 2 network in order to inhibit TOR signalling (Kikuchi et al., 2011).  
 
Another major function of TOR signalling is the detection of amino acids, especially Leucine 
and Arginine. Recently it has also been demonstrated that arginine controls mTOR activity in 
a TSC2-RHEB dependent manner (Carroll et al., 2016). The canonical pathway commences 
with specific amino acids which are sensed by the mammalian RAG GTPases (Laplante and 
Sabatini, 2012). RAG GTPases in mammals comprises of four proteins namely RAG A, B, C 
and D. RAG A and RAG B proteins contain a GTP domain and is activated in the presence of 
GTP. Whereas, RAG C and RAG D proteins are activated in the presence of GDP. RAG A/B 
heterodimer interacts with RAPTOR, inactivating the protein by phosphorylation, which in 
turn activates TOR. This activated version of TOR is transported from the cytosol to the 
lysosome by an unknown mechanism. The translocation and activation of TOR on the 
lysosomal surface are controlled by the interaction between the RAG A/B heterodimer and 
RAGULATOR. It is coupled to the activation of GTP loaded RHEB, but this cascade is 
activated only if the RAGULATOR protein chaperones TOR to the lysosomal surface. 
Nonetheless, other proteins have also been demonstrated to sense amino acids to respond to 
the status of the cell. Proteins like Mitogen-Activated protein kinase or MAPK3, Mammalian 
vacuolar protein sorting 34 homolog or hVPS34 and Inositol polyphosphate monokinase 
(IPMK), have been demonstrated to activate TOR by the RAS-RAGULATOR system (Lynch 
et al., 2000). 
 
Finally, in order to control lipid biogenesis, TOR signalling also acts in response to lipids to 
produce the right amount of lipids necessary for homeostasis. It has been demonstrated that 
Phosphatidic acid (PA) activates mTOR, but there are no studies that show the mechanism of 
action. On the contrary, the process of activation has been studied intensively and it has been 
shown that overexpression of Phosphatidic acid synthase (PAS) and exogenous addition of 
Phosphatidic acid (PA) activates TOR persistently. Molecular basis of this activation have 
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been emerging and preliminary studies have demonstrated that this activation might be due to 
the stabilization of TOR complex by PA (Foster, 2013). 
 
All these upstream regulators of TOR converge on several cellular processes which control 
many activities of the cell. The de-regulation of many of these pathways have been 
demonstrated to cause distinctive diseases like cancer, obesity, diabetes, hepatic steatosis, etc. 
However, it is still not completely clear how upstream elements regulate TOR. Moreover, it is 
also unknown how these cascades are prioritized by the cell. Pharmacological inhibition or 
activation of these pathways, which then converge on to TOR, will aid in discovering new 
small molecules that need not necessarily act specifically on TOR for its beneficial effects 
(Laplante and Sabatini, 2012). 
 
1.24 Cellular mechanisms controlled by TOR signalling 
 
The TOR signalling pathway is involved in activation of many signalling cascades; however, 
autophagy is one of the very few processes that TOR de-activates (i.e. inhibition of TOR 
increases autophagy). This is regulated by inhibitory phosphorylation of UNC 51 like kinase 
(ULK1) or the mammalian autophagy related gene 13 (ATG13). The phosphorylation of 
ATG13 or ULK1 is responsible for inhibition of autophagy and this machinery is initiated by 
TOR. TOR controls autophagy by inhibitory phosphorylation of DAP1 (death-associated 
protein 1) that in turn suppresses autophagy. Moreover, the activation of ATG18 by TOR has 
been extensively studied to show they increase autophagy. Although TOR signalling has been 
shown to regulate autophagy, it has also been demonstrated that TOR directly regulates 
lysosomal biogenesis. TOR phosphorylates Transcription factor EB or TFEB that prevents the 
protein from entering into the nucleus, where it activates an array of autophagy initiating 
genes (Roczniak-Ferguson et al., 2012). Nutrient sensing has a major role to play in 
autophagy. When the organism is low on nutrients, the nutrients that are already present 
recycle more efficiently. This is an evolutionary mechanism that is controlled by TOR, as the 
presence of nutrients has a major role in activation or repression of TOR signalling. In case of 
a low nutrient environment the cell represses TOR, which in turn increases autophagy for 
more efficient recycling of the available nutrients to support other cellular processes. 
 
On the other hand, TOR positively regulates energy balance. It has been demonstrated that 
TOR directly controls ATP production in the cell by controlling OXPHOS in the 
mitochondria and glycolysis, which are two major pathways involved in producing ATP. 
Firstly, there are reports proving that TOR alters OXPHOS activity by directly regulating 
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mtDNA (Villa-Ceusta et al., 2014), which is responsible for encoding major components of 
OXPHOS system or ETC. This is mediated by TOR by activating PPAR–Coactivation 
activator (PGC1α). The activation of PGC1α is responsible for increasing mitochondrial 
biogenesis (Cunningham et al., 2007). Secondly, TOR is responsible for regulation of 
glycolysis. This is carried out by the upregulation of Hypoxia inducible factor 1α or HIF1α, 
which is responsible for the activation of many genes involved in glycolysis (Cheng et al., 
2014). These transcriptional regulations are said to have intermediate factors as the presence 
of TOR in the nucleus is minimal (Sun et al., 2011). Moreover, mitochondria also participate 
in a signalling cascade that lead to inhibition of TOR activity (Schieke and Finkel, 2006). 
However, the involvement of these mitochondrial signals is still not understood. 
 
TOR also positively regulates lipid biogenesis, which is necessary for forming membranes in 
many organelles of all organisms. TOR directly activates Sterol regulatory element-binding 
protein 1 or 2 (SREBP 1 or 2), which is a major transcription factor for genes that improve 
fatty acid and cholesterol biogenesis. TOR also regulates SREPB by inhibitory 
phosphorylation of LIPIN1, which is responsible for inactivation of SREBP (Porstmann et al., 
2008). It has also been demonstrated that TOR controls adipogenesis by activation of 
Peroxisome-Proliferator-activated receptor  (PPAR) (Kim and Chen, 2004). Positive 
regulation of lipid biogenesis and TOR are closely linked because of growth regulation, as 
lipids are major building blocks in the formation of almost all membranes during the 
development of an organism.  
 
The most important role of TOR is probably the positive regulation of protein synthesis. TOR 
controls protein synthesis by controlling two different mechanisms. To begin with, TOR 
phosphorylates the EIF 4E-binding protein or 4EBP. This phosphorylation inhibits 4EBP 
from binding to the EIF4E protein, which in turn activates the protein and cap dependent 
translation of proteins. The second mechanism is regulated by phosphorylation of S6 Kinase1 
protein (S6K1), which is responsible for the activation of mRNA biogenesis, translation 
initiation and also elongation in protein translation (Wang and Proud, 2006). It is very well 
known that S6K1 regulates most parts of the translational machinery, but mechanism by 
which it coordinates most of these processes is still unclear. On the other hand, TOR regulates 
protein translation by interacting with promoter regions of RNA polymerase transcribed 
genes. This is controlled by two mechanisms; (i) TOR activates Tripartite motif containing 
protein-24 or TIF-1A. This promotes the interaction with RNA polymerase 1 or POL1 which 
increases translation (Mayer et al., 2004) and; (ii) TOR inhibits MAF1 via inhibitory 
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phosphorylation, which is a repressor of Polymerase III or POLIII. This increases the 
presence of tRNA which leads to increase in translation (Shor et al., 2010). Overall, protein 
synthesis is one of the major processes controlled by TOR as this directly corresponds to the 
growth of an organism. Figure 1.11 is a flow chart of the upstream elements that control TOR 
and the downstream signals that TOR orchestrates. 
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Figure 1.11 The TOR signalling pathway 
The diagram summarizes the upstream elements that control and TOR and the downstream 
signalling mechanisms that TOR orchestrates. 
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1.25 Role of TOR signalling in diseases 
 
In majority of cancers, it has been observed that TOR signalling is hyper activated. Activation 
of TOR is responsible for increase in glycolysis and growth of cancer cells. In many cancers, 
a mutation in P53, which is a tumor suppressor or TSC1/2 heterodimer is found to be the 
cause of the disease (Hodges et al., 2001). When TSC 1and 2 is not present to inhibit TOR, it 
is hyper-activated and leads to excessive growth. This TOR hyper-activation can also lead to 
increase in inhibitory phosphorylation of 4EBP, which in turn leads to an increase in protein 
translation. This supports the hypothesis that cancer cells need more proteins that are 
necessary to support its proliferation by cell cycle increase and metastasis. Ribosome 
biogenesis is also increased in these cases which are likely to promote metastasis by providing 
machinery for growth. Although ERK1 and S6K1 have not been shown to play a very 
important role in cancer, more studies have started emerging regarding the same. It has also 
been shown in many cases that an increase in lipid biogenesis is important for maintenance of 
cancer, especially an activation in SREBP1 (Guo et al., 2014). Another pathway that leads to 
cancer through TOR regulation is the autophagy pathway; an absolute balance in autophagy is 
necessary for maintaining homeostasis of the cell. Pharmacological inhibition of parts of this 
signalling cascade has been demonstrated to halt metastasis in many cases (Mathew et al., 
2007). 
 
Involvement of TOR in many metabolic diseases has been demonstrated, but to isolate a 
particular mechanism is very difficult as it controls an array of metabolism controlling genes. 
Fasting and feeding states in mice have been used to study these effects controlled by TOR 
(Laplante and Sabatini, 2012). They switch between the anabolic and catabolic states that are 
controlled by TOR, which in turn controls metabolism. This part of TOR signalling cascade 
has not been thoroughly studied as a full body knockout of TOR causes embryonic lethality in 
mice (Murakami et al., 2004). For overcoming these conditions, tissue specific knockout mice 
have been used and promising results have been emerging from these studies (Russell et al., 
2011).  
 
In the brain, hypothalamus is the part that maintains energy balance and it is a complex 
network of signals that responds and packages signals to TOR. In response to energy balance, 
TOR can deactivate a gene called orixigenic neuropeptide or NPX, which responds to the food 
intake by an organism (Wiczer and Thomas, 2010). This deactivation leads to intake of more 
food leading to obesity which increases the incidence of other diseases such as type 2 
 50 
diabetes. In many studies it has been shown that conditional knockout of TOR in brain leads 
to lean mice even when fed with a high fat diet (Yang et al., 2012).  
 
One other major disease without a proper cure is type 2 diabetes, which is also said to be a 
cause of hyper-activation of TOR (Zoncu et al., 2011). Increase in TOR causes an increase in 
phosphorylation of S6K1, which is responsible for a feedback loop inhibition of insulin 
signalling leading to insulin resistance, thereby causing type 2 diabetes. As an evidence, it has 
been shown that knockout of S6K1, reduced this feedback loop and decreased insulin 
resistance (Leibowitz et al., 2008).  
 
TOR has also been shown to control muscle contraction through synthesis of specific 
proteins. In many cases, the conditional knockout of TOR in mice is said to cause myopathy. 
This is due to the loss of functionality of OXPHOS, ultimately leading to death. It has also 
been shown that through the control of PGC1α, TOR increases the accumulation of glycogen 
in muscles (Risson et al., 2009). 
 
TOR has also been shown to cause many neurodegenerative diseases like Parkinson’s, 
Alzheimer’s, Huntington’s and Amyotrophic Lateral Sclerosis. The common cause of all or 
most of these neurodegenerative diseases are protein aggregates or damaged proteins. Hyper-
activation of TOR leads to a decrease in autophagy, which causes protein aggregation as 
proteins are not recycled. Additionally, TOR activation also promotes protein synthesis, 
which increases the possibility of protein aggregation (Laplante and Sabatini, 2012). Many 
mouse models have been developed to phenocopy human diseases like Parkinson’s and 
Huntington’s which causes neurodegration and increases the presence of aggregate prone 
proteins. Pharmacological inhibition of TOR has been shown to rescue these phenotypes 
providing neuroprotection and improving clearance of these proteins. 
 
It is not very surprising that one of the many pathways that play a role in ageing is TOR. 
Although it has been demonstrated that TOR and dietary restriction produces similar increase 
in lifespan. However, it has also been demonstrated that there is no additive effect with both 
interventions; which denotes that they act in the same pathway (Blagosklonny, 2010). 
Additionally it has been demonstrated that TOR is hyper- activated in aged organisms and 
rapamycin feeding can extend the lifespan of old mice (Harrison et al., 2009). However, 
specific molecular mechanisms of these pathways are still unknown. TOR is also shown to be 
involved in many other lesser studied diseases, one of which is Nonalcoholic fatty liver 
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disease. When TOR is activated, ketogenesis and lipogenesis are increased, which causes 
accumulation of fat in the liver leading to the disease (Rinella, 2015).  
 
1.26 Pharmacological inhibitors of the TOR complex 
 
TOR was first discovered in budding yeast when the mechanism of action for rapamycin was 
investigated. Rapamycin was initially used as an anti-fungal agent and also as an 
immunosuppressant. The drug was approved by FDA as an immunosuppressant to be used 
during transplantation of organs. However, it was continually examined for its anti-
proliferative action as a valid therapy for cancer (Seto, 2012). It is still under investigation and 
rapamycin is not used in cancer trials because of its unstable chemical structure and 
insolubility in water. To overcome these limitations, many other analogs of rapamycin like; 
Temosirolimus, Everolimus and Deforolimus have been used and have been demonstrated to 
inhibit TOR. These drugs have been studied for the past decade and research has shown many 
advantages and disadvantages over rapamycin. These drugs have still not been used in human 
trials. There have also been some rapalogs discovered like 32-deoxy rapamycin or 
zotorolimus. These novel drugs have been used instead of rapamycin in many studies due to 
their chemical stability and water solubility unlike rapamycin, making them more convenient 
for human trials (Lamming et al., 2013).  
 
Even though it has been almost 20 years since TOR was discovered, there is no clear proof of 
concept of how TOR is inhibited by rapamycin. Rapamycin has also been shown to inhibit 
TOR by a completely novel mechanism as it does not bind to the kinase domain of TOR. Pre-
clinical trials have demonstrated to be anti-proliferative for some cancers. However most of 
them are resistant to rapamycin which makes it more difficult to study (Dumont and Su, 
1996). As novel inhibitors of TOR are being discovered at a very fast rate and also the 
mechanisms of action for old inhibitors are surfacing, we can be sure that more precise and 
effective drugs will be discovered in the near future. 
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1.27 Aims 
 
The ability of an organism to respond to stress progressively declines with age; therefore 
studying the process of stress adaptation can aid in understanding the mechanisms of quality 
control that fail during ageing. It has been already reported that damaged mitochondria 
accumulate with age (Lopez-Otin et al., 2013). Understanding why this happens under a stress 
condition that mimics the ageing process is beneficial to prevent or delay the onset of age 
related diseases. It has also been shown that metabolic rate increases with temperature, where 
the mitochondria play a crucial role (Scialo et al., 2015). I aimed to investigate the signalling 
mechanisms through which mitochondria regulate this adaptation. The specific aims of this 
study were; 
 
1) To ascertain if a mitochondrial ROS signal is essential for this adaptation (Chapter 3). 
2) To understand which ROS entity; either H2O2 or O2- is involved in this process (Chapter 4).  
3) To investigate the role of mitochondrial ROS in controlling TOR signalling (Chapter 5).  
4) Can mitochondrial turnover be responsible to maintain homeostasis of an organism 
(Chapter 6)? 
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Chapter 2. Materials and methods 
 
 
2.1 Reagents 
 
All reagents used in this thesis, their providers and catalogue numbers are listed in Table 
2.1. 
 
Reagent Company Catalogue number 
Acetyl coenzyme A lithium salt Sigma A2181-100MG 
Active dried yeast 
Dutscher 
Scientific 
789093 
Adenosine 5′-diphosphate sodium salt 
(ADP) 
Sigma A2754-5X1G 
Antimycin A 
Santa Cruz 
Biotechnology 
sc-202467A 
Bovine Serum Albumin (BSA) Sigma A7906-100G 
BSA (fatty acid free) Sigma A7030-10G 
Bradford Reagent Sigma B6916-500ML 
Bromophenol Blue Sigma B0126-25G 
Chroloform Sigma 288306 
Clarity Western ECL substrate kit Biorad 170-5061 
cOmplete, Mini, EDTA-free Protease 
Inhibitor Cocktail Tablets in EASYpacks. 
Roche 4693159001 
DEPC water Qiagen 129112 
Dichlorofluorescin (H2DCF) Sigma D6883-50MG 
5,5′-Dithiobis(2-nitrobenzoic acid) Sigma D8130-5G 
D-(+)-Glucose 
Santa Cruz 
Biotechnology 
sc-211203A 
Dithiothreitol  (DTT) 
Life 
Technologies 
R0862 
Digitonin 
Santa Cruz 
Biotechnology 
sc-280675 
Dimethylsulfoxide (DMSO), sterile filtered 
Santa Cruz 
Biotechnology 
sc-359032 
Table 2.1 List of reagents 
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DNase I + DNase I Buffer  
Thermo Fisher 
Scientific 
89836 
dNTP 
Thermo Fisher 
Scientific 
18427088 
Drosophila Agar Type II 
(Apex bioresearch products) 
Dutscher 
Scientific 
789150 
D-(+)-Saccharose VWR 27480.294 
Ethanol (EtOH) 
Fisher Scientific 
UK 
E/0650DF/17 
Ethylenediaminetetraacetic acid (EDTA) Sigma EDS-100G 
Ethyleneglycol-bis(2-amino-ethylether)-
N,N,N',N'-tetracetic acid (EGTA) 
Sigma 03777-10G 
Guanidine Hydrochloride 
Santa Cruz 
Biotechnology 
sc-202637 
sn-Glycerol 3-phosphate 
bis(cyclohexylammonium) salt 
Sigma G7886-5G 
HEPES Sigma H3375-25G 
Isopropanol Sigma 190764 
Magnesium Chloride, Hexahydrate 
Santa Cruz 
Biotechnology 
sc-203126A 
Maize meal 
TRS white 
maize meal 
4767967 
 
MitoSOX 
Life 
Technologies 
M36008 
Nipagin M (methyl 4-hydroxybenzoate) Sigma H5501-500G 
Phosphate Buffered Saline (PBS) tablets Cambio MC-09-9400-100 
Phospho(enol)pyruvic acid monopotassium 
salt 
Sigma 860077-1G 
PMSF (Phenylmethanesulfonyl fluoride) Sigma P7626-1G 
Potassium cyanide (KCN) Sigma 60178-25G 
Potassium Hydroxide (KOH) Sigma 484016-1KG 
Potassium Phosphate, Monobasic (KH2PO4) 
Santa Cruz 
Biotechnology 
sc-203211A 
L-Proline Sigma P5607-25G 
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Propionic acid VWR 8.00605.1000 
Propyl gallate Sigma P3130-100G 
ProSeive EX Running Buffer  Lonza 200307 
ProSeive EX Transfer Buffer  Lonza 200309 
Random Hexamer Primer 
Thermo Fisher 
Scientific 
48190011 
RevertAid Reverse Transcriptase + 
RevertAid Reverse Transcriptase Buffer 
Thermo Fisher 
Scientific 
EP0441 
RNase Inhibitor 
Thermo Fisher 
Scientific 
EO0381 
Rotenone 
Santa Cruz 
Biotechnology 
sc-203242 
SensiFAST SYBR Hi-ROX Kit Bioline BIO-92020 
Sodium dodecyl sulfate (SDS) 
Santa Cruz 
Biotechnology 
sc-264510C 
Skimmed milk powder Sigma 70166-500G 
Sodium citrate dihydrate Sigma W302600-1KG-K 
Sodium L-ascorbate Sigma A4034-100G 
Sodium pyruvate Sigma P2256-25G 
Sodium succinate dibasic hexahydrate Sigma S9637-500G 
Soybean flour 
Santa Cruz 
Biotechnology 
sc-215897A 
TMPD (N,N,N′,N′-Tetramethyl-p-
phenylenediamine dihydrochloride) 
Sigma 87890-25G 
Treacle 
Lyle’s Black 
Treacle 
- 
Tris 
Santa Cruz 
Biotechnology 
sc-3715B 
Tris-HCl Promega H5121 
Triton X-100 Promega H5141 
Tri-reagent 
Molecular 
research centre 
TR118 
Tween 20 Sigma P9416-100ML 
Wheat germ MP biomedical 0290328805 
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2.2 Preparation of fly food 
 
The reagents shown in Table 2.2 were measured into a glass beaker and slowly added to the 
required volume of deionized water (pre-warmed to 37oC, under constant agitation with a 
magnetic stirrer) in another glass beaker.  
 
 
Weights are listed per 1000 ml of fly food 
Final concentration Dry weight Ingredient 
1 % (w/v) 10 g Drosophila agar type II 
1.5 % (w/v) 15 g D-(+)-Saccharose 
3 % (w/v) 30 g D-(+)-Glucose 
3.5 % (w/v) 35 g Active dried yeast 
1.5 % (w/v) 15 g Maize meal 
1 % (w/v) 10 g Wheat germ 
1 % (w/v) 10 g Soya flour 
3 % (w/v) 30 g Treacle 
 
 
 
 The food ingredients and water were mixed thoroughly and the yeast was allowed to ferment 
for 5 minutes before the temperature was gradually increased to approximately 85oC. The 
food mix was allowed to boil for 20 minutes before being allowed to cool to below 70oC. 
When the temperature dropped to below 70oC, propionic acid (final concentration = 0.5 % 
(w/v)) and nipagin M (made in a 10 % (w/v) stock solution in absolute EtOH; final 
concentration in food = 0.1 % (w/v)) were added. Additional deionized water was added to 
the required volume. Food was stirred continuously throughout the whole procedure. It was 
then dispensed into vials (2 ml per vial) or bottles (30 ml per bottle) and allowed to set over 
several hours before being plugged and stored at 4oC until use. Before use, food was allowed 
to warm up to room temperature for 2 hours. Food supplemented with rapamycin was 
prepared by adding 50mM stock of rapamycin dissolved in EtOH to achieve a final 
concentration of 200µM in the food. EtOH supplementation was used as a control food. Both 
rapamycin and EtOH were added after the addition of propionic acid and nipagin. 
 
 
Table 2.2 List of ingredients for preparing of fly food 
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2.3 Fly stocks and lifespan assessments 
 
 
 
 
All UAS transgenic and GAL4 driver lines were backcrossed for at least 6 generations into a 
DAH background. UAS-AOX flies have been previously described in (Fernandez-Ayala et al., 
2009). Detailed descriptions of fly stocks are shown in Table 2.3. The flies were maintained on 
standard media (1% agar, 1.5% sucrose, 3% glucose, 3.5% dried yeast, 1.5% maize, 1% wheat, 
1% soya, 3% treacle, 0.5% propionic acid, 0.1% Nipagin). The transgenes were expressed by 
crossing virgin females with the GAL4 gene, under the control of the daughterless promoter 
Fly Strain Source Details 
Dahomey Bjedov et al., 2010 Wild type flies incorporated with the 
w1118 mutation by repeated 
backcrossing. 
wDah ; UAS-AOX   
 
Fernandez-Ayala et al., 2009 Dahomey backcrossed UAS-AOX on 
2nd Chromosome. 
wDah ; daGAL4 Bloomington Drosophila 
Stock Center (BDSC) 
Dahomey backcrossed daughterless 
GAL4 driver on 3rd Chromosome 
(BDSC No: 55849). 
 
wDah ; UAS-mito-ORP1-
roGFP2 
Albrecht et al., 2011 Dahomey backcrossed 
mitochondrially targeted ROS 
reporter on 2nd Chromosome. 
wDah ; UAS-mtCatalse Mockett et al., 2010 Dahomey backcrossed 
mitochondrially targeted catalase on 
2nd Chromosome. 
wDah ; UAS-Sod2 Bloomington Drosophila 
Stock Center (BDSC) 
Dahomey backcrossed Sod2 
overexpressors on 2nd Chromosome 
(BDSC No: 24494). 
 
wDah  ; TubGS Neretti  et al., 2009 Dahomey backcrossed Tubulin 
GAL4/GeneSwitch driver on 3rd 
Chromosome. 
wDah  ; UAS-Pink1 Park et al., 2009 Dahomey backcrossed Pink1 
overexpressors on 3rd Chromosome. 
wDah  ; UAS-Parkin Park et al., 2009 Dahomey backcrossed Parkin 
overexpressors on 3rd Chromosome. 
Table 2.3 List of fly stocks 
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with males containing the UAS-Transgene construct. In order to induce gene expression using 
tubulin-Gene Switch-Gal4 an appropriate amount of Mifepristone (RU-486) stock solution (or 
the same amount of ethanol) was added to produce a final concentration of 200 M in the 
standard food. With the help of this system I was able to temporally modulate the expression of 
the transgene or the knockdown by changing the concentration of the drug in the food. 
Additionally since this expression system is inducible, I was able to avoid any developmental 
phenotypes that might be caused by the GAL4 system. We have made use of the ubiquitous 
daGAL4 expression system or tubulin-Gene Switch-Gal4 for expression in all the flies used in 
subsequent experiments. Controls were obtained by crossing males containing the transgene 
constructs, with Dahomey virgin flies for the daughterless promoter crosses. Only female flies 
were used in this study. 24 hours after eclosion the flies were anesthetized on CO2 and collected 
to vials with standard fly food at a density of 20 flies per vial. The flies were then maintained at 
29oC in a light: dark cycle controlled incubator for further experiments. For flies used for 
lifespan experiments, flies were changed to new vials every 2-3 days and the number of dead 
flies was scored. Lifespan experiments were performed with a minimum of 80 flies and repeated 
at least twice. For lifespan experiments in hypoxia and hyperoxia, 20 flies per vial were 
maintained at oxygen levels of 5% and 50%, respectively, at 25°C. Flies in hypoxia and 
hyperoxia were changed to new vials once in 7 days and 4 days respectively to avoid detrimental 
effects of rapid reoxygenation.  The median and maximum lifespan (the last 10% of surviving 
flies) were calculated for each experiment. Adult flies, developed at 25oC and aged at 29oC for 
approximately 10 days were used for all the experiments, unless otherwise stated.  
 
2.4 Quantitative real time PCR 
 
RNA extraction 
 
For complete RNA extraction, a total of 10 flies were anesthetized on ice in a tube and 
immediately frozen at -80oC. The frozen flies were ground completely using a plastic 
homogenizer in 50µl of Tri-Reagent (Molecular Research Center Inc, Ohio, USA), and then after 
grinding another 450µl of Tri-Reagent was added to the vial. The homogenates were then 
incubated at room temperature, for 5 minutes. After which, 100 µl of pure chloroform was added 
and the samples were vortexed thoroughly, followed by incubation at room temperature for 2-3 
minutes, before centrifuging for 15 minutes at 12000g at 4 oC.  
 
The upper aqueous phase obtained was transferred to a new tube, and then 500µl of isopropanol 
was added. RNA was precipitated at room temperature for 10 minutes, and then followed by 
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centrifugation.  The obtained pellet was thoroughly washed by adding 1ml of DEPC water with 
75% ethanol. Washing was followed by vortexing the mix, and then centrifuging at 7500g at 4oC 
for 5 minutes. After centrifugation, the ethanol mix was completely removed by using 0.5mm 
needle for suction.  
 
The pellet was then air dried for 5-10 minutes at room temperature. After this, the RNA pellet 
was re-suspended with 89µl of DEPC treated water, and then subsequently treated with DNaseI 
(FERMENTAS INC., Maryland, USA) and DNaseI buffer (FERMENTAS INC., 
Maryland,USA) 1µl and 10µl respectively in a total volume of 100µl in order to remove any 
DNA contamination. Further, the samples were incubated at 37oC for approximately 1 hour.  
 
Ethanol precipitation of the DNaseI treated samples was followed after that. The RNA was 
precipitated by adding 1/10 volumes of 3M Sodium Acetate pH 5.2 and 2.5 volumes of 95% 
ethanol in DEPC treated water. The samples were incubated at -20°C for a minimum of 30 
minutes up to 1 hour. Then, the samples were centrifuged at 16000g for 20 minutes at 4oC. The 
supernatant was removed by using a vacuum needle followed by washing with 1ml of 75% 
ethanol in DEPC-Water. The step was repeated to ensure proper washing. The pellet was left to 
dry at room temperature for 5 minutes, and then re-suspended with, 10µl of DEPC water. The 
RNA concentration was then measured using a Nano-Drop 2000c (Thermo Scientific, 
Wilmington, USA) apparatus, and adjusted to around 1µg/µl, and then stored at -80oC for cDNA 
synthesis. 
 
cDNA Synthesis 
 
For each cDNA sample prepared, a triplicate was made, and then pooled together for complete 
cDNA synthesis. Each synthesis reaction has a final volume of 20 µl, and a total of 2μg of RNA 
sample. All the following reactions were performed in a 96 well 0.2 ml plate. 2µl of the RNA 
sample was added to the corresponding reaction well, containing 9.6µl of DEPC water, 1µl of 
10mM dNTP and 0.4µl of random hexamers. The mixed samples were then incubated in a 
thermal cycler at 90oC for 3 minutes. After incubation, the samples were added with 4µl of 5X 
reverse transcriptase buffer and 1µl of RNase inhibitor. The samples were then incubated for 10 
minutes at 25oC. Finally 2µl of Reverse transcriptase was added to each individual reaction mix.  
 
The samples were then, again incubated in a stepwise manner in a programmed cycle of 25oC for 
10 minutes, 37oC for 60 minutes and 70oC for 10 minutes. All the triplicated samples were 
pooled in a single tube and then, the cDNA was stored at -20oC. 
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qPCR-Standard curve method 
 
The “primer 3” primer design software was used to design the best primer for each specific gene. 
The cDNA samples were thawed. A stock was prepared by pooling together 5µl of all the 
prepared cDNA samples. 20 µl of the stock is then diluted in 80µl of nucleic acid free water 
(FERMENTAS INC., Maryland, USA), and then serial diluted to three other concentrations, 
namely 1, 1:10, 1:100 and 1:1000, making four standard dilutions in total. The stock was 
prepared in order to determine the standard curve and to be sure that, all the gene amplifications 
fall inside the standard curve. Samples were diluted 20 times. All the standards and samples were 
added in triplicates in the 96 well plates and then stored for further use. 
 
The reaction mix contains 10µl of SENSI FAST enzyme (Bioline, Taunton, USA), 0.4µl of 
forward and reverse primer and 5.2 µl of Nuclease free water. The total adds upto 16µl of the 
reaction mix in the well. I have used fast optical 96 well plates (Applied Biosystems, San 
Francisco, USA) for qPCR. Then 4µl of samples and standards were pipetted into the reaction 
mix, making the reaction volume to 20µl. The reaction mix and the samples were thoroughly 
mixed. The plate was then sealed with optical clear cover and subjected for a short spin. The 
plate was placed in a StepOne, qPCR machine (Applied Biosystems, San Francisco, USA) and 
then, the cycle involving 95 oC for 5s, 60oC for 10s and then finally 72oC for 5s was initiated. 
This cycle is a repeated upto 45 times for the valid quantification. The values were quantified by 
StepOne v2.1 software (Applied Biosciences, San Mateo, USA). All the samples used for 
quantifications with different primers were also used for quantification with Gapdh primers for 
Gapdh (CG12055). These values were then used for normalization from the values obtained 
from other primers.  A list of all primers used in this thesis is given in Table 2.4. 
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Gene/Primer Name Primer Sequence 
16s Forward  5’ - TTCGTCCAACCATTCATTCC - 3’ 
16s Reverse  5’ - TCTAACCTGCCCACTGAAAA - 3’ 
Catalase Forward 5’ - TGATTCCTGTGGGCAAAATG - 3’ 
Catalase Reverse 5’ - CAGACGACCATGCAGCATCT - 3’ 
Co1 Forward 5’ - GGAGGATTACCTTTTTTAGG - 3’ 
Co1 Reverse 5’ - CCTGGAGCATTAATTGGAGATG - 3’ 
Cytb Forward 5’ - AAATTCCGAGGGATTCAATTTT - 3’ 
Cytb Reverse 5’ - TCAACTGGTCGAGCTCCAAT - 3’ 
Delg Forward 5’ - CAGCCAGAAGAGTTCCTCCA - 3’ 
Delg Reverse 5’ - CTCGGGTATCTTCAGGCGTA - 3’ 
Dj-1 beta Forward 5’ - GGGAAATCCCTCACCTCGTAT - 3’ 
Dj-1 beta Reverse 5’ - TTTTGAGGGCGAACTCGTAG - 3’ 
Gapdh Forward 5’ - GACGAAATCAAGGCTAAGGTCG - 3’ 
Gapdh Reverse 5’ - AATGGGTGTCGCTGAAGAAGTC - 3’ 
Glyoxalase Forward 5’ - GTCACCTCAATGGTGGCCTTG - 3’ 
Glyoxalase Reverse 5’ - GCCAAGTTCTCGCTGTACTTTC - 3’ 
Hsp22 Forward 5’ - CCTTTCACGCCTTCTTCCAC - 3’ 
Hsp22 Reverse 5’ - TAGCCATCCTTGTTGACGGT - 3’ 
Hsp60 Forward 5’ - ATGTTCCGTTTGCCAGTTTC - 3’ 
Hsp60 Reverse 5’ - GATCACATTGCGACCCTTG - 3’ 
Hsp70 Forward 5’ - ACTCACACACAATGCCTGCT - 3’ 
Hsp70 Reverse 5’ - TAGACACCCACGCAGGAGTA - 3’ 
Impl3 Forward 5’ - CGGGATTGGACACCATAAGC - 3’ 
Impl3 Reverse 5’ - GCAACACCGACATCCTCAAG - 3’ 
ND1 Forward 5’ - TTGAGAAAGCTGCCTCCCTA - 3’ 
ND1 Reverse 5’ - CACCACCAACGACAACAAAG - 3’ 
Parkin Forward 5’ - GATACGTGTTCTGCCGCAAT - 3’ 
Parkin Reverse CTGCATTTTGGACAGGGCTT - 3’ 
Pink1 Forward 5’ - GCCGCAATATGTCGCTGTAT - 3’ 
Pink1 Reverse 5’ - ATCGTCCTGCAGCTCGATTA - 3’ 
PxGPx Forward 5’ - AGGTGTTCGCCAAGGTAAGAC - 3’ 
Table 2.4 List of Primers 
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PxGPx Reverse 5’ - GGTCTGCTTGGCCTTTAGGTA - 3’ 
Rpl32 Forward 5’ - AGCATACAGGCCCAAGATCGTGAAGAA - 3’ 
Rpl32 Reverse 5’ - CACGTTGTGCACCAGGAACTTCTTGAA - 3’ 
Sdhb Forward 5’ - CATCAACACCTCCAAGTCGC - 3’ 
Sdhb Reverse 5’ - ACAGCATGCACTCGTACAGG - 3’ 
Sod Forward 5’ - GAACTCGTGCACGTGGAATC - 3’ 
Sod Reverse 5’ - GGTGGTTAAAGCTGTCTGCGT - 3’ 
Sod2 Forward 5’ - GTCTGGTGGTGCTTCTGGTG - 3’ 
Sod2 Reverse 5’ - GCCCGTAAAATTTCGCAAAC - 3’ 
Spargel Forward 5’ - AAACTGAGGATCCTGGCACA - 3’ 
Spargel Reverse 5’ - CGCTTTGGATGCTGGCTATT - 3’ 
 
2.5 Western blot analysis 
 
Protein extraction 
 
Around 10 flies were anesthetised with CO2 and stored at -80oC in a tube. Frozen flies or fresh 
flies were then grinded using a sterile plastic homogenizer, in a homogenizing buffer (1,5% 
Triton X-100, 1 tablet of pre-made complete mini EDTA-free protease inhibitor and 1 tablet of 
available phosphatase inhibitor (Roche Diagnostics, Mannheim, Germany), dissolved in 1 X 
PBS. After crushing the flies, they were incubated on ice for around 10 minutes, to let the 
protease inhibitor work. The samples were then subjected to centrifugation for 15 minutes at 
13000g at 4oC. Following this, the supernatant or the total fly extract was transferred to a new 
tube.  
 
SDS-PAGE 
 
The protein concentration of the samples was measured using a Bradford Assay. The samples 
were diluted up to 35 µg of protein in each sample with required amount of sterilized water and 
Sample buffer (40% v/v of Glycerol, 8% v/v SDS, 25% v/v 1M Tris-HCL pH 6.8 and 
Bromophenol blue slurry 0.015%). 8ml of sterilized water is added along with 20% v/v of 1M 
dithiothreitol (DTT) just before using. The diluted samples were then heated on a heating block 
at 100oC for a minimum of 5 minutes and then moved to ice.  
 
The electrophoresis tank was filled with 1X Running buffer diluted from 10 X Running buffer 
(Lonza, Basel, Switzerland). A readymade gel from Bio-Rad (AnyKD, Criterion TGX, Marnes-
la-Coquette, France) was used. The protein ladders were filled with volume of 3µl at one end 
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and 7µl at the other. 25µl of the samples were added in each well accordingly. The tank was 
subjected to a voltage of 130 V until the proteins have migrated into the gel. The voltage was 
then increased to 150 V and run for approximately 40 minutes or until the proteins have migrated 
till the end of the gel. The gel was then removed from its casing and then soaked in the running 
buffer until further use. 
 
Blotting 
 
Two techniques were used for transfer of proteins to a nitrocellulose membrane. I) Dry Blotting 
and II) Wet Blotting. 
 
Dry blotting device, iBlot Dry Blotting System (Invitrogen, New York, USA) was used for dry 
blotting. The recommended kit, iBlot gel transfer stacks (Invitrogen, New York, USA) were 
used. They were placed in the recommended order, and the blot was run at 20 V for a span of 6 
minutes. After completion, the membrane was carefully transferred to a bath of 1X PBS. For 
Wet blotting the tank was filled with 1X blotting buffer diluted from 10 X Western Blot 
transfer buffer (Lonza, Basel, Switzerland).  The sandwich was then packed in the proper order 
and the blot was started. The blotting was done at 40V at room temperature for approximately 
1 hour. After the run was complete, the sandwich was unpacked and then, the membrane was 
carefully transferred to a bath containing 1 X PBS solution. 
 
Immunodetection 
 
After transfer, the membranes were washed throughly with 1X PBS and then stained with 
Ponceau S (0.1 % w/v Ponceau S in 5% v/v acetic acid, made upto 1 litre with double distilled 
water) for a few seconds, to verify the complete transfer of proteins to the membranes. The 
membranes are washed throughly to remove the stain, with water or 1X PBS. The mebranes 
were then subjected to blocking in 5% Milk, dissolved in 1X PBS-Tween for 1 hour, with 
continous shaking. Different dilutions of primary antibodies with the appropriate secondary 
antibodies were used, which were also diluted in  5% Milk in 1X PBS-Tween. The conditions 
and manufacturer information for all the anitbodies used are described in detail in the Table 
2.5 below.  
 
The membranes were incubated in the primary antibody in 5% Milk, dissolved in 1X PBS-
Tween overnight at 4oC. After the incubation, the membranes were washed again with 1X 
PBS-Tween and incubated in the appropriate secondary antibody complementary to the 
primary for 1 hour at room temperature. The membranes were then washed repeatedly with 
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1X PBS-Tween and then, finally washed with PBS. For exposing the membranes or detection 
of the antibody, they were treated with substrate solutions Luminol enhancer and Immuno 
Star HRP peroxide buffer (Bio-Rad, Marnes-la-Coquette, France) in the ratio 1:1. The 
membranes were exposed using a Kodak Biomax hypercasette and developed using a AGFA 
developer (AGFA, Mortel, Belgium). Fuji Medical X-Ray films (FUJIFILM, Tokyo, Japan) 
were used for developing. The images were quantified using ImageJ (La Jola, California). 
 
 
 
Antibody Company Catalogue # Dilution 
4E-BP Cell Signaling  9452 1:250 
AKT Cell Signalling 9272 1:1000 
AMPK Cell Signalling 2757 1:1000 
AOX Prof Howy Jacobs, Finland Fernandez-Ayala 
et al., 2009 
1:100,000 
FOXO Cell Signalling 12829 1:1000 
GAPDH Everest Biotech EB07069 1:30000 
p4E-BP (Thr 
37/46) 
Cell Signaling 3929 1:250 
pAKT (Ser 473) Cell Signalling 4060 1:1000 
pAMPK (Thr 
172) 
Cell Signalling 2535 1:1000 
Parkin Sigma-Aldrich SAB1300355 1:2000 
pFOXO (Ser 
253) 
Cell Signalling 9466 1:100 
PINK1/PARK6 Sigma-Aldrich SAB1300802 1:500 
pS6K (Thr 389) Cell Signalling 9206 1:1000 
Ref(2)P Abcam ab178440 1:100 
S6K Santa Cruz sc-230 1:250 
Sestrin Dr. Michael Karin lab, San Diego Lee et al., 2010 1:2500 
Ubiquitin Cell Signaling 3936 1:1000 
Lamp1 Abcam Ab24170 1:1000 
Anti-Rabbit Vector Laboratories PI-1000 1:10000 
Anti-Mouse Vector Laboratories PI-2000 1:10000 
Table 2.5 List of Antibodies 
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2.6 Isolation of mitochondria 
 
Around 40 flies were immobilized by placing on ice and then transferred to a chilled mortar. 
The number of flies used were similar for all the experiments involving the use of isolated 
mitochondria. 1 ml of ice-cold mitochondria isolation medium with BSA (250mM sucrose, 
5mM Tris-HCL, 2mM EGTA, 0.1% w/v of BSA) was added. Then, the flies were crushed 
using a pestle very carefully. The homogenate was filtered using a 200µm polyamide mesh. 
Another 1ml of the mitochondria isolation medium with BSA was added on top of the mesh. 
Homogenate was transferred to a tube and centrifuged at, 200g for 5 minutes at 4oC.  
 
Supernatant was collected and centrifuged at 9000g for 10 minutes at 4oC. The obtained pellet 
was then resuspended in 50µl  of isolation buffer without BSA (250mM sucrose, 5mM Tris-
HCL, 2mM EGTA). The protein concentration of sample was calculated by Bradford’s Assay. 
After which the mitochondria were stored at -80oC for a few experiments. For other experiments 
fresh mitochondria were used.  
 
2.7 Mitochondrial oxygen consumption measurements 
 
Around 20 flies were transferred to a chilled mortar, and then, 500µl of isolation buffer without 
BSA (250mM sucrose, 5mM Tris-HCL, 2mM EGTA) was added. The flies were crunched to a 
certain extent, being extra careful not to break the mitochondrial membrane. This was done to 
avoid misleading respiration measurements. The homogenate was transferred on top of a 200µm 
polyamide net and collected in a beaker and transferred to a tube. Additional 500µl of isolation 
buffer without BSA was added on top of the net. All the extracts were carefully removed and 
transferred to a tube. This sample was immediately used for the oxygen consumption 
measurements. 
 
Mitochondrial oxygen consumption from the homogenates was measured by high resolution 
respirometry, using an Oxygraph 2-K (Oroborous instruments, Innsbruck, Austria). Prior to the 
measurements, the chambers were thoroughly cleaned with 70% Ethanol and distilled water to 
remove any kind of contamination. Exactly 50µl of the fly homogenate was added in each 
chamber already filled with 1.95ml of assay buffer with BSA (120mM KCl, 5mM KH2PO4, 
3mM Hepes, 1mM EGTA,1mM MgCl2, 0.2% w/v BSA and calibrated to pH 7.2 at 25oC) and 
chambers were closed. All complexes in the ETC were considered for measurements. To begin 
with, Complex I linked substrates, namely; 5µl of 2M pyruvate+5µl of 2M proline and 4µl of 
0.5M ADP were added. In order to study respiration without the participation of respiratory 
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Complex I, 1l of 1mM rotenone was added. After which 30 µl of 1.3M Glycerol-3-Phosphate 
was added to analyse Complex III+IV activities and then Complex III was inhibited by 1µl of 
5mM Antimycin A. After the reaction was completely blocked, Complex IV substrates 
Ascorbate (0.8M) and TMPD (0.2M) were added in the respective volumes of, 5µl and 4µl. The 
whole reaction was inhibited by 2µl of 1M Potassium Cyanide.  
 
Individual HAMILTON GASTIGHT syringes (Hamilton Bonaduz AG, Bonaduz, Switzerland) 
were used for all substrates and inhibitors. Respiration rates were measured by taking into 
account the stable rates produced after the addition of substrates i.e. Pyruvate+Proline+ADP, 
G3P and Ascorbate+TMPD. Respiration rates after the addition of KCN was also tabulated. 
Pruvate+Proline+ADP dependent respiration was tabulated as CI-linked respiration, G3P 
dependent respiration was tabulated as CIII-linked respiration and the Ascorbate+TMPD 
respiration minus the respiration after the addition of KCN was tabulated as  
CIV-linked respiration. Respiration was measured as the stable rate produced, after the addition 
of substrate and the addition of specific inhibitors.  The protein concentrations of the previously 
extracted samples were measured by Bradford’s Assay. The concentrations obtained, were used 
to normalize the previously obtained respiration rates, and the data were tabulated. The data were 
then further normalized to the amount of mitochondria calculated by the citrate synthase assay 
described in Chapter 2.13. 
 
2.8 Mitochondrial ROS production 
 
Around 40 flies were stunned on ice and used for the isolation of mitochondria as described 
before. The mitochondria were immediately placed on ice after the extraction. The protein 
concentration of the samples was measured by Bradford assay. The volumes to be added were 
calculated so that it was made upto 0.5 mg/ml concentration in 100µl final volume of the 
wells. 
 
The buffer was prepared containing 50µl of 10mM of commercially available Amplex red 
(Invitrogen, Oregon , USA) stock solution, 100µl of 10 mM Horse Radish Peroxidase  
(Invitrogen, Oregon , USA) stock solution and 80µl of 6250 U/ml SOD stock solution 
(Sigma-Aldrich, Buchs, Switzerland). The whole mix was made upto 10 ml by filling up the 
rest of the volume by assay buffer with BSA (120mM KCL, 5mM KH2PO4, 3mM Hepes, 1mM 
EGTA,1mM MgCl2, 0.2% w/v BSA and calibrated to pH 7.2 at 25oC). The prepared 100 µl 
volume of buffer was always stored on ice. In each well appropriate amount of buffer was 
added, considering the amount of substrates, inhibitors and mitochondria to be added. 
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Initially, the mitochondria were added in all the required wells, and then, all the inhibitors 
were added according to specific final concentrations. The appropriate substrates (Table 2.5) 
were added in the wells just before the measurements, to validate the immediate reaction 
response.  
 
 
 
Reaction Solutions Final Concentration Volume Used 
Substrates   
Pyruvate+Proline 5mM 2µl 
Inhibitors   
Oligomycin 1µg/µl 2 µl 
 
 
A total of 9 experiments were performed. A blank without mitochondria but with all the other 
components of the reaction was used as negative control. The experiments are as follows: (1) 
mitochondria; (2) mitochondria with oligomycin (used as a blank for the experimental 
samples); (3) mitochondria +  pyruvate+proline (experimental samples). 
 
All of the above mentioned reactions were conducted in separate wells and considered as 
individual experiments. Mitochondrial concentration was added in equal concentrations for all 
reactions, according to the calcuations initially made. The susbstrates and the inhibitors 
volumes used, are mentioned in the Table 2.5 . The reaction plate, containing all the reactions, 
was measured in kinetic mode in a Chameleon V plate reader (Hidex, Turku, Finland) for a 
span of 30 minutes. During the whole measurement, the temperature was maintained at 25oC, 
and the wavelength was set to 530nm excitation and 595nm emission. The reaction was 
stopped after 30 minutes approximately, and the calculations for ROS production were done 
using the slope of the increase in fluorescence.  
 
Appropriate experiments were also performed to obtain standard curves, to measure the 
concentration of ROS subsequentially. The standard curve for calculating the units of 
flourescence produced was prepared using  glucose oxidase enzyme. A glucose oxidase stock 
was prepared by adding 0.04 U/ml in water. A solution of glucose (280mM) was also 
prepared for each reaction. Appropriate volumes of the assay buffer were added to each wells 
to make it up to 100µM final reaction volume in each well, with different volumes of glucose 
Table 2.6 Concentration and final volume of substrates and inhibitors 
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oxidase namely; 0.5,10,15,20,25 µl. The stock of the glucose oxidase was diluted upto 1:1000 
times in water before adding it to the wells. Then, the reaction was started by adding 5µl of 
280mM glucose to complete the reaction volume. The flourescence was then measured using 
the same conditions as used for the ROS measurements for the standard curve. The standard 
curve values were then plotted and the ROS measurements for the samples were plotted 
against the standard curve to obtain relative flourescence units. 
 
2.9 CAFE assay 
 
The flies were aged for 7 days at 29oC, before using them for the experiments. To begin with, 
around 10 tubes per fly group were taken. The tubes were then punched with holes on the top 
and the sides, sufficient for the capillary to fit and for air circulation. 10 tubes with 1 fly each 
was considered as one experiment and experiments were repeated at least 4 times. The flies 
were then anesthetized on CO2 and then transferred to a 1.5 ml tube. The capillaries were then 
filled with CAFE assay food containing, 5% sucrose and 5% yeast extract. After which, the 
capillaries were fit inside the holes in the tube with the flies. The whole container, in which all 
the tubes were placed, was also filled with a small amount of water to maintain equilibrium in 
humidity. The quantification of actual ingestion of food by the flies was done by putting a 
known amount of food in the capillaries, and then measuring the variations every 24 hours. 
The evaporation of the food was controlled by measuring the capillaries in the tubes without 
flies. The analysis was carried out for around 120 hours. The whole set up was placed at 29oC 
for the required measurements. 
 
2.10 Activity of flies 
 
Around 40 flies were anesthethised on CO2 and put in separate capillaries with standard fly 
food (1% agar, 1.5% sucrose, 3% glucose, dried yeast, 1.5% maize, 1% wheat, 1% soya, 3% 
treacle, 0.5% propionic acid, 0.1% Nipagin).   
 
The capilarries were plugged at one end with rubber cork, and other end with a sponge to 
allow the inlet of air. The locomotion activity of the flies was measured using a Digitherm 
Circ Kinetics monitoring incubator (Tritech Research, Los Angeles, USA). The analysis 
temperature was maintained at 29oC and a 12 hour alternative light and dark cycle was set. 
The capillaries with fly food and the flies were connected to a monitoring device. The number 
of times the fly crossed the center of the capillary was monitored by an in-built sensor. The 
readings were integrated by using TriKinetics software. The average locomotor activity of 40 
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flies every 30 minutes, were combined and calculated for statistical analysis. The total 
analysis was done over a time span of 96 hours.  
 
2.11 Weighing of the flies 
 
Around 10 flies were anesthetized by CO2 and then transfered into a tube. The weight of the 
tube was normalized and the weight of the flies was calculated. The experiments were 
performed 10 times. 
 
2.12 AMP, ADP and ATP measurements 
 
20 female flies were put to sleep in a tube on ice. Abdomens were removed then the heads and 
thoraxes were transferred to a tube and placed on ice. The samples were then washed by 
pipetting in sterile PBS to remove any remaining eggs or food particulates. PBS was removed 
and replaced with 100 µl of homogenization buffer (6M Guanidine-HCl, 100 mM Tris pH 
7.8, 4 mM EDTA). Flies were homogenized using a motor pestle and homogenates were 
cleared by centrifugation (4oC, 16,000 x g, 20 minutes). 80 µl of supernatant was taken and 
protein concentration was determined via Bradford assay. 25 µl of undiluted sample was used 
for AMP determination with the AMP-Glo assay kit (#V5011; Promega, USA), according to 
the manufacturer's protocol, with slight modifications. Briefly, 25 µl sample or AMP standard 
was pipetted into a well of a white 96-well plate and 25 µl AMP-Glo reagent was added, 
mixed by pipetting and allowed to incubate at room temperature for 1 hour. Following which, 
50 µl of AMP detection solution was added and the plate was incubated at room temperature 
for 10 minutes before measurement. Following AMP determination, the samples were used 
for ADP detection with the ADP-Glo Kinase assay kit (#V6930; Promega, USA), according 
to the manufacturer's protocol, with slight modifications. Briefly, 25 µl sample or ADP 
standard was pipetted into a well of a white 96-well plate and 25 µl ADP-Glo reagent was 
added, mixed by pipetting and allowed to incubate at room temperature for 1 hour. Following 
which 50 µl of Kinase detection reagent was added and the plate was incubated at room 
temperature for 1hour before measurement. Following ADP determination, the remaining 
sample volume was diluted 10 times in dH2O for ATP determination using the luciferase-
based the ATP determination kit (#A22066; Invitrogen, UK) as per the manufacturer's 
instructions. All measurements were done using a FLOUstar OMEGA microplate reader 
(BMG Labtech, Germany). Both assays and standards were measured in duplicate and 
nucleotide concentration was determined through interpolation with a standard curve. 
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2.13 Mitochondrial density measurements via the citrate synthase assay 
 
Approximately 40-60 flies were immobilised on ice and then transferred to a chilled mortar. 
Alternatively samples prepared to measure respiration were used. The flies were homogenised 
in 500 µl of ice-cold mitochondria isolation medium (250 mM sucrose, 5 mM Tris-HCl, 2 
mM EGTA), and the homogenate was filtered through cheesecloth. Then, an additional 500 µl 
of the mitochondria isolation medium containing 1 mM DTT was added, and the samples 
were frozen at -80°C overnight. Next, the samples were defrosted, and 50 µl of the whole 
homogenate sample was diluted 1:5 in mitochondria isolation medium containing 1 mM 
PMSF. The remainder of the whole homogenate sample was used to isolate mitochondria as 
described above. The isolated mitochondria were then diluted 1:4 in mitochondria isolation 
buffer containing 1 mM PMSF. Measurements were performed in a 96-well plate, in which 
182 µl of reaction buffer (100 mM Tris-HCl (pH 7.5) and 2.5 mM EDTA), 2 µl of 30 mM 
acetyl-CoA and 2 µl of 10 mM DTNB were added to each well. Finally, the samples (either the 
whole homogenate or isolated mitochondria) were added. The reaction was initiated by adding 
10 µl of 10 mM oxaloacetate (OAA), and the linear increase in absorbance at 412 nm was 
followed for 20 minutes using a PerkinElmer EnVision 2104 plate reader (PerkinElmer, 
Waltham, USA). Blanks were made from the same samples without the addition of OAA and 
then measured. Triplicates of all samples were used. Mitochondrial density was calculated by 
dividing the specific citrate synthase activity measured in the whole-fly homogenates by the 
specific citrate synthase activity measured in isolated mitochondria.  
 
2.14 Analysis of protein oxidative damage markers by mass spectrometry 
 
The following experiment was done in the laboratory of Prof Reinland Pamplona, Universitat 
de Lleida, Lleida, Spain. The levels of markers of protein oxidation [the protein carbonyl 
aminoadipic semialdehyde (AASA)], glycoxidation carboxymethyl-lysine (CML)], and 
lipoxidation [malondialdehydelysine (MDAL)] were determined by gas chromatography/mass 
spectrometry (GC/MS). The trifluoroacetic acid methyl ester derivatives of these markers 
were measured in acid-hydrolyzed, delipidated and reduced protein samples using an isotope 
dilution method as previously described (Sanz et al., 2010) with an HP6890 Series II gas 
chromatograph (Agilent), a MSD5973A Series and a 7683 Series automatic injector, an HP-
5MS column (30-m × 0.25-mm × 0.25-μm), and the described temperature program (Sanz et 
al., 2010). Quantification was performed by external standardization using standard curves 
constructed from mixtures of deuterated and nondeuterated standards. Analyses were carried 
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out by selected ion-monitoring GC/MS (SIM-GC/MS). The ions used were: lysine and [2H8] 
lysine, m∕z 180 and 187, respectively; 6-hydroxy-2-aminocaproic acid and [2H4]6-hydroxy-2-
aminocaproic acid (stable derivatives of AASA), m∕z 294 and 298, respectively; CML and 
[2H4] CML, m∕z 392 and 396, respectively; and MDAL and [2H8] MDAL, m∕z 474 and 482, 
respectively. The amounts of product were expressed as the μ molar ratio per mol of lysine.  
 
2.15 Measurement of ROS in Drosophila brains 
 
Approximately 20-40 adult flies were immobilized on ice. The immobilized flies were then 
transferred to a piece of aluminium foil placed on ice to keep them immobilized. The flies of 
the same genotype were used one by one for dissection. Using fine forceps the flies were 
lifted by its wings to avoid any damage. The flies were then dipped in 70% EtOH for 15 
seconds to remove any lipids that might interfere with the dissections. The cleaned flies were 
then transferred to a glass dissecting well filled with 1X PBS. The brain of the fly was 
carefully dissected without causing any physical damage to avoid improper measurements. 
All the dissections were done under a light microscope. Following dissection, fly brains were 
transferred to a tube containing either in MitoSOX or H2DCF using a Pasteur pipette. 
Experiments were done earlier to optimize the concentrations of MitoSOX or H2DCF. 30 μM 
final concentration of either MitoSOX or H2DCF was used to detect superoxide levels in the 
mitochondrial matrix or total cellular peroxide levels respectively. The fly brains were 
incubated for 10 minutes and then MitoSOX or H2DCF was removed and replaced with 1X 
PBS. The washing with 1X PBS was repeated 3 times. The fly brains were then immediately 
mounted on a Poly-Lysine coated dish and used for imaging. Images were acquired using an 
LSM510 confocal microscope (Zeiss, Jena, Germany) equipped with a 10x 0.3 NA objective 
as Z stacks throughout the sample using either a 543 nm or 488 nm line of an Argon laser to 
excite MitoSOX or H2DCF, respectively. For in vivo ROS imaging using mtORP1-roGFP 
reporter lines (Albrecht et al., 2011), whole flies containing the reporter and driver, along 
with any other indicated constructs were put to sleep on ice before being dissected and imaged 
under Ex. 488 (reduced) or 405 (oxidized) nm/Em. 510 nm. The total intensity of each 
individual brain imaged was quantified using ImageJ (La Jola, California). 
 
 
 
 72 
2.16 Lysotracker staining of Drosophila brains 
 
Adult brains were dissected as described in the previous section. An optimized concentration 
of 30 μM was used for the Lysotracker Red staining (Molecular Probes, Eugene, USA).    
Incubations and washings were similar to the previous section. Images were acquired using an 
LSM510 confocal microscope (Zeiss, Jena, Germany) equipped with a 10x 0.3 NA objective 
as Z stacks throughout the sample using 400nm line of an Argon laser to excite Lysotracker 
Red. The total intensity of each individual brain imaged was quantified using ImageJ (La Jola, 
California). 
 
2.17 Proteasome assay 
 
Around 5 flies for 20S Proteasome and 15 flies for 26S proteasome were homogenized in the 
respective homogenizing buffers containing, 0.5% Triton X-100, 250mM NaCl, 3mM EDTA, 
3mM EGTA and 20mM Tris pH 7,55 for 20S and 0.2% IGEPAL, 5mM ATP, 10% Glycerol, 
20mM KCl, 1mM EDTA, 1mM DTT and 20mM Tris pH 7,55 for 26S. After homogenization 
the samples were cleared by centrifugation at maximum speed for 15 minutes at 4oC. The 
samples were filtered and the supernatant was collected. The protein concentration of the 
samples was measured by Bradford assay. 180 µl and 170µl of assay buffer for each reaction 
containing 25mM Tris pH 7.55 and 25µM Suc-LLVY-AMC, 40µM Boc-LRR-AMC and 
100µM Z-LLE-AMC were used for measuring Chymotrypsin-like, Trypsin-Like and Caspase-
like activity respectively. 20µl and 30µl of the samples were used for 20S and 26S respectively. 
The assays were done in a black 96 well plate and measured at wavelength, excitation 380nm 
and emission 460nm for 30 minutes. The kinetics was stopped and 2µl of 2mM z-leu-leu-leu-al 
was added to each reaction to inhibit the proteasome and then measured again at the same 
wavelength, as mentioned above for another 30 minutes. Calculations were done by subtracting 
the values obtained after the addition of z-leu-leu-leu-al from the values obtained before its 
addition. Finally the values were normalized to protein concentration determined by Bradford 
assay. 
 
2.18 PCR arrays 
 
Around 10 flies were used for mRNA isolation as described above. cDNA was synthesised 
from RNA using the RT2 first-strand cDNA synthesis kit (Qiagen Technologies, Hilden, 
Germany). cDNA was added to wells containing RT2 SYBR Green master mix (Qiagen 
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Technologies, Hilden, Germany) in an array format of 4x96 wells, with each plate containing 
384 wells. Each of these 96-well formats contained 84 signal transduction pathway genes, 5 
housekeeping genes and positive and negative controls. The PCR array plate was carefully 
sealed with an optical adhesive film provided by the manufacturer. A total of 41 cycles were 
run. The first cycle consisted of 10 minutes at 95°C, and the other 40 cycles were 2-step 
cycles (15 seconds at 95°C and 1 minute at 60°C). A Bio-Rad CFX384 q-PCR machine was 
used for all of the above-mentioned protocols (Bio-Rad, Hercules, USA). The average 
threshold cycle (CT) value for each well was calculated using Bio-Rad software (Bio-Rad, 
Hercules, USA). The corresponding (CT) values were normalised to those of the housekeeping 
genes and tabulated. A gene was considered to be significantly up or downregulated when the 
difference between the (CT) values was greater than or equal to 10%, respectively.  
 
2.19 Statistical analysis 
 
All data were analysed using Prism 6 (GraphPad, La Jolla, California) using either 1-way 
ANOVA with Newman-Keul's post-test or using the unpaired Student’s T-test where 
appropriate. Lifespan data were analysed using the log-rank Mantel Cox Test. p<0.05 was 
taken as statistically significant. * denotes statistically significant differences between 
experimental groups. Data are shown as mean + SEM. 
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Chapter 3. A mitochondrial ROS signal is required for stress adaptation 
 
 
3.1 Mechanisms of stress adaptation 
 
The mechanism of stress adaptation in flies can be studied by culturing them at high 
temperatures, as the increase in culturing temperature from 25°C to 29°C can impose an 
additional stress (Loeschcke et al., 1997). Stress adaptation is essential to maintain proper 
functioning of an organism. This adaptation has shown to fail at older ages, and flies cultured at 
higher temperatures are an important tool for the study. For instance, Drosophila being a 
poikilothermic organism accumulates damage faster at higher temperatures (Sorensen et al., 
2013). The increase in rearing temperature from 25°C to 29°C also causes activation of heat 
shock response (HSR) and interestingly, induction of HSR extends lifespan at low temperatures 
(Morrow et al., 2004). In conclusion, identifying the mechanisms controlling stress adaptation 
and then inducing them in absence of stress could be a valid strategy to extend healthy lifespan.  
 
Mitochondria are important organelles that act as one of the central regulators of stress 
adaptation in many organisms. For example, muscle mitochondrial stress has shown to activate 
AMPK signalling and consequentially muscle mitohormesis in mice (Ost et al., 2015). Their 
activity is strongly linked to temperature changes (Guderley and St-Pierre, 2002). However, it is 
not clear yet how mitochondria adjust their own function in response to stress. There have been 
several studies suggesting that both ROS-dependent and ROS-independent mitochondrial 
mechanisms can contribute to ageing and stress adaptation (Scialo et al., 2013). ROS are 
intriguing molecules as they cause oxidative damage and also act as signal messengers (Ristow 
and Schmeisser, 2011). This duality leads to a complicated relationship between ROS and stress 
adaptation. However, it is unknown how these adaptations are initiated at the molecular level. 
 
Accumulation of damaged mitochondria is one of the major hallmarks of ageing and many 
neurodegenerative diseases (Osellame and Duchen, 2013). Unfortunately, we are still lacking the 
knowledge on what causes the decline in the mitochondrial function that is observed. 
Understanding these mechanisms will aid us to prevent many neurodegenerative diseases such as 
Parkinson’s or Alzheimer’s.  
 
Mitochondrial turnover is the result of the balance between mitochondrial biogenesis and 
mitochondrial elimination. Mitochondrial biogenesis is regulated by the convergence of signals 
on the peroxisome proliferator-activated receptor gamma (PPAR) family that promote 
transcription of mitochondrial genes, activating nuclear respiratory factor 1 and 2 (NRF 1 or 2) 
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(Scarpulla, 2011). On the other hand, the elimination of the damaged mitochondria is done by a 
process called mitophagy, which is a selective macro-autophagic process. Canonical mitophagy 
is mediated by the PTEN-induced putative kinase 1 (PINK1) and PARKIN (Clark et al., 2006). 
The cleavage of PINK1 by mitochondrial proteases is inhibited and the full length PINK1 
protein stabilizes on the mitochondrial outer membrane upon mitochondrial depolarization 
(Narendra et al., 2008). This stabilization of PINK1 recruits PARKIN and activates it through 
ubiquitination (Matsuda et al., 2010). Ubiquitination of PARKIN is responsible for 
ubiquitination dependent activation or deactivation of several cytosolic proteins, one of them 
being p62 or ref (2) p in flies, which is responsible for recruiting the autophagic machinery (Song 
et al., 2016). Mitochondria are eventually sequestered to the lysosome to be digested. 
Alternatively, other pathways independent of PARKIN have also been shown. NDP52 and 
OPTINUERIN, two proteins which were previously linked to xenophagy, have been shown to be 
recruited by PINK1 upon stabilization to recycle damaged mitochondria (Lazarou et al., 2015). 
Unfortunately, it is not very clear how mitophagy occurs in vivo, as the process has been 
demonstrated in vitro where the conditions are non-physiological. It has been shown that 
mitochondria that use OXPHOS (cells cultured in galactose) inhibit mitophagy by avoiding the 
crucial recruitment and activation of DRP1 for undergoing fission, thereby avoiding the 
recruitment of PARKIN (MacVicar and Lane, 2014).  
 
In this study, I aimed to analyse the role of mitochondria in stress adaptation focusing on the role 
of mtROS and its downstream effects. In this chapter, Drosophila melanogaster was used as 
the experimental model. I took advantage of the alternative oxidase (AOX), which is not a part 
of the ETC of humans or fruit flies, but is present in plants and fungi (McDonald et al., 2009). 
AOX reduces the generation of mtROS, preventing the over-reduction of ETC (Scialo et al., 
2016). Figure 3.1 illustrates the function of AOX in the ETC. Overall; these changes in the 
mitochondria of the fruit flies decrease the ability of the organism to respond to stress. 
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The expression of AOX bypasses the flow of electrons through Complex III and 
Complex IV, by directly receiving electrons from the ubiquinone pool and 
converting oxygen to water. AOX expression thereby also reduces generation of 
mtROS from Complex III and prevents over-reduction of the ETC. 
Figure 3.1 Ectopical expression of AOX in fruit flies and a schematic of how 
AOX interacts with the ETC 
e- 
e- 
e- 
- 
- 
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3.2 AOX expression reduces ROS production 
 
To begin with, I verified the expression of AOX in flies by western blotting (Figure 3.2A). Next, 
in order to verify that AOX expression reduces ROS production, I took an in vitro approach. 
Using the Peroxidase/Amplex Red ROS detection system I verified that AOX expression 
significantly decreased ROS in vitro (Figure 3.2 B). To then determine if AOX reduces ROS ex 
vivo, I dissected fly brains from AOX expressing flies (AOX flies hereafter) and their respective 
controls. Fly brains were then stained with MitoSOX, a dye that accumulates in the matrix of the 
mitochondria due to its positive charge, and fluoresces upon its reaction with superoxide. AOX 
flies showed a significant decrease in the MitoSOX fluorescence (Figure 3.2 C and D). In order 
to re-confirm the results with MitoSOX, I also stained fly brains with H2DCF, a dye that is 
specific to peroxides (i.e. emits fluorescence when oxidized by H2O2 or other peroxides). AOX 
flies showed significantly less fluorescence with H2DCF as well, confirming that superoxide and 
peroxide levels were reduced (Figure 3.2 C and D).  
 
Finally, in order to verify if mitochondrial ROS levels were reduced in vivo, I used a mitoORP1-
roGFP reporter line. roGFP is an engineered GFP sensor with a modified cysteine sensitive 
for oxidation (Albrecht et al., 2011). The probe is also engineered to be sensitive for H2O2 
oxidation as it is fused to ORP1 which is a H2O2 sensor. Flies containing the reporter and da-
GAL4 driver with the AOX construct were used. The mitoORP1-roGFP reporter lines with 
the da-GAL4 driver were used as controls. The flies expressing AOX along with the reporter 
constructs showed significantly less peroxide levels (Figure 3.3 A and B). These results 
confirmed that AOX reduces ROS in vivo as well.  
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(A) Representative western blot membrane showing AOX protein levels of indicated 
genotypes. GAPDH is used for normalization purpose. (B) Quantification of in vitro ROS 
production by Amplex Red assay of indicated genotypes (n=5) (Control = 0.1940 ± 0.009 
nanomoles H2O2 min-1 mg protein-1). (C) Representative images of dissected fly brains 
stained with MitoSOX and H2DCF of indicated genotypes. (D) Quantification of C (n=5). 
Non-expressing flies (2>UAS-AOX) (Control in the figure) and UAS-AOX expressing flies 
(daGAL4>UAS-AOX) (AOX in the figure) were used. A daughterless GAL4 promoter was 
used for the expression of the transgene. P values were calculated using student’s t-test. 
Data are shown as mean ± SEM. * = p<0.05; denotes statistically significant difference 
between mentioned genotypes. Scale bars are 100µm. This work was done in 
collaboration with Dr. Filippo Scialo. The molecular weight of proteins detected by 
western blots are given as kiloDalton (kDa) units. 
B 
 
C D 
A 
 
AOX
GAPDH
AOX +                     +
daGAL4             - +
 
 
 
37kDa 
36kDa 
Figure 3.2 AOX expression reduces ROS levels in vitro and ex vivo. 
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1.1.1.1.1.1.1.1.1  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
B 
(A) In vivo ROS measurements in brains dissected from flies expressing a mitochondrially-
localized redox-active GFP-based reporter (mitoORP1-roGFP) alone (top, n=5) or with AOX 
expression (+AOX; bottom, n=5). A daughterless GAL4 promoter was used for the expression 
of the transgene. (B) Quantification of non-expressing (Control in the figure) and UAS-AOX; 
UAS-mtORP1-roGFP expressing (AOX in the figure) flies (A). P values were calculated 
using student’s t-test. Data are shown as whisker box plots minimum-maximum. * = p<0.05; 
denotes statistically significant difference between mentioned genotypes. Scale bars are 
100µm. This work was done in collaboration with Dr. Filippo Scialo. 
 
mitoORP1-roGFP 
Figure 3.3 ROS production in vivo is reduced in AOX flies. 
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3.3 AMP, ADP, ATP levels and behaviour are not affected in AOX flies 
 
As AOX is ectopically expressed in the mitochondrion of the fly (Fernandez-Ayala et al., 
2009), I performed experiments to check if the expression of AOX perturbs energy levels. I 
measured the steady state levels of AMP, ADP and ATP in AOX flies. An AMP, ADP or 
ATP detection kit was used to measure nucleotide levels. I did not detect any changes in the 
AMP, ADP or ATP levels (Figure 3.4 A). Additionally, as the steady state levels of these 
nucleotides were unchanged, the ratios were also not altered (Figure 3.4 B).  
 
I then analysed if AOX expression affects any of the fly behaviours. I was able to confirm that 
the expression of AOX does not cause any alteration in the activity of the fly, by using 
Trikinetics Locomotion detection software (Figure 3.5 A). AOX expression also did not 
change the feeding behaviour of the flies, measured with a capillary feeding assay (CAFÉ 
assay); over a period of 5 days (Figure 3.5 B). However, the weight of the flies was modestly 
increased (Figure 3.5 C).  
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(A) AMP, ADP and ATP levels of indicated genotypes (n=8) (Control AMP = 101.5±17.14 
nanomoles mg protein-1; Control ADP = 754.9±49.57 nanomoles mg protein-1; Control ATP 
= 1236±69.06 nanomoles mg protein-1) (B) Ratio of the nucleotides AMP: ATP and ADP: 
ATP of indicated genotypes (n=8). Non-expressing flies (2>UAS-AOX) (Control in the 
figure) and UAS-AOX expressing flies (daGAL4>UAS-AOX) (AOX in the figure) were 
used. A daughterless GAL4 promoter was used for the expression of the transgene. P values 
were calculated using student’s t-test. Data are shown as mean ± SEM. 
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Figure 3.4 Nucleotide levels are unaltered in AOX flies. 
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A B 
C 
(A) Locomotion count per hour of indicated genotypes (n=40) (Control = 
82.08±4.378 Counts Hour-1). (B) Food intake measured by CAFÉ assay of indicated 
genotypes (n=20) (Control = 1.155±0.132 µl). (C) Weight in milligrams of indicated 
genotypes (n=10) (Control = 1.103 milligrams per fly). Non-expressing flies 
(2>UAS-AOX) (Control in the figure) and UAS-AOX expressing flies 
(daGAL4>UAS-AOX) (AOX in the figure) were used. A daughterless GAL4 
promoter was used for the expression of the transgene. P values were calculated 
using student’s t-test. Data are shown as mean ± SEM. 
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Figure 3.5 AOX expression does not affect fly behaviour. 
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3.4 Oxidative stress is not reduced, but antioxidant levels are downregulated in AOX 
flies 
 
I analysed if the total oxidative stress in the AOX flies were reduced, since I observed a 
decrease in ROS levels in AOX flies (Figure 3.2). I analysed the levels of specific markers of 
oxidative damage (aminoadipic semi aldehyde (AASA) and glutamic semi aldehyde (GSA) 
for detection of oxidation, carboxymethyl-lysine (CML) was used for detection of 
glycoxidation and carboxyethyl-lysine (CEL) was used for detection of glycoxidation and 
MDA-lys was used as a marker for lipoxidation) by mass spectrometry. However, I did not 
observe any overall differences in oxidative, glycoxidative or lipoxidative damage, except for 
an increase in lipoxidation and glycoxidation in AOX flies (Figure 3.6).  
 
I then measured mRNA levels of different antioxidants like Superoxide dismutase (Sod), 
Superoxide dismutase 2 (Sod2), Catalase, Glutathion Peroxidase (PXGPx), Glyoxalase 1 and dj-
1beta (Park7) by quantitative PCR. Even though the expression of AOX did not reduce 
oxidative protein damage, it caused a significant decrease in levels of most of the antioxidants 
measured, except for Sod2 mRNA levels which was increased; supporting the fact that the lower 
ROS levels in AOX flies causes a feed forward response to reduce the levels of antioxidants 
(Figure 3.7).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 84 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0
50
100
150
%
 C
o
n
tr
o
l 
F
li
e
s
0
50
100
150
%
 C
o
n
tr
o
l 
F
li
e
s
GSA AASA
CML CEL
MDA-lys
0
50
100
150
%
 C
o
n
tr
o
l 
F
li
e
s
0
50
100
150
200
%
 C
o
n
tr
o
l 
F
li
e
s
0
50
100
150
%
 C
o
n
tr
o
l 
F
li
e
s
μm
ol/
mo
l ly
s 
%
 
C
o
n
tr
o
l f
lie
s 
* 
 
Measurements for markers of oxidative (GSA, AASA), glycoxidative (CML, CEL) 
damage to proteins and lipoxidative (MDA-lys) damage to proteins of indicated 
genotypes (n=4) (Control GSA = 9910±1578 µmoles moles lys-1; Control AASA = 
178±52 µmoles moles lys-1; Control MDA-lys = 307±116 µmoles moles lys-1; Control 
CML = 121±20 µmoles moles lys-1; Control CEL = 767±73 µmoles moles lys-1). 
Non-expressing flies (2>UAS-AOX) (Control in the figure) and UAS-AOX expressing 
flies (daGAL4>UAS-AOX) (AOX in the figure) were used. A daughterless GAL4 
promoter was used for the expression of the transgene. P values were calculated 
using student’s t-test. Data are shown as mean ± SEM. * = p<0.05; denotes 
statistically significant difference between mentioned genotypes. This work was 
done in collaboration with Dr. Reinald Pamplona, Lleida, Spain. 
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Figure 3.6 Markers of oxidative damage are not reduced in AOX flies. 
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Quantification of mRNA levels of Sod, Sod2, Catalase, PXGPx, Glyoxalase 1 and dj-1beta 
by quantitative PCR of indicated genotypes (n=4). Non-expressing flies (2>UAS-AOX) 
(Control in the figure) and UAS-AOX expressing flies (daGAL4>UAS-AOX) (AOX in the 
figure) were used. A daughterless GAL4 promoter was used for the expression of the 
transgene. P values were calculated using student’s t-test. Data are shown as mean ± 
SEM. * = p<0.05; denotes statistically significant difference between mentioned 
genotypes. 
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Figure 3.7 Antioxidant levels are decreased in AOX flies. 
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3.5 Mitochondrial density is increased in AOX flies 
 
I sought to investigate if mitochondrial turnover was disrupted. I used the Citrate synthase 
assay as a proxy to measure mitochondrial density. I found that AOX flies had significantly 
more mitochondrial density (Figure 3.8 A). I confirmed the citrate synthase results by 
measuring mtDNA copy number of one mitochondrial and one nuclear gene by using 
quantitative PCR (described in detail in Chapter 2.4). The ratio clearly showed that there was 
a significant increase in mtDNA copy number in AOX flies (Figure 3.8 B). This led me to 
believe that AOX expression may have disrupted the ROS signalling mechanisms that are 
essential for stress response.  
 
In order to ascertain that changes in mitochondrial number was caused by AOX expression, and 
therefore by reduced mtROS levels, I used the inducible GeneSwitch system to temporarily 
regulate the expression of AOX. AOX was induced by collecting and ageing the flies on the food 
with RU-486 (explained in materials and methods). To cease AOX expression appropriately 
aged flies were removed from the RU-486 food and transferred to food with just EtOH. I 
analysed the protein levels of AOX to verify induction and removal of the protein (Figure 3.9 A) 
and observed that upon AOX induction, mitochondrial density increased; whereas, the opposite 
was observed when expression of AOX was ceased (Figure 3.9 B). This suggested that 
mitochondrial density is modified in response to changes in AOX/mtROS levels. 
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A B 
(A) Citrate synthase activity measuring mitochondrial density of indicated genotypes 
(n=18) (Control = 2.481±0.071 Absorbance Units mg protein-1). (B) mtDNA copy number 
of indicated genotypes (n=8). Non-expressing flies (2>UAS-AOX) (Control in the figure) 
and UAS-AOX expressing flies (daGAL4>UAS-AOX) (AOX in the figure) were used. A 
daughterless GAL4 promoter was used for the expression of the transgene. P values were 
calculated using student’s t-test. Data are shown as mean ± SEM. * = p<0.05; denotes 
statistically significant difference between mentioned genotypes. 
 
             
 
Figure 3.8 Mitochondrial density is increased in AOX flies. 
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37kDa 
 
A 
B 
(A) Representative western blot membranes showing AOX protein levels. Left panel 
representing AOX protein levels in non-expressing flies (0) and UAS-AOX expressing 
flies (TubGS>UAS-AOX) (+RU-486 ON) for 1,2,3,4 and 6 days were used. Right panel 
representing AOX protein levels in non-expressing flies (0), UAS-AOX expressing flies 
(TubGS>UAS-AOX) un-induced after expression for 5 days earlier (-RU-486 OFF) for 
6,7,8,9 and 10 days were used. GAPDH is used for normalization purpose. (B) Left panel 
representing citrate synthase measurements in non-expressing flies (0) and UAS-AOX 
expressing flies (TubGS>UAS-AOX) (+RU-486 ON) for 2, 4 and 6 days (n=4) (Control 
= 0.5157±0.067 Absorbance Units mg protein-1). Right panel representing citrate synthase 
measurements in non-expressing flies (0), UAS-AOX expressing flies (TubGS>UAS-
AOX) un-induced after expression for 5 days earlier (-RU-486 OFF) for 6, 8 and 10 days 
(n=4) (Control = 0.250±0.011 Absorbance Units mg protein-1). An inducible Tubulin 
GeneSwitch GAL4 promoter was used for the expression of the transgene. P values were 
calculated using 1-way ANOVA with Newman-Keul's post-test. Data are shown as 
mean ± SEM. * = p<0.05; denotes statistically significant difference between mentioned 
genotypes. The art lines in the figure denote the statistically significant difference 
between the marked genotypes. The molecular weight of proteins detected by western 
blots are given as kiloDalton (kDa) units. 
36kDa 
Figure 3.9 Induction and removal of AOX expression increases and decreases 
mitochondrial density respectively. 
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3.6 Mitochondrial biogenesis is unaltered in AOX flies 
 
As I have established in Chapter 3.4 that there is an accumulation of mitochondria, I wanted 
to check if mitochondrial biogenesis was altered. To check if mitochondrial biogenesis was 
increased in response to the presence of AOX in ETC, I measured levels of expression of 
Spargel (homologue of mammalian Pgc-1α) and Ets at 97D (Delg, homologue of the α subunit 
of mammalian transcription factor NRF-2/GABP) using quantitative PCR. Only a modest 
increase in mRNA levels of Spargel was observed, while Delg mRNA levels were unchanged 
(Figure 3.10). 
 
To further confirm if the increase in mitochondrial density was caused by the modest increase 
in mRNA levels of Spargel, I checked mRNA levels of several mitochondrial genes by 
quantitative PCR. Although mRNA levels of mitochondrial Cytochrome b (Cytb; CIII 
subunit) was increased, mRNA levels of other ETC components like mitochondrial NADH-
ubiquinone oxidoreductase chain 1 (ND1; CI subunit), Succinate dehydrogenase, subunit B 
(Sdhb; CII subunit), mitochondrial Cytochrome c oxidase subunit I (CoI; CIV subunit) were 
either unchanged or decreased (Figure 3.11). Expression of mitochondrial genes was not 
consistently induced in AOX flies, making it unlikely that the increase in mitochondrial number 
was caused by an increase in mitochondrial biogenesis. This led me to suspect an alteration in 
mitochondrial turnover caused by AOX expression. 
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Quantification of mRNA levels of Spargel and Delg by quantitative PCR of indicated 
genotypes (n=4). Non-expressing flies (2>UAS-AOX) (Control in the figure) and UAS-AOX 
expressing flies (daGAL4>UAS-AOX) (AOX in the figure) were used. A daughterless GAL4 
promoter was used for the expression of the transgene. P values were calculated using 
student’s t-test. Data are shown as mean ± SEM. * = p<0.05; denotes statistically 
significant difference between mentioned genotypes. 
Figure 3.10 Spargel and Delg levels are unaltered in AOX flies. 
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Quantification of mRNA by quantitative PCR of indicated genotypes (n=4). Non-
expressing flies (2>UAS-AOX) (Control in the figure) and UAS-AOX expressing flies 
(daGAL4>UAS-AOX) (AOX in the figure) were used. A daughterless GAL4 promoter was 
used for the expression of the transgene. P values were calculated using student’s t-test. 
Data are shown as mean ± SEM. * = p<0.05; denotes statistically significant difference 
between mentioned genotypes. 
 
Figure 3.11 mRNA levels of several mitochondrial genes were unaltered in AOX flies. 
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3.7 Mitochondrial functionality is compromised in AOX flies 
 
 
To understand the mitochondrial function of these flies, I performed high-resolution 
respirometry. I hypothesized that the mitochondrial accumulation phenotype caused in the 
AOX flies might be due to the improper recycling of damaged mitochondria. Pyruvate, 
Proline and ADP stimulated CI-linked respiration, G3P stimulated CIII- linked respiration and 
Ascorbate and TMPD stimulated CIV-linked respiration was unchanged when normalized to 
total protein content of the samples (Figure 3.12 A). However, when I normalized these 
respiration measurements to the total mitochondrial density (measured using citrate synthase 
assay as described earlier), I observed a significant decrease in respiration of AOX flies across 
the panel (Figure 3.12 B). The fact that mitochondrial respiration was significantly reduced in 
AOX flies even though mitochondrial density was increased; denote that the accumulated 
mitochondria are severely damaged.  
 
I also observed an increase in the mRNA levels in markers of mitochondrial unfolded protein 
response (Heat shock protein 22 (Hsp22) and Heat shock protein 60 (Hsp60)) and also in the 
levels of markers of cytosolic stress (Heat shock protein 70 (Hsp70)), indicating an accumulation 
of dysfunctional mitochondria (Figure 3.13 A) (Deocaris et al., 2006). In order to confirm this 
observation, I measured expression levels of Ecdysone-inducible gene L3 (ImpL3) (the 
Drosophila homologue of lactate dehydrogenase A) and found a strong up-regulation of mRNA 
levels (Figure 3.13 B). Upregulation of Impl3 levels (used as a proxy for mitochondrial 
damage) also indicates that the cells have switched to a more glycolytic metabolism.  
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A 
B 
 
(A) Comparison of oxygen consumption of indicated genotypes (n=6). CI-linked (Control = 
654.3±76.70 picomoles O2 min-1 mg protein -1), CIII-linked (Control = 486±25.73 picomoles 
O2 min-1 mg protein -1) and CIV-linked (Control = 2360±25.73 picomoles O2 min-1 mg 
protein -1) oxygen consumption measured. (B) Representing respiration data normalized to 
respiration per mitochondrion in indicated genotypes (n=6). CI- CIII- and CIV-linked 
respiration was measured. Non-expressing flies (2>UAS-AOX) (Control in the figure) and 
UAS-AOX expressing flies (daGAL4>UAS-AOX) (AOX in the figure) were used. A 
daughterless GAL4 promoter was used for the expression of the transgene. P values were 
calculated using student’s t-test. Data are shown as mean ± SEM. * = p<0.05; denotes 
statistically significant difference between mentioned genotypes. 
 
Figure 3.12 Mitochondrial respiration is decreased in AOX flies. 
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A 
B 
(A) Quantification of mRNA levels of Hsp22, Hsp60 and Hsp70 by quantitative 
PCR of indicated genotypes (n=4). (B) Quantification of mRNA levels of ImpL3 by 
quantitative PCR of indicated genotypes (n=4). Non-expressing flies (2>UAS-AOX) 
(Control in the figure) and UAS-AOX expressing flies (daGAL4>UAS-AOX) (AOX 
in the figure) were used. A daughterless GAL4 promoter was used for the expression 
of the transgene. P values were calculated using student’s t-test. Data are shown as 
mean ± SEM. * = p<0.05; denotes statistically significant difference between 
mentioned genotypes. 
Figure 3.13 mRNA levels of mtHSP’s and ImpL3 are upregulated in AOX flies. 
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3.8 Pink1 protein levels are decreased in AOX flies 
 
In fruit flies, mitochondria are recycled by the canonical Pink1-Parkin mitophagy pathway 
(Clark et al., 2006) (discussed in detail in Chapter 1.19). I found a significant decrease in 
protein levels of Pink1 measured by Western Blotting, but the protein levels of Parkin were 
not changed (Figure 3.14 A and B). These data indicated that recycling of damaged 
mitochondria was disrupted by reduction of mtROS levels. 
 
I also measured mRNA levels of Pink1 and Parkin and found a significant decrease in mRNA 
levels of Pink1 but not Parkin (Figure 3.15). This indicates that Pink1 is regulated at post-
transcriptional level as well.  
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A 
B 
(A) Representative western blot membranes showing Pink1 and Parkin protein 
levels of indicated genotypes. GAPDH is used for normalization and quantification 
purposes. (B) Quantification of (A) (n=3). Non-expressing flies (2>UAS-AOX) 
(Control in the figure) and UAS-AOX expressing flies (daGAL4>UAS-AOX) (AOX 
in the figure) were used. A daughterless GAL4 promoter was used for the 
expression of the transgene. P values were calculated using student’s t-test. Data 
are shown as mean ± SEM. * = p<0.05; denotes statistically significant 
difference between mentioned genotypes. The molecular weight of proteins 
detected by western blots are given as kiloDalton (kDa) units. 
Figure 3.14 Pink1 but not Parkin protein levels are decreased in AOX flies. 
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Quantification of mRNA levels of Pink1 and Parkin by quantitative PCR of indicated 
genotypes (n=4). Non-expressing flies (2>UAS-AOX) (Control in the figure) and UAS-
AOX expressing flies (daGAL4>UAS-AOX) (AOX in the figure) were used. A 
daughterless GAL4 promoter was used for the expression of the transgene. P values 
were calculated using student’s t-test. Data are shown as mean ± SEM. * = p<0.05; 
denotes statistically significant difference between mentioned genotypes. 
 
 
 
Figure 3.15 Pink1, but not Parkin mRNA levels are reduced in AOX flies. 
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3.9 Protein turnover mechanisms are disrupted in AOX flies 
 
Mechanism of protein turnover is well established and well conserved in almost all organisms 
(discussed in detail in Chapter 1.20).  To begin with, I checked the functionality of protein 
turnover mechanisms were functioning properly. I used a previously described assay to 
measure the activity of 20S and 26S proteasome (Rivett et al., 2002). I detected a decrease in 
Chymotrypsin-like, Trypsin-Like and Caspase-like activity in both 20S and 26S proteasome in 
AOX flies (Figure 3.16 A and B).  
 
Loss of proteostasis is also considered as a hallmark of ageing (Ryazanov et al., 2002). Protein 
levels of Ubiquitin and p62 (Ref (2) P) were significantly increased (Figure 3.17 A and B), 
which also indicated dysfunctional protein turnover. However, defective protein turnover may 
also be caused by the loss in autophagy (described in the following chapters).  
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A 
B 
(A) Measurements for Chymotrypsin like (CT-L), Caspase like (C-L) 
and Trypsin like (T-L) 20S proteasome activity of indicated genotypes 
(n=6). (B) Measurements for Chymotrypsin-like (CT-L), Caspase-like 
(C-L) and Trypsin-like (T-L) 26S proteasome activity of indicated 
genotypes (n=6). Non-expressing flies (2>UAS-AOX) (Control in the 
figure) and UAS-AOX expressing flies (daGAL4>UAS-AOX) (AOX in the 
figure) were used. A daughterless GAL4 promoter was used for the 
expression of the transgene. P values were calculated using student’s t-
test. Data are shown as mean ± SEM. * = p<0.05; denotes statistically 
significant difference between mentioned genotypes. 
 
Figure 3.16 Proteasome activity is decreased in AOX flies. 
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A 
B 
(A) Representative western blot membrane showing ubiquitinated protein levels of 
indicated genotypes. GAPDH is used for normalization and quantification purposes. (B)  
Left panel showing representative western blot membrane showing Ref (2) P protein 
levels of indicated genotypes. GAPDH is used for normalization and quantification 
purposes. Right panel showing quantification of left panel (n=3). Non-expressing flies 
(2>UAS-AOX) (Control in the figure) and UAS-AOX expressing flies (daGAL4>UAS-
AOX) (AOX in the figure) were used. A daughterless GAL4 promoter was used for the 
expression of the transgene.  P values were calculated using student’s t-test. Data are 
shown as mean ± SEM. * = p<0.05; denotes statistically significant difference between 
mentioned genotypes. The molecular weight of proteins detected by western blots are 
given as kiloDalton (kDa) units. 
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Figure 3.17 Ubiquitinated proteins and Ref (2) P protein levels are increased in AOX 
flies. 
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3.10 Inactivation of proper quality control mechanisms compromises the survival of 
AOX flies 
 
I then observed that expression of AOX drastically reduced survival of the flies (Figure 3.18) 
at high temperatures; whereas, normal culture temperature does not alter AOX lifespan 
(Fernandez-Ayala et al., 2009). It can be hypothesized that with the loss of mtROS signal 
caused by AOX expression, the flies were not able to activate the necessary signals and 
overcome persistent damage.  
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Survival curve of indicated genotypes (n=200). A table with statistics for the 
lifespan is presented in Appendix A. 
 
Figure 3.18 AOX expression decreases fly lifespan. 
p<0.001 
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Chapter 4. Determining the nature of the ROS signal generated under 
stress 
 
4.1 A background on mitochondrial ROS signalling mechanisms 
 
Mitochondrial ROS were initially not considered as signalling molecules since they were said to 
cause oxidative damage. This dual function of ROS has made it very complicated to establish 
how or why ROS causes ageing. However, carefully controlling levels of oxygen and 
maintaining very similar physiological levels of ROS in cell culture; it has been evident that this 
mtROS signal might be responsible for initiating major signalling pathways essential for healthy 
ageing (Hamanaka and Chandel, 2010). Furthermore, extensive studies are required in order to 
elucidate these ROS signalling mechanism in vivo.  
 
ROS are often considered as a unique entity, but over the decade it has been reported that 
different ROS have different properties and are independent molecules (Scialo et al., 2013). For 
instance, extreme increase of O2- is detrimental for Drosophila, but increasing cellular levels of 
H2O2 extends lifespan (Sohal, 1988; Broughton et al., 2005; Stefanatos et al., 2012). Similarly, 
O2- and H2O2 may play different roles in mitochondrial turnover and activation of other 
downstream mechanisms. Therefore, using strategies to delineate the effect of different ROS 
molecules is necessary to understand how they operate in vivo. On the other hand, mild 
mitochondrial stress caused by the increase in ROS, increases or activates signalling pathways 
that are needed to protect the organism long term. This activation has been demonstrated to 
prolong the organism’s lifespan. This mechanism known as mitohormesis is gaining attention 
and is being explored extensively owing to the work across different model organisms from 
yeast, mice and rats (Yun and Finkel, 2014). 
 
Results presented in Chapter 3 indicated that the loss of mtROS signalling (AOX flies) 
compromised many of the survival mechanisms, thereby compromising fly lifespan. However, as 
expression of AOX modifies the generation of mtROS by controlling the redox state of 
Coenzyme Q (CoQ), I was not able to differentiate the ROS entity responsible for this signalling 
(H2O2 or O2-). AOX is also upstream of the antioxidant response to H2O2 or O2- (El-Khoury et 
al., 2014) and I have already demonstrated that AOX reduces both ROS species.  
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To understand which of the ROS species (H2O2 or O2-) is involved in this signalling, I took 
advantage of the powerful genetics of Drosophila melanogaster. I ectopically expressed Catalase 
in the mitochondrial matrix. Catalase converts H2O2 to H2O, making the ROS molecule 
completely inert. I also overexpressed Sod2, which is in the mitochondrial matrix and converts 
O2- to H2O2. Figure 4.1 represents the function of Sod2 and mitochondrial Catalase in the 
mitochondria. In this chapter, I specifically manipulate the levels of both superoxide and 
Hydrogen peroxide to understand which ROS entity is responsible for the changes in the 
mitochondrial functionality observed in Chapter 3. 
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Sod2 and mtCAT are important antioxidants in the mitochondria converting O2- to H2O2 
and H2O2 to H2O, respectively. 
 
 
Figure 4.1 Superoxide dismutase 2 (Sod2) and mitochondrial Catalase (mtCAT) 
interact with O2- and H2O2 respectively. 
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4.2 Ectopical expression of Catalase and overexpression of Sod2 in the mitochondria 
reduces H2O2 and O2- respectively 
 
To validate the fly models, I analysed the mRNA levels of Catalase and Sod2 in the 
mitochondrial Catalase expressing flies (mtCAT flies hereafter) and the Sod2 overexpressing 
flies (Sod2 flies hereafter), respectively. I detected a significant increase in mRNA levels of both 
Catalase and Sod2 in the respective flies (Figure 4.2 A). To confirm that mitochondrial 
expression of Catalase reduces H2O2 production, I dissected fly brains from mtCAT flies and 
their respective controls. When the fly brains were stained with MitoSOX, mtCAT flies showed 
no decrease in MitoSOX fluorescence, confirming that mtCAT does not affect superoxide levels 
(Figure 4.2 B). I also stained fly brains with H2DCF, a dye specific to peroxides that fluoresces 
in reaction with H2O2 and other peroxides. mtCAT flies showed significantly less fluorescence 
with H2DCF, confirming that mtCAT reduces H2O2 and functions as expected (Figure 4.2 C). 
On the other hand, Sod2 flies showed a significant decrease in MitoSOX fluorescence 
confirming that overexpression of Sod2 reduces O2- levels (Figure 4.2 B). I also found that 
overexpression of Sod2 increases fluorescence of brains stained with H2DCF, indicating that 
Sod2 overexpression increases H2O2 levels (Figure 4.2 C). 
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(A) Quantification of mRNA levels of  Catalase and Sod2 by quantitative PCR of indicated 
genotypes (n=4) (B) Left panel showing representative images of dissected fly brains stained 
with MitoSOX of indicated genotypes. Right panel showing quantification of left panel (n=5). 
(C) Left panel showing representative images of dissected fly brains stained with H2DCF of 
indicated genotypes. Right panel showing quantification of left panel (n=5). (i) Non-
expressing flies (2>UAS-mtCAT) (Control in the figure), (ii) UAS-mtCAT expressing flies 
(daGAL4>UAS-mtCAT) (mtCatalase in the figure), (iii) non-expressing flies (2>UAS-Sod2) 
(Control in the figure) and (iv) Sod2 overexpressing flies (daGAL4>UAS-Sod2) (Sod2 in the 
figure) were used. A daughterless GAL4 promoter was used for the expression of transgenes. 
P values were calculated using student’s t-test. Experimental groups were compared to their 
respective controls. Data are shown as mean ± SEM. * = p<0.05; denotes statistically 
significant difference between mentioned genotypes. Scale bars are 100µm. This work was 
done in collaboration with Dr. Filippo Scialo. 
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Figure 4.2 Reduction in H2O2 and O2- is observed in mtCAT and Sod2 flies respectively. 
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4.3 Oxidative stress is not reduced and antioxidant levels are unaltered in mtCAT and 
Sod2 flies 
 
 
I analysed the levels of specific markers of oxidative damage as described in the Chapter 3.4, 
since ROS levels were significantly altered in these flies. However, I did not see any 
significant difference in oxidative, glycoxidative or lipoxidative damage between the groups, 
except for a moderate increase in AASA (marker for protein oxidation) in mtCAT flies 
(Figure 4.3 A).  
 
I then wanted to see if there was any retrograde response to other antioxidants (Whelan and 
Zuckerbraun, 2013). I detected only moderate changes in the mRNA levels of Glutathion 
Peroxidase and dj-1β were down regulated; whereas, mRNA levels of Glyoxalase 1 was 
unregulated in Sod2 flies. However, in mtCAT flies only Glutathion Peroxidase mRNA levels 
were downregulated. Other antioxidants like Sod, Sod2, and Catalase were unaltered (Figure 4.3 
B). These results demonstrate that the feedback mechanisms are not active in these fly models. 
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Figure 4.3 Oxidative stress is not reduced and antioxidant levels are unaltered. 
(A) Measurements for markers of oxidative (GSA, AASA), glycoxidative (CML, CEL) 
and lipoxidative (MDA-lys) damage in flies of indicated genotypes (n=6) (Control 
(mtCAT) GSA = 6890±268.9 µmoles moles lys-1, Control (Sod2) GSA = 7153±319.1 
µmoles moles lys-1) (Control (mtCAT) AASA = 1404±522 µmoles moles lys-1 and Control 
(Sod2) AASA = 597.8±16.16 µmoles moles lys-1) (Control (mtCAT) CML = 227.4±17.4 
µmoles moles lys-1 and Control (Sod2) CML = 512.5±27.55 µmoles moles lys-1) (Control 
(mtCAT) CEL = 1329±27.13 µmoles moles lys-1 and Control (Sod2) CEL = 1113±49.83 
µmoles moles lys-1) (Control (mtCAT) MDA-lys = 353±23.45 µmoles moles lys-1 and 
Control (Sod2) MDA-lys = 319±22 µmoles moles lys-1). This work was done in 
collaboration with Dr. Reinald Pamplona.  (B) Quantification of mRNA levels of  Sod, Sod2, 
Catalase, Glutathion Peroxidase, Glyoxalase 1 and dj-1β by quantitative PCR  of indicated 
genotypes (n=4). Catalase and Sod2 qPCR measurements are same as Figure 4.2 A, but with 
addition of other experimental groups. Non-expressing flies (2>UAS-mtCAT) (Control in the 
figure), UAS-mtCAT expressing flies (daGAL4>UAS-mtCAT) (mtCatalase in the figure), non-
expressing flies (2>UAS-Sod2) (Control in the figure) and Sod2 overexpressing flies 
(daGAL4>UAS-Sod2) (Sod2 in the figure) were used. A daughterless GAL4 promoter was 
used for the expression of transgenes. P values were calculated using student’s t-test. 
Experimental groups were compared to their respective controls. Data are shown as mean 
± SEM. * = p<0.05; denotes statistically significant difference between mentioned 
genotypes. 
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4.4 Mitochondrial density is increased in mtCAT but not in Sod2 flies 
 
In order to test whether O2- or H2O2 had a leading role in the phenotypes observed in AOX 
flies, I measured the mitochondrial density in mtCAT and Sod2 flies. I detected a significant 
increase in mitochondrial density in mtCAT flies; whereas, mitochondrial density was 
significantly reduced in Sod2 flies (Figure 4.4 A).  
 
I then measured mtDNA copy number to confirm the increase in mitochondrial density. The 
ratio between the nuclear and the mitochondrial DNA clearly showed a significant increase in 
mtCAT flies and a significant decrease in Sod2 flies (Figure 4.4 B). These results demonstrate 
that O2- and H2O2 may have different effects on downstream signalling cascades. 
 
Corroborating my results from this chapter, I have established that mtCAT flies phenocopy 
AOX flies, denoting that H2O2 may be involved in maintaining mitochondrial functionality. 
Moreover, mitochondrial recycling was improved in Sod2 flies, which as described earlier 
produce less O2- and more H2O2. These findings also ascertain the fact that an increase in 
mtH2O2 is not harmful and can function as a ROS messenger. 
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(A) Citrate synthase activity measuring mitochondrial density of indicated genotypes 
(Control (mtCAT) = 1.652±0.16 Absorbance Units mg protein-1 and Control (Sod2) = 
1.882±0.079 Absorbance Units mg protein-1) (n=9). (B) mtDNA copy number of 
indicated genotypes (n=4). Non-expressing flies (2>UAS-mtCAT) (Control in the figure), 
UAS-mtCAT expressing flies (daGAL4>UAS-mtCAT) (mtCatalase in the figure), non-
expressing flies (2>UAS-Sod2) (Control in the figure) and Sod2 overexpressing flies 
(daGAL4>UAS-Sod2) (Sod2 in the figure) were used. A daughterless GAL4 promoter 
was used for the expression of transgenes. P values were calculated using student’s t-
test. Experimental groups were compared to their respective controls. Data are shown 
as mean ± SEM. * = p<0.05; denotes statistically significant difference between 
mentioned genotypes. 
 
A B 
 
 
 
Figure 4.4 Mitochondrial density is increased in mtCAT but not in Sod2 flies. 
* 
* 
* 
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4.5 Spargel and Delg mRNA levels are unaltered in both mtCAT and Sod2 flies 
 
In order to discern whether the increase in mitochondrial density is not because of an increase 
in mitochondrial biogenesis, I measured the mRNA levels of Spargel and using quantitative 
PCR. I confirmed that mitochondrial biogenesis was not altered in response to changes in 
mtH2O2, as both mtCAT and Sod2 did not alter mRNA levels of Spargel and Delg (Figure 4.5).  
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Quantification of mRNA levels of Spargel and Delg by quantitative PCR of indicated 
genotypes (n=4). Non-expressing flies (2>UAS-mtCAT) (Control in the figure), UAS-
mtCAT expressing flies (daGAL4>UAS-mtCAT) (mtCatalase in the figure), non-
expressing flies (2>UAS-Sod2) (Control in the figure) and Sod2 overexpressing flies 
(daGAL4>UAS-Sod2) (Sod2 in the figure) were used. A daughterless GAL4 promoter 
was used for the expression of transgenes. P values were calculated using student’s t-
test. Experimental groups were compared to their respective controls. Data are 
shown as mean ± SEM.  
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Figure 4.5 Spargel and Delg mRNA levels are unaltered in both mtCAT and Sod2 
flies. 
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4.6 Mitochondrial functionality is compromised in mtCAT flies but improved in Sod2 
flies 
 
I then used the mtCAT and Sod2 flies to analyse mitochondrial respiration. Similar to the 
AOX flies, I did not observe any difference between the samples when the respiration 
measured was normalized to total protein content of the samples (Figure 4.6 A). However, 
mtCAT expression decreased CI, CIII and CIV-linked respiration, when the measurements 
were normalized to their respective mitochondrial densities. On the other hand, Sod2 
expression increased mitochondrial respiration. These experiments demonstrate that mtCAT 
flies phenocopy AOX flies, denoting a leading role of mtH2O2 in maintaining mitochondrial 
functionality (Figure 4.6 B). 
   
In order to ascertain that mitochondria are damaged, I analysed the mRNA levels of different 
heat shock proteins, as they are used as markers for mitochondrial damage. I observed severe 
induction in Heat shock protein 22 (Hsp22) and Heat shock protein 70 (Hsp70), indicating an 
accumulation of dysfunctional mitochondria in mtCAT flies. However, we only observed a 
modest but not significant increase in Heat shock protein 60 (Hsp60). Sod2 flies on the other 
hand, decreased the induction of Hsp70 and did not affect other markers (Figure 4.7). In order to 
confirm this observation, I measured mRNA levels of ImpL3 (used as a marker for mitochondrial 
damage) and found a strong up-regulation in mtCAT flies; whereas, the mRNA levels remained 
unaltered in Sod2 flies (Figure 4.7). This indicated that loss of mtH2O2 signalling and loss in 
recycling of damaged mitochondria caused the fly to switch to a more glycolytic metabolism. 
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A 
B 
CI+III+IV CIII+IV CIV 
 
(A) Comparison of oxygen consumption of indicated genotypes (n=3). CI-linked 
(Control (mtCAT) = 2063±92.68 picomoles O2 min-1 mg protein-1 and Control (Sod2) = 
1993±242.7 picomoles O2 min-1 mg protein-1), CIII-linked (Control (mtCAT) = 
1308±32.32 picomoles O2 min-1 mg protein-1 and Control (Sod2) = 1270±45.17 
picomoles O2 min-1 mg protein-1) and CIV-linked (Control (mtCAT) = 9947±154.8 
picomoles O2 min-1 mg protein-1 and Control (Sod2) = 9555±86.12 picomoles O2 min-1 
mg protein-1) oxygen consumption measured in indicated genotypes. (B) Representing 
respiration data normalized to respiration per mitochondrion in indicated genotypes 
(n=3). CI- CIII- and CIV-linked respiration was measured. Non-expressing flies 
(2>UAS-mtCAT) (Control in the figure), UAS-mtCAT expressing flies (daGAL4>UAS-
mtCAT) (mtCatalase in the figure), non-expressing flies (2>UAS-Sod2) (Control in the 
figure) and Sod2 overexpressing flies (daGAL4>UAS-Sod2) (Sod2 in the figure) were 
used. A daughterless GAL4 promoter was used for the expression of transgenes. P 
values were calculated using student’s t-test. Experimental groups were compared to 
their respective controls. Data are shown as mean ± SEM. * = p<0.05; denotes 
statistically significant difference between mentioned genotypes. 
Figure 4.6 Mitochondrial respiration is decreased in mtCAT flies and improved in 
Sod2 flies. 
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Quantification of mRNA levels of Hsp22, Hsp60, Hsp70 and ImpL3 by quantitative 
PCR of indicated genotypes (n=4). Non-expressing flies (2>UAS-mtCAT) (Control in 
the figure), UAS-mtCAT expressing flies (daGAL4>UAS-mtCAT) (mtCatalase in the 
figure), non-expressing flies (2>UAS-Sod2) (Control in the figure) and Sod2 
overexpressing flies (daGAL4>UAS-Sod2) (Sod2 in the figure) were used. A 
daughterless GAL4 promoter was used for the expression of transgenes. P values 
were calculated using student’s t-test. Experimental groups were compared to their 
respective controls. Data are shown as mean ± SEM. * = p<0.05; denotes 
statistically significant difference between mentioned genotypes. 
 
Figure 4.7 mRNA levels of mtHSP’s and ImpL3 are upregulated in mtCAT flies. 
* 
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4.7 Pink1 protein levels are decreased in mtCAT flies 
 
Canonical Pink1-Parkin mitophagy is generally considered to be active when the 
mitochondrial membrane potential is low, which in turn is generally associated with damaged 
mitochondria (discussed in detail in Chapter 1.19). In this chapter, I show that an active 
mtH2O2 signal regulates the levels of Pink1, probably affecting Parkin recruitment to the 
mitochondrion. By Western Blotting, I demonstrate that Pink1 protein levels are significantly 
reduced in mtCAT flies; whereas, Pink1 protein levels are increased in Sod2 flies. The protein 
levels of Parkin are however unaltered (Figure 4.8 A and B). Taking into account the loss in 
Pink1 protein levels in AOX and mtCAT flies, and also a modest increase in Sod2 flies, I can 
hypothesize that a mtH2O2 signal regulates Pink1 levels in vivo. 
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A 
B 
 
(A) Representative western blot membranes showing Pink1 and Parkin protein 
levels. GAPDH is used for normalization and quantification purposes. (B) 
Quantification of (A) (n=3). Non-expressing flies (2>UAS-mtCAT) (Control in the 
figure), UAS-mtCAT expressing flies (daGAL4>UAS-mtCAT) (mtCatalase in the 
figure), non-expressing flies (2>UAS-Sod2) (Control in the figure) and Sod2 
overexpressing flies (daGAL4>UAS-Sod2) (Sod2 in the figure) were used. A 
daughterless GAL4 promoter was used for the expression of transgenes. P values 
were calculated using student’s t-test. Experimental groups were compared to 
their respective controls. Data are shown as mean ± SEM. * = p<0.05; denotes 
statistically significant difference between mentioned genotypes. The molecular 
weight of proteins detected by western blots are given as kiloDalton (kDa) units. 
 
 
Figure 4.8 Pink1 protein levels are decreased in mtCAT flies. 
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4.8 Protein turnover is disrupted in mtCAT flies 
 
I then used mtCAT and Sod2 flies, to examine whether O2- or H2O2 is responsible for the 
modulation of protein turnover. Although the effect was not as severe as in AOX flies, 
mtCAT flies reduced Caspase-Like and Trypsin-Like activity of the 20S proteasome and 
Chymotrypsin-Like and Caspase-Like activity of the 26S proteasome. Whereas, Sod2 
overexpressing flies increased the activities of all the parameters studied in the 20S 
proteasome, but activity of the 26S proteasome remained largely unchanged (Figure 4.9 A and 
B). It can be hypothesized that the 20S proteasome is the primary target for the ROS signal. It is 
a more efficient way of recycling proteins that does not require the proteins to be ubiquitin 
tagged for recycling. However, when the mtH2O2 signal is reduced, proteasomal activity is 
always reduced; and when the mtH2O2 signal is increased the activity is always improved. 
This further supports the hypothesis that mtH2O2 signal is not only responsible for 
mitochondrial turnover but also for mechanisms involving protein turnover. 
 
I also found a significant increase in Ubiquitin tagged and p62 (Ref (2) P in flies) protein 
levels in mtCAT flies; whereas, protein levels remained unaltered in Sod2 flies (Figure 4.10 A 
and B). This confirms the results obtained earlier in this chapter, and that protein turnover 
mechanisms are altered by mtH2O2.  
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A 
B 
(A) Measurements for Chymotrypsin-like (CT-L), Caspase-like (C-L) and 
Trypsin-like (T-L) 20S and 26S proteasome activity of indicated genotypes (n=6) 
B) Measurements for Chymotrypsin-like (CT-L), Caspase-like (C-L) and 
Trypsin-like (T-L) 20S and 26S proteasome activity of indicated genotypes 
(n=6). Non-expressing flies (2>UAS-mtCAT) (Control in the figure), UAS-mtCAT 
expressing flies (daGAL4>UAS-mtCAT) (mtCatalase in the figure), non-expressing 
flies (2>UAS-Sod2) (Control in the figure) and Sod2 overexpressing flies 
(daGAL4>UAS-Sod2) (Sod2 in the figure) were used. A daughterless GAL4 
promoter was used for the expression of transgenes. P values were calculated using 
student’s t-test. Experimental groups were compared to their respective controls. 
Data are shown as mean ± SEM. * = p<0.05; denotes statistically significant 
difference between mentioned genotypes. 
 
Figure 4.9 Proteasomal activity is decreased in mtCAT flies and increased in 
Sod2 flies. 
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A 
B 
(A) Representative western blot membranes showing Ubiquitin and Ref (2) P 
protein levels of indicated genotypes. GAPDH is used for normalization and 
quantification purposes. (B)  Quantification of bottom panel of (A) (n=3). Non-
expressing flies (2>UAS-mtCAT) (Control in the figure), UAS-mtCAT expressing 
flies (daGAL4>UAS-mtCAT) (mtCatalase in the figure), non-expressing flies 
(2>UAS-Sod2) (Control in the figure) and Sod2 overexpressing flies 
(daGAL4>UAS-Sod2) (Sod2 in the figure) were used. A daughterless GAL4 
promoter was used for the expression of transgenes. P values were calculated using 
student’s t-test. Experimental groups were compared to their respective controls. 
Data are shown as mean ± SEM. * = p<0.05; denotes statistically significant 
difference between mentioned genotypes. The molecular weight of proteins 
detected by western blots are given as kiloDalton (kDa) units. 
 
 
 
Ref (2) P 
170-50 kDa 
92 kDa 
36 kDa 
Ubiquitin 
Ref (2) P 
GAPDH 
Figure 4.10 Ubiquitinated proteins and Ref (2) P protein levels are increased in 
mtCAT flies. 
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4.9 mtH2O2 activates a transcriptional program for stress adaptation 
 
To further understand the mechanisms involved in the control of adaptation by mtH2O2, I 
analysed the expression of 87 genes involved in signal transduction by using quantitative PCR. 
AOX expression altered the expression of 44% of these genes, while mtCAT expression and 
Sod2 overexpression had a weaker effect altering the expression of 20% and 27% of the genes, 
respectively. Such differences can be explained because AOX directly affects the leak of 
electrons from the ETC and suppresses ROS production from both sides of the inner membrane; 
whereas, mtCAT and Sod2 can only intercept a portion of ROS released into the matrix, 
specifically acting on H2O2 and superoxide, respectively. Decreased mtH2O2 signal caused a 
down-regulation of genes, while increased mtH2O2 levels were associated with up-regulation of 
genes. Two pathways appeared to be most affected: P53 signalling (cathD, ef1alpha48d, 
mus209, tsp66e) and adaptation to hypoxia (CG10899, tango, and reptin). More importantly, the 
genes up-regulated in AOX or mtCAT flies were never up-regulated in Sod2 overexpressing 
flies, while the genes down-regulated in AOX or mtCAT flies were never down-regulated in 
Sod2 flies (Figure 4.11). This observation pertains to the fact that an extremely specific 
transcriptional programme is associated with the levels of mtH2O2. Moreover, reducing O2- and 
reducing H2O2 in two different fly models produced distinctly different transcriptional profiles. 
These results clearly demonstrate that O2- and H2O2 should not be considered as a single ROS 
entity for studies related to activation and/or deactivation of signal mechanisms. They should be 
explored as two distinctly different ROS molecules and should be modulated independent to one 
another in order to determine more robust mechanisms. Table 4.1 shows the list of all the genes 
analysed in the qPCR array for AOX, mtCAT and Sod2 flies. 
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Sod2 
AOX 
mtCatalase
e 
Venn diagram showing number of genes upregulated (↑) and number of genes 
downregulated (↓) in response to changes in mtH2O2 levels. daGAL4>AOX (AOX 
in the figure), daGAL4>UAS-mtCAT (mtCatalase in the figure) and 
daGAL4>UAS-Sod2 (Sod2 in the figure) flies were used, compared to respective 
controls. A daughterless GAL4 promoter was used for the expression of transgenes. 
P values were calculated using student’s t-test. p<0.05; denotes statistically 
significant fold change between mentioned genotypes. 
 
Figure 4.11 Distinctly different trancription profiles are observed with a 
decrease and increase in mtH2O2. 
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Pathways and Genes involved  AOX mtCatalase Sod2  
 
Hedgehog Pathway 
 
 
 
Fold Change 
 
 
Fold Change 
 
 
Fold Change 
Atonal (ato) CG 7508 0.81 NC NC 
Interference Hedgehog (iHog) CG 9211 NC NC NC 
Mirror (mirr) CG10601 0.84 NC NC 
Patched (ptc) CG2411 0.83 NC NC 
Supernumery limb (smlb) CG3412 0.86 0.85 1.34 
Smoothened (smo) CG11561 NC 0.81 NC 
Wingless (wg) CG4889 
 
0.89 NC 1.38 
Hippo Pathway 
 
 
Fold Change 
 
Fold Change 
 
Fold Change 
Branchless (Bnl) CG4608 0.79 NC NC 
Cyclin E (cycE)CG3938 NC 0.85 NC 
Diminutive (dm) CG10798 NC NC NC 
Expanded (ex) CG4114 0.83 NC NC 
Four Jointed (fj) CG10917 0.86 NC NC 
Kibra Ortholog (Kibra) CG33967 NC NC NC 
Outstretched (os) CG5993 0.88 NC NC 
Spitz (Spi) CG10334 NC NC NC 
Thread (th) CG12284 NC 0.84 1.33 
Unpaired 2 (upd2) CG5988 0.77 NC NC 
Unpaired 3 (upd3) CG33542 NC NC NC 
Vein (vn) CG10491 
 
NC NC NC 
Hypoxia  
 
 
Fold Change 
 
Fold Change 
 
Fold Change 
CG10899 0.86 NC 1.33 
Glucose Transporter 1 (glut1) CG43946 0.85 NC NC 
Ecdysone-inducible gene L3  (Impl3) 
CG10160 
1.43 NC NC 
Tango (tgo) CG11987 0.85 0.75 1.29 
Cysteine string protein (csp) CG6395 NC NC 1.34 
Cyclin G (cycG) CG11525 0.74 NC 1.33 
Ornithin Decarboxylase 1 (odc1) 
CG8721 
NC 0.78 NC 
Ornithin Decarboxylase 2 (odc2) 
CG8719 
0.81 NC NC 
Reptin (rept) CG9750 
 
0.79 0.84 1.29 
All Genes in the qPCR array that are downregulated, upregulated  or unchanged, when 
mtH2O2 is decreased or increased. daGAL4>AOX (AOX in the table), daGAL4>UAS-
mtCAT (mtCatalase in the table) and daGAL4>UAS-Sod2 (Sod2 in the table) flies were 
used, compared to their respective controls. A daughterless GAL4 promoter was used for 
expression of the transgenes. P values were calculated using student’s t-test. p<0.05; denotes 
statistically significant fold change between mentioned genotypes. 
Table 4.1 Transcription profile for all genes in conditions of decreased and increased 
mtH2O2. 
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JAK/STAT Pathway 
 
 
Fold Change 
 
Fold Change 
 
Fold Change 
Cytochrome P451-4e1 (Cyp4e1) CG2062 NC NC NC 
G-Protein α subunit (Galpha73b) 
CG12232 
0.88 NC NC 
Grain (grn) CG9656 NC NC NC 
Heat shock protein 27 (Hsp27) CG4466 0.79 0.87 1.33 
Net (net) CG11450 NC NC NC 
Suppressor of cytokine signaling 36E 
(socs36e) CG15154  
 
0.81 NC NC 
Notch Pathway 
 
 
Fold Change 
 
Fold Change 
 
Fold Change 
Delta (di_delta) CG3619 0.84 NC NC 
Fringe (fng) CG10580 0.79 NC NC 
Hairy (h) CG6496 0.76 NC NC 
Hairy (hey) CG11194 ↓0.84 NC NC 
Notch (n) CG3936 
  
NC NC 1.40 
Oxidative Stress 
 
 
Fold Change 
 
Fold Change 
 
Fold Change 
Glutamate Cysteine Ligase modifier 
(gclm) CG4919 
NC NC 1.33 
Glutathione S transferase D1 (gstd1) 
CG10045 
NC 0.79 1.28 
Keap1 (keap1) CG3962 NC NC NC 
Refractory to sigma 1 (ref(2)p) 0.81 0.85 NC 
Thioredoxin-2 (trx-2) CG31884 
 
NC NC 1.31 
p53 Pathway 
 
 
Fold Change 
 
Fold Change 
 
Fold Change 
Cathepsin D (cathD) CG1548 0.87 0.81 1.34 
CG8630 NC NC NC 
Elaongation Factor 1α48D 
(ef1alpha48d) CG8280 
NC 0.88 1.29 
Heat shock protein cognate 1 (hsc70-1) 
CG8937 
1.35 NC NC 
Mutagen sensitive 209 (mus209) CG9193 0.81 0.84 1.39 
p53 CG33336 NC 0.79 1.40 
Tetraspanin 66E (tsp66e) CG4999 
 
0.80 0.80 1.37 
 
 
PPAR Pathway 
 
 
 
 
Fold Change 
 
 
 
Fold Change 
 
 
 
Fold Change 
CG10924 NC NC NC 
CG2107 NC NC NC 
CG3961 NC NC NC 
Fatty Acid transport protein (fatp) 
CG7400 
NC NC NC 
Midway (mdy) CG31991 NC NC 1.34 
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Phosphoinositide dependent kinase 
(pk61c) CG1210 
 
NC 0.80 NC 
TGF beta Pathway 
 
 
Fold Change 
 
Fold Change 
 
Fold Change 
Brinker (brk) CG9653 NC NC NC 
Division abnormally delayed (dally) 
CG4974 
NC NC NC 
Decapentaplegic (dpp) CG9885 NC NC NC 
Follistatin (fs) CG33466 NC NC NC 
Ionotrophic receptor 76a (ir76a) 
CG42584 
 
0.84 NC NC 
Toll/IMD/NfkB Pathway 
 
 
Fold Change 
 
Fold Change 
 
Fold Change 
Attacin-A (atta) CG10146 0.81 NC NC 
Attacin-B (attb) CG18372 NC NC NC 
Attacin-C (attc) CG4740 NC NC NC 
Attacin-D (attd) CG7629 NC NC NC 
Cactus (cact) CG5848 0.77 0.79 1.41 
Defensin (def) CG1385 NC NC NC 
Drosomycin (drs) CG10810 NC NC NC 
Metchnikowin (mtk) CG8175 
 
NC NC NC 
Torso Pathway  
 
 
Fold Change 
 
Fold Change 
 
Fold Change 
Brachyentron (byn) CG7260 0.81 NC NC 
Fork head (fkh) CG10002 0.79 NC NC 
Hunchback (hb) CG9786 0.84 NC 1.33 
Huckebein (hkb) CG9768 0.77 NC 1.37 
Tailless (tll) CG1378  
 
0.80 NC 1.67 
 
 
Wnt Pathway 
 
 
 
 
Fold Change 
 
 
 
Fold Change 
 
 
 
Fold Change 
Arrow (arr) CG5912 0.84 NC NC 
Axin (axn) CG7926 NC NC NC 
CyclinD (cycD) CG9096 0.77 0.74 1.38 
Frizzled (fz) CG17697 NC NC NC 
Nemo (nm) CG7892 0.76 NC NC 
Pangolin (pan) CG34403 NC 0.84 NC 
Ultrabithorax (ubx) CG10388 0.84 NC NC 
Wnt Oncogene Analog 4 (wnt4) CG4698 0.84 NC NC 
Wnt Oncogene Analog 5 (wnt5) CG6407 NC NC NC 
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4.10 Survival of flies with low levels of mtH2O2 is compromised; whereas, increasing 
mtH2O2 improves fly lifespan 
 
In this chapter I have demonstrated that several pathways are altered due to the loss of 
mtH2O2 signal. I wanted to verify if these alterations affect the survival of fruit flies. 
Interestingly, when survival analyses were performed, mtCAT expressing flies lived 
significantly shorter under a mild thermal stress (Figure 4.12). It can be hypothesized that, a 
balance in mtH2O2 production is necessary. When this balance is lost by reducing mtH2O2, 
signalling cascades like mitochondrial turnover and/or protein turnover are disrupted, 
reducing fly survival. On the other hand, when mtH2O2 was increased by overexpressing 
Sod2, fly survival was significantly increased (Figure 4.12).  
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Survival curves of indicated genotypes (n=200). A table with statistics for the 
lifespan is presented in Appendix A. 
 
 
Figure 4.12 Decreasing mtH2O2 (mtCAT flies) reduces fly lifespan; whereas, 
increasing mtH2O2 (Sod2 flies) increases fly lifespan. 
p<0.001 
p<0.001 
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4.11 mtH2O2 is necessary to modulate a hyperoxic and hypoxic stress response signal 
 
To discern if the observed decrease in survival was specific to thermal stress, I exposed the 
AOX, mtCAT and Sod2 flies to hypoxia (5% Oxygen) and hyperoxia (50% Oxygen). 
Interestingly, I found that H2O2 signal is necessary in order to adapt to changes in oxygen 
concentration, as the flies with decreased levels of H2O2 (AOX and mtCAT flies) lived shorter 
in both conditions (Figure 4.13). However, when the H2O2 levels were increased (Sod2 flies), 
there was a modest increase in lifespan in both conditions (Figure 4.13). It can also be argued 
that the decrease in lifespan of AOX flies in hypoxic conditions is caused by its interaction 
with the ETC. As AOX reduces the ROS produced by CIII, it has been demonstrated that this 
ROS plays a major role in hypoxic adaptation. However, I observed a decrease in lifespan of 
AOX flies in hyperoxic conditions, which demonstrates the role of mtH2O2 signal for 
adaptation under oxygen stress. Furthermore, I also detected a decrease and increase in 
lifespan in mtCAT and Sod2 flies, respectively, in both conditions. In summary, it can be 
ascertained that mtH2O2 signal is necessary to orchestrate a response to changes in oxygen 
concentration. Further experiments are necessary in order to elaborate this signalling cascade.  
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Survival curves of indicated genotype in 50% Oxygen (Hyperoxia) 
(n=200) and survival curves of indicated genotype in 5% Oxygen 
(Hypoxia) (n=200).  A table with statistics for the lifespan is presented in 
Appendix A. 
 
Figure 4.13 mtH2O2 is necessary for adaptation under oxygen stress. 
Days Days 
Days Days 
Days Days 
p<0.001 p<0.001 
p<0.001 
p<0.001 
p<0.001 p<0.001 
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Chapter 5. mtH2O2 regulates TOR signalling  
 
5.1 A brief overview of signalling mechanisms involved in aging 
 
An appropriate signalling following a stress response is necessary to activate pathways that 
detect and respond to stress. These pathways (e.g. nutrient sensing or energy sensing pathways) 
are responsible to make adjustments in case of energy demands or nutrient requirements (Jewell 
and Guan, 2013), including the necessary modifications to mitochondrial function. It has been 
previously hypothesized that de-regulation of the nutrient sensing pathways or a reduction in 
mitochondrial function is due to the damage caused by the excessive ROS produced, and was 
considered a hallmark of ageing (Harman, 1972). This hypothesis however was challenged in the 
following years. Moreover, in recent years several studies have demonstrated that ROS can be a 
consequence of ageing rather than a cause (Copeland et al., 2009). 
 
One of the major pathways responsible for these alterations is the TOR pathway (discussed in 
detail in Chapter 1.22). It has been shown that pharmacological inhibition of TOR Complex I by 
rapamycin increases autophagy. This preserves cellular homeostasis by improving the recycling 
of nutrients and damaged proteins (Bjedov et al., 2010). Even though there are several 
downstream targets of TOR, increase in autophagy has been the most prominent one studied, 
related to lifespan extension. On the other hand, mild down-regulation of ETC genes has also 
proven to be beneficial as it causes a mild mitochondrial dysfunction. It then interferes with an 
array of pathways like, activation of mitochondrial UPR (Unfolded protein response) or 
repression of insulin signalling that extends lifespan (Copeland et al., 2009 ; Owushu-Ansah et 
al., 2013). Both phenomena seem related and there have been several reports showing that TOR 
can directly regulate mitochondrial function (Schieke and Finkel, 2006). However, it is unclear if 
TOR stimulates or represses mitochondrial function.  
 
In this chapter, I demonstrate how ROS, or more specifically mtH2O2, affects TOR signalling, 
since this interaction has not been demonstrated earlier. I hypothesized that there might be 
alterations in the TOR pathway, as I observed significant changes in the transcription profile of 
flies with low mtH2O2. Moreover, protein and organelle turnover, two major mechanisms 
controlled by TOR, were also impaired in these conditions. To further confirm this hypothesis, I 
used AOX flies cultured in a mild heat stress; 29oC, which reduced both mtH2O2 levels and 
mitochondrial turnover. I also inhibited TOR by feeding rapamycin to the flies to analyse the 
impact of TOR inhibition on downstream signalling pathways. Figure 5.1 is a schematic 
illustration of the TOR signalling pathway. 
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S6K4E-BP
dTOR
AKT
ULK1
AMPK
Rapamycin
TOR integrates several signalling cascades. It is one the major pathways 
that controls homeostasis of an organism by mediating cellular nutrient and 
energy sensing.  
Figure 5.1 Schematic diagram illustrating in brief the upstream and 
downstream elements of TOR signalling. 
Translation 
 
 
 
Translation Autophagy 
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5.2 Lysosomal number is decreased when the mtH2O2 signal is disrupted 
 
I have established in Chapter 3 and 4, that mtH2O2 signal is required to initiate mitochondrial 
turnover by acting as a signal to flag damaged mitochondria. Since mitochondrial turnover 
was disrupted in flies with low mtH2O2 (AOX and mtCAT); and was increased in flies with 
high mtH2O2 (Sod2), I wanted to understand whether general autophagy or macro-autophagy 
was altered by a mtH2O2 signal. First, I stained whole fly brains with Lysotracker Red, a 
fluorescent dye that labels acidic organelles. It is used as a general indicator for the amount of 
lysosomes. I observed a significant decrease in the fluorescence by Lysotracker Red in AOX 
flies and mtCAT flies, but not in Sod2 flies (Figure 5.2 A and B). I also previously observed an 
accumulation of p62 (Ref (2) P in flies) and decreased proteasome activity in the AOX and 
mtCAT flies (described in Chapter 3.8 and 4.8). Altogether these results indicate dysfunctional 
autophagy (Korolchuk et al., 2010; Glick et al., 2010); whereas, none of these changes were 
observed in Sod2 flies. This supports the hypothesis that mtH2O2 signal is involved in 
maintaining a proper autophagic flux. 
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A 
B 
(A) Representative images of dissected fly brains stained with Lysotracker Red of 
indicated genotypes. (B) Quantification of (A) (n=4). Non-expressing flies (2>UAS-
AOX) (Control in the figure), UAS-AOX expressing flies (daGAL4>UAS-AOX) (AOX in 
the figure), non-expressing flies (2>UAS-mtCAT) (Control in the figure), UAS-mtCAT 
expressing flies (daGAL4>UAS-mtCAT) (mtCatalase in the figure), non-expressing flies 
(2>UAS-Sod2) (Control in the figure) and Sod2 overexpressing flies (daGAL4>UAS-
Sod2) (Sod2 in the figure) were used. A daughterless GAL4 promoter was used for the 
expression of transgenes. P values were calculated using student’s t-test. Experimental 
groups were compared to their respective controls. Data are shown as mean ± SEM. * 
= p<0.05; denotes statistically significant difference between mentioned genotypes. 
Scale bars are 100µm. This work was done in collaboration with Dr. Filippo Scialo. 
 
 
B 
Lysotracker Red 
>2 >daGAL4 
AOX 
mtCatalase 
Sod2 
A 
Figure 5.2 Lysosomal number is decreased when the mtH2O2 signal is disrupted. 
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5.3 TOR signalling is hyper-activated in AOX flies 
 
Autophagy is negatively regulated by TOR through inhibitory phosphorylation of ULK1 (Nazio 
et al., 2013). As I observed a decrease in autophagy in the previous chapter, I decided to 
investigate if TOR signalling was altered in AOX flies. I detected a significant increase in 
phosphorylated state of RPS6-p70-protein kinase (S6K) (proxy for TOR activity), which is a 
direct phosphorylation target of TOR. The non-phosphorylated state of the protein was 
unchanged, which denoted that the increase in phosphorylation was not because of the 
abundance of the protein but because of TOR hyper-activation. This was further confirmed by 
measuring the phosphorylation state of another downstream target of TOR, Thor (4E-BP) 
(eukaryotic translation initiation factor 4E binding protein), which was significantly increased as 
well (Figure 5.3 A and B). 
 
In order to further confirm that the hyper-activation of TOR signalling was caused by AOX 
expression; I used the “GeneSwitch” inducible expression system to modulate the expression of 
AOX (described in detail in Chapter 1.9). I observed that activation of TOR signalling 
(phosphorylation of S6K as a proxy) occurred in parallel to the increase in mitochondrial density.  
(Figure 3.9 B). I observed that when AOX expression was induced, TOR signalling was hyper-
activated, and when AOX expression was halted, TOR signalling was reverted back to normal 
(Figure 5.4 A and B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                
 
 136 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
B 
(A) Representative western blot membranes showing pS6K, S6K, p4E-BP and 
4E-BP protein levels of indicated genotypes. GAPDH is used for normalization 
and quantification purposes. (B) Quantification of (A) (n=3). Non-expressing flies 
(2>UAS-AOX) (Control in the figure) and UAS-AOX expressing flies 
(daGAL4>UAS-AOX) (AOX in the figure) were used. A daughterless GAL4 
promoter was used for the expression of the transgene. P values were calculated 
using student’s t-test. Data are shown as mean ± SEM. * = p<0.05; denotes 
statistically significant difference between mentioned genotypes. The molecular 
weight of proteins detected by western blots are given as kiloDalton (kDa) units. 
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Figure 5.3 TOR is hyper-activated in AOX flies. 
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A 
B 
(A) Representative western blot membranes and their respective quantification 
showing pS6K and S6K protein levels in indicated genotypes (n=3). Non-expressing 
flies (0) and UAS-AOX expressing flies (+RU-486 ON) for 1,2,3,4 and 6 days were 
used. (B) Representative western blot membranes and their respective quantification  
showing pS6K and S6K protein levels in indicated genotypes (n=3). Non-expressing 
flies (0) and UAS-AOX expressing flies un-induced after expression for 5 days earlier 
(-RU-486 OFF) for 6,7,8,9 and 10 days were used. GAPDH is used for normalization 
and quantification purposes. An inducible Tubulin GeneSwitch GAL4 promoter was 
used for the expression of the transgene. P values were calculated using 1-way 
ANOVA with Newman-Keul's post-test. Data are shown as mean ± SEM. * = p<0.05; 
denotes statistically significant difference between mentioned genotypes. The art lines 
in the figure denote the statistically significant difference between the marked 
genotypes. The molecular weight of proteins detected by western blots are given as 
kiloDalton (kDa) units. 
 
 
70 kDa 
70 kDa 
70 kDa 
70 kDa 
36 kDa 
36 kDa 
Figure 5.4 TOR is hyper-activated and restored parallel to induction and removal of 
AOX expression respectively. 
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5.4 Insulin and insulin-like growth factor signalling is modified in AOX flies 
 
In order to investigate whether the upstream regulators of TOR were altered when the mtH2O2 
levels were decreased, I used AOX flies to check the levels of several proteins that are positive 
and negative regulators of TOR. Firstly, I measured the phosphorylated protein levels of Akt1 
(AKT). Akt1 is a downstream target of Insulin/insulin-like growth factor signalling (IIS) and 
Chico (insulin receptor (INR)) in flies, which are key regulators of energy metabolism and 
growth (Clancy et al., 2001). The phosphorylated state of AKT is a positive regulator of TOR. In 
order to prevent over activation of TOR, the phosphorylation of AKT is also regulated through a 
negative feedback loop  by a downstream target of TOR; S6K1 (Wan et al., 2007). Interestingly, 
I observed a reduction in the phosphorylation of AKT in AOX flies, suggesting that the negative 
feedback loop is active (Figure 5.5 A and B). To further confirm this activation, I measured 
protein levels of forkhead box, sub group O (FOXO), which is a direct target of AKT. In 
accordance to the activation state of AKT, I detected a decrease and increase in the 
phosphorylated and non-phosphorylated form of FOXO respectively, indicating its activation 
and translocation to the nucleus (Figure 5.5 A and C) (Tzivion et al., 2011). These results 
confirmed that the decrease in the phosphorylation state of AKT is not an artefact and the 
feedback loop is active.  
 
Additionally, as FOXO was activated in AOX flies, I analysed the levels of one of its 
transcription targets; Sestrin, which is responsible for the activation of AMP-activated protein 
kinase  subunit (AMPKα) (Lee et al., 2010). I detected an increase in protein levels of Sestrin 
that correlated with an increase in the presence of phosphorylated-AMPK, which is responsible 
for deactivation of TOR (described in detail in Chapter 1.22) (Figure 5.6 A,B and C) 
(Serfontein et al., 2010). These data indicate that the upstream negative regulators of TOR were 
active, however, were not sufficient to supress TOR in conditions of low mtH2O2. 
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A 
(A) Representative western blot membranes showing pAKT, AKT, pFOXO and 
FOXO protein levels of indicated genotypes. GAPDH is used for normalization and 
quantification purposes. (B) Quantification of pAKT and AKT from (A) (n=3). (C) 
Quantification of pFOXO and FOXO from (A) (n=3). Non-expressing flies (2>UAS-
AOX) (Control in the figure) and UAS-AOX expressing flies (daGAL4>UAS-AOX) 
(AOX in the figure) were used. A daughterless GAL4 promoter was used for the 
expression of the transgene. P values were calculated using student’s t-test. Data are 
shown as mean ± SEM. * = p<0.05; denotes statistically significant difference 
between mentioned genotypes. The molecular weight of proteins detected by western 
blots are given as kiloDalton (kDa) units. 
 
 
 
B C 
60 kDa 
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82 kDa 
36 kDa 
Figure 5.5 Insulin and insulin-like growth factor signalling (IIS) are downregulated 
in AOX flies. 
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(A) Representative western blot membranes showing Sestrin, pAMPK and AMPK 
protein levels of indicated genotypes. GAPDH is used for normalization and 
quantification purposes.  (B) Quantification of Sestrin from (A) (n=3). (C) 
Quantification of pAMPK and AMPK from (A) (n=3). Non-expressing flies (2>UAS-
AOX) (Control in the figure) and UAS-AOX expressing flies (daGAL4>UAS-AOX) 
(AOX in the figure) were used. A daughterless GAL4 promoter was used for the 
expression of the transgene. P values were calculated using student’s t-test. Data are 
shown as mean ± SEM. * = p<0.05; denotes statistically significant difference 
between mentioned genotypes. The molecular weight of proteins detected by western 
blots are given as kiloDalton (kDa) units. 
A 
B 
 
 
 
C 
57 kDa 
62 kDa 
62 kDa 
36 kDa 
Figure 5.6 The feedback loop necessary to inhibit TOR hyper-activation is activated 
in AOX flies. 
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5.5 Decrease in lysosomal content in AOX flies
 
is rescued by pharmacological inhibition 
of TOR. 
 
I have observed in Chapter 5.3 that TOR was hyper-activated in AOX flies and it was linked 
to reduced autophagy, reduced mitochondrial turnover and severely shortened lifespan 
(Chapter 5.2, 3.5 and 3.9). I then wanted to investigate whether the pharmacological 
inhibition of TOR by rapamycin (described in detail in Chapter 1.26) would reverse or at least 
partially rescue the phenotype conferred by AOX expression.   
 
I was able to successfully inhibit TOR signalling in AOX flies by feeding them with 
rapamycin, as verified by the decrease in phosphorylation of S6K (Figure 5.7 A and B). This 
clearly shows that the rapamycin doses used for the inhibition of TOR was effective. I then 
wanted to analyse if the rapamycin treatment improved lysosomal number in AOX flies. 
Lysotracker staining demonstrated that rapamycin treatment restored lysosomal content in AOX 
flies (Figure 5.8 A and B). I reconfirmed these results by checking the protein levels of Lamp1 
which was also restored upon rapamycin treatment (Figure 5.8 C and D).  
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(A) Representative western blot membranes showing pS6K and S6K protein levels of 
indicated genotypes. GAPDH is used for normalization and quantification purposes.  (B) 
Quantification of (A) (n=3). Non-expressing flies (2>UAS-AOX) (Control in the figure), 
UAS-AOX expressing flies (daGAL4>UAS-AOX) (AOX in the figure) and UAS-AOX 
expressing flies (daGAL4>UAS-AOX) fed with rapamycin (AOX + Rapa in the figure) 
were used. A daughterless GAL4 promoter was used for the expression of the transgene. 
P values were calculated using 1-way ANOVA with Newman-Keul's post-test. Data 
are shown as mean ± SEM. * = p<0.05; denotes statistically significant difference 
between mentioned genotypes. The molecular weight of proteins detected by western 
blots are given as kiloDalton (kDa) units. 
A 
B 
70 kDa 
36 kDa 
Figure 5.7 TOR signalling is restored when AOX flies are fed with rapamycin. 
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+ Rapa
A B 
C 
(A) Representative images of dissected fly brains stained with Lysotracker Red of 
indicated genotypes. (B) Quantification of (A) (n=4). This work was done in 
collaboration with Dr. Filippo Scialo. (C) Representative western blot membrane 
showing Lamp1 protein levels of indicated genotypes. GAPDH is used for 
normalization and quantification purposes. (D) Quantification of (C) (n=3). Non-
expressing flies (2>UAS-AOX) (Control in the figure), UAS-AOX expressing flies 
(daGAL4>UAS-AOX) (AOX in the figure) and UAS-AOX expressing flies 
(daGAL4>UAS-AOX) fed with rapamycin (AOX + Rapa in the figure) were used. A 
daughterless GAL4 promoter was used for the expression of the transgene. P values 
were calculated using 1-way ANOVA with Newman-Keul's post-test or using student 
t-test. Data are shown as mean ± SEM. * = p<0.05; denotes statistically significant 
difference between mentioned genotypes. The art lines in the figure denote the 
statistically significant difference between the marked genotypes. Scale bars are 
100µm. The molecular weight of proteins detected by western blots are given as 
kiloDalton (kDa) units. 
 
 
 
120 kDa 
36 kDa 
D 
Figure 5.8 Lysosomal content in AOX flies is rescued when the flies are fed with 
rapamycin. 
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5.6 Mitochondrial accumulation is rescued by rapamycin feeding in AOX flies 
 
 
We have previously demonstrated that a mtH2O2 signal is necessary; in order to initiate turnover 
of damaged mitochondria (Chapter 3 and Chapter 4). However, I hypothesized that when the 
mtH2O2 signal responsible to flag damaged mitochondria or to stabilize Pink1 is absent; 
improving autophagy may not be necessarily advantageous. This may be because the autophagy 
machinery is not able to successfully detect damaged mitochondria, specifically for sequestering 
them to the autophagosome. This phenomenon might lead to improper recycling of mitochondria 
by the autophagic machinery, by using alternate mitochondrial markers other than Pink1, which 
do not flag damaged mitochondria. 
 
I then checked if the increase in mitochondrial density in AOX flies was rescued by rapamycin 
treatment. Rapamycin treatment, as expected, reduced the mitochondrial density in AOX flies 
(Figure 5.9).  
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Citrate synthase activity measuring mitochondrial density of indicated genotypes 
(Control = 1.159±0.013 Absorbance Units mg protein-1) (n=9). Non-expressing flies 
(2>UAS-AOX) (Control in the figure), UAS-AOX expressing flies (daGAL4>UAS-
AOX) (AOX in the figure) and UAS-AOX expressing flies (daGAL4>UAS-AOX) fed 
with rapamycin (AOX + Rapa in the figure) were used. A daughterless GAL4 promoter 
was used for the expression of the transgene. P values were calculated using 1-way 
ANOVA with Newman-Keul's post-test. Data are shown as mean ± SEM. * = 
p<0.05; denotes statistically significant difference between mentioned genotypes. 
The art lines in the figure denote the statistically significant difference between the 
marked genotypes. 
 
 
 
Figure 5.9 Mitochondrial accumulation is rescued in AOX flies fed with rapamycin. 
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5.7 Mitochondrial dysfunction is not rescued by rapamycin feeding in AOX flies 
 
Interestingly, reduction in mitochondrial respiration was not rescued by rapamycin feeding in 
AOX flies. As described earlier (Chapter 3.6), I did not see any difference between AOX flies 
and controls when respiration rates were normalized to total protein content; however, AOX flies 
fed with rapamycin had a modest but significant decrease in respiration (Figure 5.10 A). 
Additionally, even though AOX flies fed with rapamycin, rescued mitochondrial accumulation, 
the respiration rates per mitochondrion were not increased as expected, when normalized to 
mitochondrial density (Figure 5.10 B). This confirms the hypothesis that a mtH2O2 signal is 
necessary to flag damaged mitochondria for recycling.  
 
To reconfirm that mitochondrial dysfunction was persistent after rapamycin feeding; I measured 
mRNA levels of Hsp22 and Hsp60 whose levels are increased when mitochondria are damaged 
(Chapter 3.6). I detected a significant increase in mRNA levels of both Hsp’s in the rapamycin 
fed AOX flies, surprisingly, even more than AOX flies without rapamycin feeding. I detected a 
similar increase with mRNA levels of Impl3 as well, indicating that the flies are switching to a 
more glycolytic metabolism, due to the severely dysfunctional mitochondria (Figure 5.11). In 
summary, these results support the hypothesis that mitochondrial recycling upon rapamycin 
feeding is not specific to damaged mitochondria. All or most of the damaged mitochondria are 
hence not recycled exacerbating the phenotype of the fly. These results also indicate that hyper-
activation of TOR in AOX flies can be a consequence and not the cause of accumulation of 
damaged mitochondria. It can be further hypothesized that the accumulation of mitochondria or 
the increase in mitochondrial number is interpreted as a signal to grow by the cell; thus 
consequently activating TOR to increase cell size and protein synthesis. Further investigation 
however is required in order to dissect and demonstrate this hypothesis. 
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A 
(A) Comparison of oxygen consumption of indicated genotypes (n=3). CI-linked 
(Control = 544±25.98 picomoles O2 min-1 mg protein-1), CIII-linked (Control = 
328.58±35.98 picomoles O2 min-1 mg protein-1) and CIV-linked (Control = 1243±40 
picomoles O2 min-1 mg protein-1) oxygen consumption measured. (B) Representing 
respiration data normalized to respiration per mitochondrion of indicated genotypes 
(n=3). CI-linked, CIII-linked and CIV-linked oxygen consumption measured. Non-
expressing flies (2>UAS-AOX) (Control in the figure), UAS-AOX expressing flies 
(daGAL4>UAS-AOX) (AOX in the figure) and UAS-AOX expressing flies 
(daGAL4>UAS-AOX) fed with rapamycin (AOX + Rapa in the figure) were used. A 
daughterless GAL4 promoter was used for the expression of the transgene. P values 
were calculated using 1-way ANOVA with Newman-Keul's post-test. Data are 
shown as mean ± SEM. * = p<0.05; denotes statistically significant difference 
between mentioned genotypes. 
 
CIV CIII+IV CI+III+IV 
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Figure 5.10 Mitochondrial respiration is not rescued in AOX flies fed with 
rapamycin. 
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Quantification of mRNA levels of Hsp22, Hsp60 and ImpL3 by quantitative PCR of 
indicated genotypes (n=4). Non-expressing flies (2>UAS-AOX) (Control in the 
figure), UAS-AOX expressing flies (daGAL4>UAS-AOX) (AOX in the figure) and 
UAS-AOX expressing flies (daGAL4>UAS-AOX) fed with rapamycin (AOX + Rapa in 
the figure) were used. A daughterless GAL4 promoter was used for the expression of 
the transgene. P values were calculated using 1-way ANOVA with Newman-Keul's 
post-test. Data are shown as mean ± SEM. * = p<0.05; denotes statistically 
significant difference between mentioned genotypes. The art lines in the figure 
denote the statistical significance between all three genotypes.  
 
Figure 5.11 Mitochondrial damage is exacerbated in AOX flies fed with rapamycin. 
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5.8 Survival of AOX flies is not rescued by rapamycin feeding 
 
Rapamycin has been shown to increase lifespan in several model organisms like yeast, 
worms, flies and mice. A dose dependent increase in lifespan has also been demonstrated in 
many model organisms (Bjedov et al., 2010). As I previously detected a hyper-activation of 
TOR and a severely compromised lifespan in AOX flies, I wanted to investigate if feeding 
rapamycin to AOX flies might improve their survival.  
 
To begin with, I fed AOX flies with rapamycin every day and analysed their survival. 
Interestingly, AOX flies fed with rapamycin had an even shorter lifespan than AOX flies 
without the feeding (Figure 5.12 A). This can be explained by the fact that mitochondrial 
damaged was exacerbated in AOX flies fed with rapamycin when compared to AOX flies 
feeding on normal food (Figure 5.10 and 5.11). I then hypothesized that the continuous 
feeding of rapamycin can cause defects in translation by inhibiting TOR Complex II, leading 
to a severe reduction in lifespan. This can be an additional burden for AOX flies, thereby 
reducing their lifespan even more drastically. To test the hypothesis, I fed AOX flies with 
rapamycin for only 2 days a week. Transient feeding did not reduce the lifespan of AOX flies, 
but neither did it rescue their lifespan (Figure 5.12 B). In summary, these results demonstrate 
that a mtH2O2 signal might be necessary in order to keep TOR signalling in check and 
maintain homeostasis.   
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Survival curves of indicated genotype.  (n=200). A table with statistics for the lifespan is 
presented in Appendix A. 
B 
A 
Figure 5.12 Continuous feeding of rapamycin shortened the lifespan of AOX flies; 
whereas, lifespan was unaltered upon transient feeding. 
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Chapter 6. Restoring mitophagy rescues the physiological phenotype 
triggered by low mtH2O2 levels 
 
 
6.1 Overview of canonical Pink1-Parkin mediated mitophagy 
 
Canonical mitophagy is mediated by the PINK1-PARKIN axis, but how Pink1 is activated 
upon mitochondrial damage and Parkin is recruited by Pink1 is still a highly debated topic. It 
has been suggested that PINK1 needs to auto-phosphorylate itself upon mitochondrial 
depolarization in order to recruit PARKIN. However, there have also been some reports 
supporting the hypothesis that PARKIN is responsible for the activation of PINK1 (Okatusu 
et al., 2012;Narendra et al., 2008). On the other hand, numerous other studies in flies and 
worms have also demonstrated that Parkin overexpression rescues Pink1 mutant phenotype, 
denoting the fact that Pink1 can also be completely dispensable for mitochondrial turnover 
(Clark et al., 2006).  
 
I have demonstrated in Chapter 3 and 4, that mitophagy is disrupted when mtH2O2 levels are 
decreased (AOX and mtCAT flies). In this chapter, I restored mitophagy in a low mtH2O2 
background (AOX flies) to see if restoration of mitophagy can rescue TOR signalling and 
lifespan of AOX flies. This will help us to differentiate the upstream and downstream elements 
of this network. Figure 6.1illustrates the canonical PINK1-PARKIN mitophagy pathway. 
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It has been demonstrated that PINK1 and PARKIN are essential for detection and 
turnover of damaged mitochondria.  
Mitophagy 
Mitochondrial  
Damage 
PINK1 
Stabilization 
PARKIN 
Recruitment 
Figure 6.1 Schematic diagram illustrating in brief the canonical PINK1-
PARKIN mitophagy pathway. 
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6.2 Verification of overexpression of Parkin and Pink1 in Drosophila 
 
Parkin and Pink1 overexpression was achieved by using a UAS-Parkin and UAS-Pink1 
constructs and an inducible Tubulin GeneSwitch GAL4 promoter. I verified the 
overexpression by measuring protein levels of Parkin and Pink1 in the respective 
overexpressing fly lines. I detected a significant increase in protein levels for both Parkin and 
Pink1, confirming that the overexpression constructs are functional (Figure 6.2). 
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Top panel showing representative western blot membrane of Parkin protein 
levels in non-expressing flies (TubGS>UAS-Parkin; –RU-486 OFF) (Parkin in the 
figure) and Parkin overexpressing flies (TubGS>UAS-Parkin; +RU-486 ON) 
(Parkin in the figure). Bottom panel showing representative Western blot 
membrane of Pink1 protein levels in non-expressing flies (TubGS>UAS-Pink1; –
RU-486 OFF) (Pink1 in the figure) and Pink1 overexpressing flies (TubGS>UAS-
Pink1; –RU-486 ON) (Pink1 in the figure) flies. An inducible Tubulin GeneSwitch 
GAL4 promoter was used for the expression of the transgene. GAPDH was used 
for normalization purpose. The molecular weight of proteins detected by western 
blots are given as kiloDalton (kDa) units. 
 
 
 
Figure 6.2 Validation of Pink1 and Parkin overexpression.  
54 kDa 
36 kDa 
82 kDa 
36 kDa 
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6.3 Parkin, but not Pink1 overexpression restores mitochondrial turnover in AOX flies 
 
Results presented in Chapter 3 and 4 indicated that mitochondrial turnover was regulated by 
mtH2O2, and reduction of mtH2O2 compromised stress adaptation and survival. I then sought 
to understand whether increasing mitochondrial turnover by activating the canonical Pink1-
Parkin mitophagy pathway would rescue the AOX phenotype. In agreement with the 
hypothesis, Parkin overexpression in AOX flies reduced the accumulation of mitochondria 
(Figure 6.3). Surprisingly, Pink1 overexpression in AOX flies did not rescue the 
mitochondrial accumulation (Figure 6.3). These results partially validated the hypothesis that 
the Pink1 protein needs to undergo an oxidative modification to be activated. When the 
mtH2O2 necessary for redox regulation of the protein is absent, overexpression of the protein 
is not beneficial. Moreover, these results also indicate that overexpression of Parkin is a 
bypass for this H2O2 signal. 
 
To further understand the process of Parkin dependent mitophagy, I stained live fly brains 
with H2DCF. Parkin overexpression reduced the ROS levels modestly, but not significantly, 
in the AOX flies. This might be due to the decrease in damaged mitochondria; however, 
Pink1 overexpression did not change the ROS levels (Figure 6.4 A and B). This experiment 
demonstrates that Parkin is located downstream of the ROS signal.  
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Citrate synthase activity measuring mitochondrial density of indicated genotypes 
(Control = 0.7783±0.024 Absorbance Units mg protein-1) (n=9). AOX expressing 
flies (TubGS>UAS-AOX; +RU-486 ON) (AOX in the figure), UAS-AOX; Parkin 
overexpressing flies (TubGS>UAS-AOX; UAS-Parkin; +RU-486 ON) (AOX; 
Parkin in the figure) and UAS-AOX; Pink1 overexpressing flies (TubGS>UAS-
AOX; UAS-Pink1; +RU-486 ON) (AOX; Pink1 in the figure). An inducible 
Tubulin GeneSwitch GAL4 promoter was used for the expression of the 
transgene. P values were calculated using 1-way ANOVA with Newman-Keul's 
post-test. Data are shown as mean ± SEM. * = p<0.05; denotes statistically 
significant difference between mentioned genotypes. 
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Figure 6.3 Parkin, but not Pink1 overexpression rescues the mitochondrial 
accumulation caused by AOX expression. 
M
ito
ch
on
dr
ia
l p
ro
te
in
 d
en
sit
y 
%
 
A
O
X
 
fli
es
 
 157 
 
 
 
 
                         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
B 
H2DCF 
(A) Representative images of dissected fly brains stained with H2DCF of indicated 
genotypes. (B) Quantification of A (n=5). AOX expressing flies (TubGS>UAS-
AOX; +RU-486 ON) (AOX in the figure), UAS-AOX; Parkin overexpressing flies 
(TubGS>UAS-AOX; UAS-Parkin; +RU-486 ON) (AOX; Parkin in the figure) and 
UAS-AOX; Pink1 overexpressing flies (TubGS>UAS-AOX; UAS-Pink1; +RU-486 
ON) (AOX; Pink1 in the figure). An inducible Tubulin GeneSwitch GAL4 
promoter was used for the expression of the transgene. P values were calculated 
using 1-way ANOVA with Newman-Keul's post-test. Data are shown as mean ± 
SEM. This work was done in collaboration with Dr. Filippo Scialo. 
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Figure 6.4 Neither Parkin nor Pink1 overexpression alters ROS levels in 
AOX flies. 
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6.4 Parkin overexpression improves the mitochondrial functionality of AOX flies 
 
In order to verify the recycling of damaged mitochondria, I checked if the mitochondrial 
functionality was restored after restoring mitophagy. The respiration normalized to total 
protein content was unaltered as observed earlier (Figure 6.5 A). However, when normalized 
to their respective mitochondrial densities, mitochondrial respiration was improved by Parkin 
overexpression in AOX flies but not by Pink1 overexpression (Figure 6.5 B). Combined, 
these experiments confirm that Parkin overexpression restores recycling of damaged 
mitochondria, hence improving its function. 
 
I also detected a modest rescue in mRNA levels of Hsp22; which demonstrated that 
mitochondrial function is restored after restoring mitophagy. However, I did not detect any 
changes in the Hsp60 mRNA levels. This can be explained by the fact that induction in Hsp60 
is not as extreme as other Hsp’s in the AOX flies. Additionally, there was also no rescue in 
mRNA levels of Hsp70, but there was a significant increase in induction when Pink1 was 
overexpressed along with AOX. The mRNA levels of ImpL3 were also rescued by Parkin 
overexpression; whereas, Pink1 overexpression did not rescue the induction (Figure 6.6). This 
experiment demonstrates that Parkin overexpression, but not Pink1 overexpression, can 
restore different mitochondrial phenotypes caused by low mtH2O2 levels. 
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A 
B 
CI+III+IV CIII+IV CIV 
(A) Comparison of oxygen consumption of indicated genotypes (n=4). CI-linked 
(Control = 1065±133.4 picomoles O2 min-1 mg protein-1), CIII-linked (Control = 
590.3±52.3 picomoles O2 min-1 mg protein-1) and CIV-linked (Control = 
3155±86.36 picomoles O2 min-1 mg protein-1) oxygen consumption (B) CI-linked, 
CIII-linked and CIV-linked oxygen consumption measurements normalized to 
respective mitochondrial density (n=4). AOX expressing flies (TubGS>UAS-AOX; 
+RU-486 ON) (AOX in the figure), UAS-AOX; Parkin overexpressing flies 
(TubGS>UAS-AOX; UAS-Parkin; +RU-486 ON) (AOX; Parkin in the figure) and 
UAS-AOX; Pink1 overexpressing flies (TubGS>UAS-AOX; UAS-Pink1; +RU-486 
ON) (AOX; Pink1 in the figure). An inducible Tubulin GeneSwitch GAL4 
promoter was used for the expression of the transgene. P values were calculated 
using 1-way ANOVA with Newman-Keul's post-test. Data are shown as mean ± 
SEM. * = p<0.05; denotes statistically significant difference between mentioned 
genotypes. 
 
Figure 6.5 Parkin overexpression rescues mitochondrial respiration of AOX 
flies. 
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Quantification of mRNA levels of Hsp22, Hsp60, Hsp70 and ImpL3 by 
quantitative PCR in indicated genotypes (n=6). AOX expressing flies 
(TubGS>UAS-AOX; +RU-486 ON) (AOX in the figure), UAS-AOX; Parkin 
overexpressing flies (TubGS>UAS-AOX; UAS-Parkin; +RU-486 ON) (AOX; 
Parkin in the figure) and UAS-AOX; Pink1 overexpressing flies (TubGS>UAS-
AOX; UAS-Pink1; +RU-486 ON) (AOX; Pink1 in the figure). An inducible 
Tubulin GeneSwitch GAL4 promoter was used for the expression of the 
transgene. P values were calculated using 1-way ANOVA with Newman-Keul's 
post-test. Data are shown as mean ± SEM. * = p<0.05; denotes statistically 
significant difference between mentioned genotypes. 
 
 
Figure 6.6 Mitochondrial damage is improved by Parkin overexpression in 
AOX flies. 
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6.5 Parkin overexpression restores TOR signalling in AOX flies 
 
As I have observed earlier that AOX expression causes the hyper-activation of TOR (Chapter 
5.3), I wanted to understand if TOR signalling directly controls mitochondrial function or 
vice-versa. I measured phosphorylation of S6K as a proxy for TOR activation. In accordance 
to the results seen in mitochondrial respiration and mitochondrial density, Parkin but not 
Pink1 overexpression restored TOR signalling in AOX flies (Figure 6.7 A and B). This 
suggests a direct control of TOR signalling by mitochondrial activity. Combined, these results 
prove that restoring mitophagy is enough to restore TOR signalling, indicating that an 
appropriate mitochondrial turnover is essential. 
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(A) Representative western blot membranes showing pS6K and S6K levels in 
indicated genotypes. GAPDH is used for normalization and quantification 
purposes.  (B)  Quantification of (A) (n=3).  AOX expressing flies (TubGS>UAS-
AOX; +RU-486 ON) (AOX in the figure), UAS-AOX; Parkin overexpressing flies 
(TubGS>UAS-AOX; UAS-Parkin; +RU-486 ON) (AOX; Parkin in the figure) and 
UAS-AOX; Pink1 overexpressing flies (TubGS>UAS-AOX; UAS-Pink1; +RU-
486 ON) (AOX; Pink1 in the figure). An inducible Tubulin GeneSwitch GAL4 
promoter was used for the expression of the transgene. P values were calculated 
using 1-way ANOVA with Newman-Keul's post-test. Data are shown as mean ± 
SEM. * = p<0.05; denotes statistically significant difference between mentioned 
genotypes. The molecular weight of proteins detected by western blots are given 
as kiloDalton (kDa) units. 
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Figure 6.7 Hyper-activation of TOR in AOX flies is restored by Parkin 
overexpression. 
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6.6 Parkin overexpression rescues the survival of AOX flies 
 
As demonstrated in Chapter 3.9, AOX expression caused a significant decrease in lifespan.   
Since I have established that accumulation of damaged mitochondria activates TOR signalling 
and reduces lifespan, I hypothesized that activation of mitochondrial turnover in these 
conditions will rescue the short lifespan of AOX flies.  
 
I performed lifespan analysis in both Parkin overexpressing flies and Pink1 overexpressing 
flies, co-expressing AOX. I observed a significant extension in the survival, when Parkin was 
overexpressed in AOX flies; whereas, Pink1 overexpression did not alter AOX lifespan 
(Figure 6.8). This was in accordance to the lack of effect on other phenotypes studied. In 
summary, this chapter shows that mitochondrial turnover is indispensable for a healthy and 
long survival.    
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Survival curves of indicated genotypes (n=200). A table with statistics 
for the lifespan is presented in Appendix A. 
0 6 12 18 24 30
0
50
100
TubGS>AOX -RU-486 (OFF)
TubGS>AOX +RU-486 (ON)
TubGS>AOX; Parkin +RU-486 (ON)
TubGS>AOX; Pink1 +RU-486 (ON)
Days
P
e
rc
e
n
t 
s
u
rv
iv
a
l
 
Figure 6.8 Parkin overexpression rescues the lifespan of AOX flies. 
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Chapter 7. Discussion 
 
7.1 Introduction 
 
Accumulation of damaged mitochondria is a common characteristic for ageing and 
neurodegenerative diseases (Bratic and Larsson, 2013), but how and why this happens is still 
a mystery. Although ROS can be hypothesized as a proximal cause for this phenotype, studies 
have not been successful in demonstrating this effect definitively. ROS often functions as a 
dual entity, in damage as well as in signalling. The function of ROS, that causes damage to 
proteins and molecules have been very well studied and linked to many diseases, particularly 
that of ageing (Alfadda and Sallam, 2012). Even though many studies have emerged making 
it evident that ROS also functions in signalling pathways like hypoxia and apoptosis (Deng et 
al., 2012) (Qutub and Popel, 2008), it is still unclear if or how ROS are responsible for 
activating or deactivating many other signalling pathways like mitophagy and/or insulin 
signalling. Most of the studies on ROS signalling are also demonstrated in vitro; either in cell 
culture or isolated mitochondria. Cell culture has many advantages, but when considering 
studies on ROS signalling it might be less efficient. Culturing cells in a dish expose cells to 
high levels of oxygen than the ones observed in vivo. This can be responsible for the 
production of excessive ROS, as cells can induce a Hyperoxia like response, increasing ROS 
consequentially. This response can also lead to activation or deactivation of many signal 
transduction pathways (Kwak et al., 2006). Furthermore, cells that are used for experiments 
are also cultured on glucose instead of galactose. Glucose makes the cell highly glycolytic, 
making the cell completely dependent on glycolysis for their energy demands; therefore 
making the mitochondria dormant or with very low functionality. This hypothesis has also 
already been tested and it has been observed that PARKIN dependent mitophagy is altered 
according to the media in which cells are cultured. In these studies, it was observed that 
PARKIN dependent mitophagy in cells occur only when cultured in glucose. Under these 
conditions, PARKIN is overexpressed and FCCP is added to the culture media. However, 
when cells are cultured in galactose, mitochondrial OXPHOS is active and PARKIN 
dependent mitophagy is inhibited. Even upon FCCP addition, PARKIN dependent mitophagy 
is minimal (MacVicar and Lane, 2014).  In summary, as ROS signalling mainly depends on 
mitochondrial function, signalling studies in cell cultures may lose their credibility.  
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Activation or deactivation of TOR signalling has already been studied in many diseases and in 
ageing (Kaeberlein, 2013). TOR signalling plays a major role in cellular mechanisms like cell 
growth, proliferation, protein translation, autophagy and many more. It integrates many 
upstream elements, thus making it one of the most important signal transduction pathways. 
There have been numerous studies emerging from the TOR signalling cascade since its 
discovery (Heitman et al., 1991), but there is no solid proof of how TOR signalling performs 
as a unit. Many studies have demonstrated that inhibiting TOR improves many disease 
phenotypes like cancer and has also been shown to extend healthy lifespan (Seufferlein and 
Rozengurt, 1996; Neff et al., 2013). On the other hand, activation of TOR has been shown to 
improve homeostasis by promoting the translation of proteins. Even though many 
pharmacological and genetic interventions to activate and deactivate TOR have been used, the 
mechanism of activation or inhibition is still not very clear. However, with the discovery of 
new and more specific inhibitors and/or activators, further studies will improve our 
understanding on the molecular basis of the signalling cascade.  
 
TOR signalling modulates mitochondrial bioenergetics in many ways. It activates PGC1 α, 
which is a major modulator for mitochondrial biogenesis (Diop et al., 2015). It has also been 
shown to improve availability of substrates for glycolysis, which is utilized by the 
mitochondria as well (Sun et al., 2011). On the other hand, not many studies have 
demonstrated the role of mitochondria in controlling TOR signalling. It has been shown that 
mitochondrial ROS regulates many downstream mechanisms of TOR like autophagy or 
apoptosis (Gibson, 2013) (Simon et al., 2000), but there are no studies showing a direct 
regulation of TOR by mitochondrial ROS. In many model organisms mitochondrial damage 
and TOR signalling are increased in parallel during ageing (Bratic and Larsson, 2013), but 
whether this is a cause or a consequence of ageing is still not determined. 
 
In summary, I provide evidence that mitochondrial H2O2 signal is necessary for stress 
adaptation. When this signal is blocked by two different genetic interventions, mitochondrial 
turnover is halted. This causes an accumulation of damaged mitochondria which in turn 
causes persistent hyper-activation of TOR. I have further demonstrated that increasing 
mitochondrial turnover in a low mitochondrial H2O2 (AOX flies) background reduces 
mitochondrial density and restores TOR signalling. However, reverting the hyper-activation 
of TOR in a low mitochondrial H2O2 background does not improve this phenotype. This 
demonstrates that activation of TOR signalling can be a homeostatic response, instead of a 
consequence, in order to improve glycolysis for energy balance. I aim to elucidate this redox 
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signalling pathway in detail which will be a valuable clinical tool to prevent ageing and onset 
of age-related diseases.  
 
7.2 A mtH2O2 rather than a O2- signal is responsible for cellular stress response 
 
As discussed earlier, ROS are considered as a double entity; causing damage and acting as 
signalling molecules. Many studies which describe ROS as a damaging agent have been 
performed which is due to the fact that damage can be easily studied. Whereas, it is extremely 
difficult to perform experiments to study ROS as a signalling molecule due to its very short 
half-life of around 1µs to 1ms.  ROS has been shown to act as signals by modifying cysteine 
residues in proteins, changing their conformation and therefore their activity (Miki and 
Funato, 2012). This phenomenon has been described in signalling cascades like apoptosis, 
hypoxia and few other (Ray et al., 2012). To overcome the hurdles of studying ROS as a 
signalling molecule in cell culture, I have taken an in vivo approach altering ROS by genetic 
interventions. I ectopically expressed AOX in the fruit fly (Figure 3.2 A). AOX accepts 
electrons from the ubiquinone pool, thus preventing the over-reduction of the ubiquinone 
pool, the leak of electrons and the generation of ROS (Fernandez-Ayala et al., 2009). I 
hypothesize that this prevention in reduction of the ubiquinone pool caused by AOX is the 
block in the signal that is responsible for cellular stress response.  
 
Currently, there is a huge controversy in the field of ROS regarding the most appropriate 
method to measure ROS in vivo (Halliwell and Whiteman, 2004). To ascertain that AOX 
reduces the leak of electrons from the ETC and thereby reduces ROS, I measured ROS using 
four different techniques to demonstrate the change in different ROS molecules. AOX flies 
significantly reduced O2- and H2O2 levels both in vitro and ex vivo (Figure 3.2 B, C and D). 
Furthermore, I also confirmed the decrease in ROS in vivo (Figure 3.3 A and B). However, 
this reduction in ROS did not improve the damage caused to proteins (Figure 3.6). This led 
me to hypothesize that ROS might act as a signal instead of a damaging molecule. It can also 
be hypothesized that a certain level of ROS is necessary to facilitate the cellular signalling 
processes. 
 
As AOX has no proton pumping properties and can reduce proton motive force, it is possible 
that it affects ATP production. However, I measured the levels of ATP, ADP, and AMP in the 
fly and observed no changes (Figure 3.4 A and B). This can also occur because of the 
upregulation of glycolysis, which will be discussed in the following pages. Moreover, 
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feeding, locomotion or the weight of the fly were unchanged denoting that AOX expression 
did not cause any phenotypic changes (Figure 3.5 A, B and C). These results demonstrate that 
the effect of AOX predominantly alters ROS levels.  
 
AOX is upstream of the dismutation of O2- or H2O2; hence it is difficult to determine the ROS 
species involved in the signalling process. O2- is rapidly dismutated to H2O2 by Superoxide 
dismutases, like SOD1, in the intermembrane space and cytosolic compartments and SOD2, 
in the mitochondrial matrix. On the other hand, H2O2 is converted to water by many enzymes 
like CATALASE, GLUTATHIONE PEROXIDASES and PEROXIREDOXINS making the 
molecule inert. H2O2, however, when compared to O2- is less reactive and due to its neutral 
charge can diffuse through biological membranes and act in signalling far from its site of 
production. To differentiate these ROS signals, I used two different fly models.  (i) I 
ectopically expressed Catalase in the mitochondria of the fly (Figure 4.2 A) and (ii) I 
overexpressed a version of superoxide dismutase which is present in the mitochondria (Figure 
4.2 A). I demonstrated that ectopic expression of Catalase reduces H2O2 but does not alter 
levels of O2- (Figure 4.2 B and C). Sod2 overexpression on the other hand reduced levels of 
O2-and increased H2O2 levels marginally (Figure 4.2 B and C), therefore being a very valuable 
tool in studying ROS signalling. In addition to studying ROS signalling, these flies have been 
used in several labs to study their effect on lifespan. Over the last decade or two, several labs 
have demonstrated contradictory lifespan results. Overexpression of Sod2, in some studies did 
not affect the lifespan of flies and in some studies extended fly lifespan (Mockett et al., 1999; 
Mockett et al., 2010; Mockett et al., 2001). On the other hand, mitochondrial Catalase 
expression has never been demonstrated to extend lifespan of flies (Mockett et al., 2003). 
However, in mice, mitochondrial Catalase expression extended lifespan (Schriner et al., 
2005). It has to be taken into consideration the different experimental conditions used for 
these lifespan analysis e.g. diet or background that can significantly affect these results. More 
stringent conditions have to be maintained in order to demonstrate these results more 
convincingly.   
 
I observed that a reduction in mitochondrial H2O2 in flies (AOX and mitochondrial Catalase), 
caused an increase in mitochondrial density. Whereas, the increase in mitochondrial H2O2 
(Sod2) reduced mitochondrial density (Figure 3.8 A and Figure 4.4 A). Mitochondrial density 
is also a balance between mitochondrial turnover and mitochondrial biogenesis. In order to 
confirm whether there was any alteration in biogenesis, I measured Spargel and Delg levels, 
which regulate mitochondrial biogenesis in flies. I detected only a modest increase in mRNA 
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levels of Spargel in AOX flies (Figure 3.10). Furthermore, Spargel mRNA levels were 
unchanged in the mitochondrial Catalase expressing flies (Figure 4.5). I also detected a 
significant increase in mtDNA copy number, without any changes in mtDNA encoded ETC 
subunits (Figure 3.8 B, Figure 3.11 and Figure 4.4 B). These results indicate that the increase 
in mitochondrial density is caused due to accumulation of damaged mitochondria rather than 
an increase in mitochondrial biogenesis. To confirm that there is accumulation of damaged or 
respiratory deficient mitochondria, I analysed mitochondrial respiration. To begin with, I used 
whole homogenates of the AOX flies, which showed no difference in respiration when 
normalized to total protein content (Figure 3.12 A). Since I detected an increase in mitochondrial 
density, independent of mitochondrial biogenesis, it is unlikely that the mitochondrial 
bioenergetics is preserved. I then measured mitochondrial density in these homogenates used for 
respiration. When the respiration values from the homogenates were normalized to the 
mitochondrial density values instead of the total protein content, I saw a significant decrease in 
respiration of AOX flies (Figure 3.12 B). Interestingly, I observed a similar decrease in 
respiration in mtCAT flies; whereas, in Sod2 flies, mitochondrial respiration was increased upon 
normalization (Figure 4.6 A and B). This analysis of respiration was used, as it gave an 
estimation of respiration per mitochondrion. I also measured mRNA levels of UPR genes 
(Hsp’s) and glycolysis regulator (lactate dehydrogenase (ImpL3)), which were upregulated in 
response to reduction in mitochondrial H2O2 (Figure 3.13 A and Figure 4.7). These results denote 
the increase in presence of damaged mitochondria. Overall, these experiments support the 
hypothesis that an active mitochondrial H2O2 signal is required to alter mitochondrial 
bioenergetics in response to stress. 
 
Results from Figures 3.8, 4.4, 3.12 and 4.6, have demonstrated that damaged mitochondria 
accumulate when mitochondrial H2O2 is reduced; therefore, I wanted to understand the 
mechanism behind this accumulation. Since Pink1-Parkin dependent mitophagy is one of the 
major regulators of mitochondrial turnover, I analysed protein levels of Pink1 and Parkin. I 
observed that canonical Pink1-Parkin mitophagy was reduced with loss of the H2O2 signal 
(Figure 3.14 A, B and Figure 4.8 A, B). These results show that ROS; more specifically mtH2O2, 
is required to initiate mitochondrial turnover independent of the generation of oxidative damage. 
In relation to this, I demonstrated that mitochondrial H2O2 levels regulate the levels of Pink1. 
When H2O2 signalling is interrupted, Pink1 levels rapidly decay which may halt mitophagy, 
explaining the accumulation of respiratory deficient mitochondria that I observed. However, I 
did not detect any changes in the Parkin protein levels (Figure 3.14 A, B and Figure 4.8 A, B). It 
can be hypothesized that the protein levels of Parkin do not explain the activity of the protein, 
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since the phosphorylated or the redox state of the protein is not measured. Additionally, as Parkin 
is a cytosolic protein it is most likely controlled by a mediator protein that relays the ROS signal 
over to Parkin. I hypothesize that a mitochondrial H2O2 signal is essential to stabilize and 
activate Pink1. This can be achieved by an interaction between the cysteine residues in the Pink1 
protein and H2O2. On the other hand, it is also possible that Pink1 activity is regulated by kinases 
or phosphatases that are redox regulated. More experiments dissecting the hypothesis are 
however required.  
 
Through simultaneous expression analysis of 87 genes, I have demonstrated that changes in 
mitochondrial H2O2 have a consistent effect on gene expression, supporting the existence of 
different transcriptomic signatures for high and low levels of mtH2O2 (Figure 4.11 and Table 
4.1). The most significant changes in gene expression were in hypoxia and P53 signalling. These 
results are not unexpected, as hypoxia adaptation is regulated by ROS produced at Complex III 
(Bleier and Drose, 2013). Preventing over-reduction of the ubiquinone pool via expression of an 
alternative oxidase (AOX) was expected to, and did in fact, reduced mitochondrial ROS and 
lifespan of flies exposed to hypoxia. A high proportion of the transcripts up-regulated by H2O2 in 
response to high temperatures (e.g. Tsp66E, CathD or Ref (2) P) were involved in autophagy. 
Accordingly, in transgenic flies with reduced mtH2O2 levels, the autophagic response was 
attenuated (Figure 5.2). The failure of these cellular mechanism caused the flies with low 
mitochondrial H2O2 (AOX and mtCAT) to live shorter. On the other hand, flies with increased 
mitochondrial H2O2 (Sod2) lived significantly longer (Figure 3.18 and Figure 4.12). 
 
In summary, I have established several novel genetic approaches to modify the ROS levels in 
vivo in the fruit fly. Using these techniques, I have revealed alternative effects of different ROS 
molecules. I demonstrated that these ROS molecules have distinctly different roles in redox 
signalling. Moreover, I have provided evidence for the existence of a mitochondrial H2O2 signal 
in the process of canonical mitophagy. Furthermore, I have also demonstrated that interruption of 
this mtH2O2 signal disrupts the response for stress adaptation. 
 
7.3 Interaction between mitochondria and TOR 
 
TOR signalling controls many signalling cascades and has been studied for several years. 
However, a distinct list of signalling cascades that TOR controls still remains unknown. It is 
very complex as it integrates many upstream and downstream elements. Since TOR controls 
many signalling cascades, it is safe to assume it also plays an important role in mitochondrial 
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bioenergetics. It has been demonstrated that TOR signalling controls mitochondrial 
functionality, however, the vice-versa has not been very well studied. Mitochondrial ROS has 
been shown to control many downstream elements that are also controlled by TOR (Schieke 
and Finkel, 2006), but a direct control of TOR by mitochondria or mitochondrial ROS has not 
been shown. Mitochondria has also been shown to control insulin signalling and nutrient 
signalling that are upstream of TOR, but these studies have been contested since. 
Mitochondrial biogenesis is another pathway governed by TOR. TOR signalling controls the 
production of new mitochondria and mitochondrial DNA by controlling the transcription of 
PGC1α and NRF1 (described in detail in Chapter 1.24). Mitochondrial recycling is also one of 
the pathways that interact with TOR. It controls the autophagic machinery, which plays a 
major role in mitophagy (Jung et al., 2010). Even though TOR signalling has been shown to 
interact with mitochondrial functionality and vice-versa, it is still not evident how this 
happens. In summary, I have established a link between mitochondrial turnover and TOR 
activation. I have also demonstrated that mitochondria are upstream regulators of TOR. 
Additionally, I have demonstrated that mitochondrial ROS is directly linked to TOR rather 
than interacting with the downstream effectors of TOR.  
 
First, I observed transcriptional changes mainly in the insulin signalling pathway and the 
autophagy pathway when the levels of mitochondrial H2O2 was reduced (Figure 4.11). Both 
these pathways are major signalling cascades that are controlled by TOR. This was the 
primary reason for me to delve into studying the TOR signalling cascade. Secondly, I also 
observed a decrease in mitophagy, when the mitochondrial H2O2 was reduced. I hypothesized 
that TOR signalling can be disrupted, causing an autophagy dependent accumulation of 
damaged mitochondria. I observed hyper-activation of TOR signalling, confirmed by the 
increase in phosphorylation of S6K and 4E-BP (Figure 5.3 A and B). I also observed a 
decrease in autophagy, which can be linked to hyper-activation of TOR signalling (Figure 5.2 
A and B). Additionally, in order to verify that TOR signalling is modified in response to AOX 
expression, in the sense; decrease in mitochondrial ROS and mitochondrial accumulation, I 
used the inducible system as described earlier to induce or terminate AOX expression. I have 
also previously demonstrated that mitochondria accumulate in parallel to the expression of 
AOX and are reverted when the AOX expression is halted. I observed a similar activation of 
TOR signalling (Figure 5.4 A and B). However, it is still unclear if the activation of TOR is 
because of the decrease in the ROS signal or because of the increase in mitochondrial 
accumulation. 
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In order to verify if the activation of TOR was a cause or consequence of the mitochondrial 
accumulation, I checked if the upstream inhibitors of TOR were active. Initially, I verified if 
the well-described S6K feedback loop was active (Efeyan and Sabatini, 2010). This feedback 
loop is responsible for keeping the activation of TOR in check as TOR hyper-activation can 
cause cancer. I have demonstrated earlier that TOR was hyper-activated when mitochondrial 
density was increased. However, I also detected an activation of the feedback loop, as 
mentioned earlier, demonstrated by the decrease in phosphorylation of AKT, mediated by 
S6K (Figure 5.5 A and B). The decrease in phosphorylation of AKT leads to FOXO activation 
(Figure 5.5 A and C) and consequentially TOR inactivation in an AMPK-TSC2 dependent 
manner (Figure 5.6 A, B and C). The failure of the feedback loop to deactivate TOR denotes 
that the activation of TOR is persistent due to the reduction of mtH2O2 or increase in 
mitochondrial density. Figure 7.1 is a schematic representation of the TOR signalling 
pathway. 
 
I then wanted to verify if the hyper-activation of TOR is an adaptive response. In order to 
understand this, I used rapamycin to inhibit TOR in AOX flies. Rapamycin is a well-known 
drug used for the inhibition of TOR and has been shown to extend lifespan robustly in many 
organisms (Ehninger et al., 2014). As described earlier, TOR signalling was hyper-activated 
in AOX flies, which caused a reduction in lifespan (Figure 3.18 and 5.3). I fed AOX flies with 
rapamycin in order to determine if deactivation of TOR will be beneficial for these flies. 
Rapamycin efficiently inhibited TOR, improved autophagy and increased mitochondrial 
turnover (Figure 5.7, 5.8 and 5.9). However, the functionality of mitochondria was not 
rescued. Mitochondrial respiration was disrupted in AOX flies fed with rapamycin, and 
respiration was even lower than the flies that were not fed with rapamycin. When normalized 
to mitochondrial density, the difference was more evident (Figure 5.10). I hypothesize that 
this might be because of improper signalling to recycle damaged mitochondria. It is possible 
that damaged mitochondria might need a functional signal in order to be recycled and this 
signal is H2O2. In AOX flies, this signal is lost causing accumulation of mitochondria.  In 
support of this hypothesis it has been demonstrated that overexpression of ATG18 (increasing 
autophagy), significantly reduced mitochondrial density in mice, independent of PINK1 or 
PARKIN. It is very unlikely that damaged mitochondria are flagged and specifically recycled 
in this process (Chang et al., 2013). Moreover, when AOX flies are fed with rapamycin, the 
increase in autophagy can cause un-specific recycling of mitochondria, leaving behind a very 
low number of functional mitochondria. Finally, the flies fed with rapamycin lived even 
shorter than AOX flies, which demonstrated that maybe TOR activation is a necessary 
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adaptation (Figure 5.12). I also fed the AOX expressing flies with rapamycin two days a 
week. However, I did not see any improvement in the fly lifespan, and the flies had similar 
lifespan as the AOX flies without rapamycin (Figure 5.12). I hypothesize that the increase in 
TOR is a homeostatic response; improving glycolysis to compensate the presence of 
dysfunctional mitochondria and sustain energy production (Sun et al., 2011; Cheng et al., 
2014).  
 
In summary, I show evidence of persistent activation of TOR due to loss of ROS signalling 
and mitochondrial accumulation. I demonstrate that an active S6K feed-back loop is not 
enough to repress TOR signalling. I also show evidence of a mitochondrial signal that is 
absolutely essential to recycle mitochondria, without which the increase of downstream 
pathways is nullified. I have thus demonstrated a novel existing link between mitochondria 
and TOR, and that activation of TOR is determined by the mitochondria.  
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Phosphorylation dependent activation or deactivation of several proteins in the 
cascade, flow into TOR, which inturn (i) inhibits (red text in figure) 
mechanisms like autophagy and starvation-induced gene transcription and (ii) 
activates (green text in figure) mechanisms like translation and ribosome 
biosynthesis among many others. 
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Figure 7.1 A schematic of upstream elements that control TOR and 
downstream elements that TOR controls. 
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7.4 Mitochondrial turnover controls TOR signalling 
 
From experiments performed earlier, I was unable to understand how mitochondria and 
mTOR interact, i.e. I was unable to discern if mitochondrial H2O2 directly controls TOR or if 
H2O2 controls TOR by controlling mitochondrial turnover. It will indeed be very interesting to 
understand if mitochondrial accumulation is a pseudo signal that activates TOR; wherein the 
cell interprets mitochondrial accumulation as signal to promote proliferation. To test this 
hypothesis, I overexpressed two of the proteins involved in canonical mitophagy; Pink1 and 
Parkin, to restore mitophagy (Figure 6.2). 
 
Overexpression of Parkin in AOX flies restored mitochondrial turnover and reduced 
mitochondrial accumulation. However, Pink1 overexpression did not restore mitochondrial 
respiration nor did it reduce the amount of mitochondria (Figure 6.3 and 6.5). Pink1 protein 
was clearly overexpressed in the flies, confirmed by Western blot; however, since Western 
blotting technique only measured the levels of total protein, I was unable to check the activity 
of the protein. I hypothesize that overexpression of Pink1 is not enough to initiate mitophagy. 
It has been shown that auto-phosphorylation of Pink1 after mitochondrial membrane potential 
dissipation is absolutely essential for the process of mitophagy (Kondapalli et al., 2012). 
PINK1 activation after its auto phosphorylation is responsible to recruit PARKIN (Okatsu et 
al., 2012; Kondapalli et al., 2012). However, a redox dependent cysteine activation of PINK1 
has not been shown yet. I hypothesize that a mitochondrial H2O2 signal is responsible for the 
activation of Pink1 and this activation is responsible for conformational changes in the Pink1 
protein avoiding degradation of the protein. This was also confirmed by checking the Pink1 
proteins levels in the flies that have more H2O2 (Sod2). Sod2 flies had more Pink1 protein 
(Figure 4.8), which partially supports the hypothesis that the protein avoids degradation. 
However as mentioned earlier, activation of the protein was still not verified. Additionally, it 
has been shown that PARKIN needs to be recruited in order to be involved in mitophagy. This 
does not explain why Parkin overexpression increases mitochondrial turnover in AOX flies. 
However, Parkin has been shown to rescue Pink1 mutant fly phenotypes (Park et al., 2006). It 
can be hypothesized that, Parkin, when overexpressed, does not need to be recruited and 
activated by Pink1; and it can be involved in mitochondrial turnover independent of Pink1. It 
is not surprising that neither Pink1 nor Parkin overexpression in the AOX flies improved the 
mitochondrial ROS signal (Figure 6.4). These experiments also demonstrate that Parkin is 
located downstream of the mitochondrial H2O2 signal. More experiments are required in order 
to determine the intermediate protein that connects the mitochondrial H2O2 signal and 
mitochondrial turnover.   
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In order to ascertain that accumulation of defective mitochondria is directly responsible for 
the hyper-activation of TOR, I checked TOR signalling in flies overexpressing Pink1 or 
Parkin, in an AOX flies. When the turnover of mitochondria was improved with Parkin 
overexpression in AOX flies, TOR signalling was reverted back to basal levels; whereas, 
Pink1 overexpression, as described earlier, neither improved the mitochondrial turnover nor 
rescued the hyper-activation of TOR (Figure 6.7). This supports the hypothesis that 
mitochondrial turnover or accumulation is directly responsible for activation of TOR. 
Additionally, Parkin overexpression significantly improved the decrease in lifespan caused by 
AOX expression; whereas, Pink1 overexpression did not (Figure 6.8). This shows that a 
proper mitochondrial turnover is absolutely essential for survival, which in turn controls TOR 
signalling. 
 
These results demonstrate how mtH2O2 regulates mitochondrial turnover and through it the 
activation of TOR. When this pathway is disrupted, mitophagy is halted and causes an 
accumulation of damaged mitochondria. This clearly shows that mitochondrial turnover is 
instrumental for an appropriate fine-tuning of TOR signalling. Moreover, I also describe a 
mechanism of how autophagy is disrupted causing the dysfunction of the proteasome and 
consequentially the accumulation of damaged proteins. As a consequence of the reduction in 
cellular quality control, the lifespan of flies under stress is severely reduced.  
 
In summary, I have uncovered a novel mtH2O2-Pink1/Parkin-TOR pathway that provides us 
with new targets for pharmacological or dietary interventions. I have established that targeting 
this pathway is a valid therapeutic strategy that should be considered for the treatment of age-
related and mitochondrial disorders. In the near future, I aim to elucidate this redox regulated 
pathway in detail. Figure 7.2 is a summary of my research findings. 
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I hypothesize that a mitochondrial H2O2 signal initiated by the over reduction of 
ubiquinone pool is responsible for the activation of Pink1. This activation is 
responsible for the recruitment of Parkin and sequestration of mitochondria to 
the autophagosome. Mitochondrial density therefore controls the activation of 
TOR which is responsible for specific adaptations of the organism. 
Figure 7.2 Summary of research findings. 
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7.5 Future work 
 
Bringing together my findings, I have identified a central role of mitochondrial H2O2 in many 
cellular signalling processes. I have used several genetic approaches to block the ROS signal; 
like ectopic expression of AOX or ectopic expression of Catalase in the mitochondrion. Even 
though these techniques are very efficient and the results obtained are reproducible, they are 
non-physiological conditions in the fruit fly as both AOX and mitochondrial Catalase are non-
endogenous proteins. Hence it will be very interesting to see what happens if we block this 
signal physiologically, either by; (i) overexpressing any of the native antioxidants to block the 
H2O2 signal or; (ii) feed the flies with known antioxidants to supress this ROS signal. 
However, both these techniques have shortcomings; (i) Overexpressing antioxidants might 
lead to prevention of damage rather than reducing the ROS signal. Moreover, the affinity 
towards ROS for different antioxidants is different and might be very difficult or improbable 
to control. I also hypothesize that either a balance between O2- and H2O2 or a specific ratio 
between the two is absolutely essential; hence it will be extremely difficult to maintain this 
balance with transgenic overexpression; (ii) The feeding experiments are very complicated as 
I will not be able to control the amount of food that the fly has consumed, hence will be 
unable to control the concentration of the antioxidant.  
 
I have also mainly used the fly’s brain for my ROS measurement experiments; whereas, in 
other molecular experiments I have used the whole flies, which mostly contain mitochondria 
from the muscle. Hence it will be good to differentiate the tissue in my experiments. I will 
also be able to see a much more significant effect by using just the post-mitotic tissue, most 
extensively found in the thorax and head. This will be advantageous to my work as the repair 
mechanisms and the damage will be much more pronounced in these tissues and will be 
advantageous to modulate. Whereas, the abdomen of the fly contains eggs which are 
constantly undergoing cell division, therefore diluting the effect observed when whole flies 
are used. It will also be interesting to determine the cell non-autonomous signal, by altering 
the ROS signal in the brain, which may lead to a phenotypic change in the muscle of the 
organism. By using tissue specific drivers, I can express AOX or mitochondrial Catalase in 
the brain or the muscle to see if it alters mitochondrial functionality or decreases the lifespan 
of the fly, just as much as ubiquitous expression. This will be very useful as I will be able to 
determine if this ROS signal is existent in different tissues. 
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It would be interesting to determine the protein or a set of proteins that orchestrate this ROS 
signal generating from the mitochondria, through oxidative modifications. I will be able to use 
mass spectrometry and site-specific proteomic mapping to assay a set of mitochondrial 
proteins to determine selectively modified cysteine residues. This will enable to ascertain the 
fact that there is indeed a ROS signal that regulates mitochondrial functionality. Additionally, 
once the redox modification of this protein or these set of proteins are identified, I will be able 
to modify the protein in vivo in different model organisms. This will aid in understanding the 
physiological relevance and the basic biology of different signalling mechanisms. 
 
Finally, it will be essential to determine how Pink1 is activated. This can be done by mass 
spectrometry by determining if Pink1 protein has a cysteine dependent on/off switch. If this 
site is determined, Pink1 can be constitutively activated irrespective of the signal. This model 
can be used to investigate several steps involved in the signalling process. It will also be 
essential to determine how Pink1 is cleaved after deactivation. Moreover, it will be essential 
to determine the process by which TOR signalling is activated detecting the accumulation of 
damaged mitochondria. By discovering the protein or set of proteins involved in this process, 
I will be able understand in detail the mechanism by which TOR and mitochondria interact, 
opening new avenues for pharmacological interventions.  
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APPENDIX A: Summary of lifespan experiments performed in this study presented as 
mean and (maximum) lifespan in number of days.  
   29C  
Figure 3.18 daGAL4  >20(>20)  
 AOX  >20(>20)  
 daGAL4>AOX  17(19)  
P value   <0.001  
Figure 4.12 daGAL4  >20(>20)  
 mtCatalase  >20(>20)  
 daGAL4>mtCatalase  10 (20)  
P value   <0.001  
 daGAL4  33(39)  
 Sod2  36(42)  
 daGAL4>Sod2  39(46)  
P value   <0.001  
   25C  
   Hypoxia Hyperoxia 
Figure 4.13 daGAL4  19 (35) 18 (27) 
 AOX  19 (35) 18 (27) 
 daGAL4>AOX  5 (12) 13(22) 
P value   <0.001 <0.001 
 daGAL4  19 (35) 17 (22) 
 mtCatalase  18 (35) 17 (22) 
 daGAL4>mtCatalase  10 (15) 15 (20) 
P value   <0.001 <0.001 
 daGAL4  22 (38) 17 (20) 
 Sod2  27 (34) 17 (20) 
 daGAL4>Sod2  31 (45) 24 (29) 
P value   <0.001 <0.001 
Figure 5.13   
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